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Steroids play a major role in the development of the CNS with those brain areas 
involved in sexual behaviour having been the focus of most neuroendocrine 
studies to date e.g. the hypothalamus and pituitary gland (Feist and Schreck, 
1996; Mong, et al., 1999; Toran-Allerand, et al., 1980). This occurs via 
intracellular and cell-surface receptors that regulate changes in protein 
synthesis (Mensah-Nyagan, et al., 1999) to modify events related to neuronal 
survival and synapse formation (Breedlove, 1992). 
Many steroidogenesis-associated enzymes have been described in the 
cerebellum and cortex, but the impact of steroids on their development has yet 
to be investigated. A steroidal fetal programming model was utilised to 
investigate how gene expression in these two brain regions is affected by 
steroid exposure during development, and examine how this may lead to a 
change in brain architecture and function.  
The main aims of this study were to identify changes in the cerebellar 
expression of genetic markers of steroid metabolism, using quantitative real-
time polymerase chain reaction (qRT-PCR), that result from exposure to 
testosterone propionate (TP) during development in male sheep. The 
cerebellum follows a clear developmental trajectory and contains an established 
cytoarchitecture that enabled us to readily identify the effects of TP treatment on 
the developing brain by utilising histological analyses. Further alterations of 
gene expression in the developing male ovine cortex were also identified using 
microarray analysis. The results provide novel findings in regards to androgen-
sensitive gene expression in the developing ovine cerebellum and cortex but 
perhaps the most striking result was that androgen over-exposure delays 
cerebellar development, which may have consequences in later life on motor 
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1.1 The cerebellum 
1.1.1 Cerebellar structure 
The cerebellum is part of the hind brain and is divided into three lobes – the 
anterior, posterior and flocculonodular lobes (Figure 1.1). Longitudinally, the 
cerebellum has a central vermis and two lateral hemispheres (Sotelo, 2004). 
The cerebellum is covered with a cortex and embedded in its core of white 
matter, the deep nuclei provide cerebellar output. Major roles of the cerebellum 
include the coordination of voluntary movements e.g. postural and limb 
movements; and motor skills, and evidence has suggested that it also has a 




Figure 1.1: Schematic of the major anatomical subdivisions of the cerebellum. This is a superior 






The cerebellar cortex contains four main types of neurons: granule cells, 
Purkinje cells and two types of inhibitory interneurons: Golgi cells and the 
stellate/basket cells (Sotelo, 2004). The cortex receives three kinds of input: 






Figure 1.2: Schematic representation of the developed cerebellar cortex. The different 
cerebellar layers and the different types of fibres which provide the cerebellar input are 
illustrated. Taken and adapted from (Squire, et al., 2003) 
 
1.1.1.1 Cerebellar Purkinje Cells 
Purkinje cell dendrites are aligned into a flat plane and are all orientated in the 
same direction – at right angles to the long axis of the folium in which they are 
located, and their soma diameter is approximately 80m (Ohyu et al., 1997). 
Altman (1972) demonstrated that rat Purkinje cells differentiate just after birth 
and the formation of the cerebellar cortex becomes complete during neonatal 
life. This is achieved through the process of migration of external granule cells 
to the IGL (discussed in further detail below), neuronal and glial growth and 
synaptogenesis.  Purkinje cells can be identified through their large nuclei and 
cytoplasm in comparison with the other cells in the cerebellum (Salouci et al., 
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2012). The Purkinje cell‟s main function is to control the sole output of motor 
coordination in the cerebellum (Salouci et al., 2012) but it has also been 
identified as a major site for neurosteroid formation in the brain (Tsutsui, 2006). 
These neurons can produce several different neurosteroids and therefore 
Purkinje cells have served as an excellent cellular model for the study of 
neurosteroid actions in the cerebellum (Tsutsui, 2008). 
1.1.1.2 Granule Cells 
In the fetal human period, the internal granule cell layer is formed by further 
proliferation and migration of the external granule cells and is situated below the 
layer of Purkinje cells (see Figure 1.3). The lamina dissecans layer separates 
the internal granular layer from the Purkinje cells. During the inward migration of 
postmitotic granule cells, the Purkinje cells enlarge and develop dendritic trees 
(Milosevic and Zecevic, 1998). Granule cells are small in size (their soma 
diameter is approximately 10m) but are the most numerous type of neuron 
found in the cerebellum (Mulac-Jericevic, et al., 2000). Many granule cells 
synapse with a single Purkinje cell via parallel fibres (Sotelo, 2004).  
 
Figure 1.3: Diagrammatic representation of the cerebellar cortex. The external granule cell layer 
(egl) is where granule cells migrate towards the inner granule cell layer (igl). Granule cells form 
synapses with Golgi cells in the molecular layer. Stellate/basket cells in the molecular layers 
form inhibitory synapses with Pk cells. Diagram taken and adapted from (Schilling et al., 2008). 
5 
 
1.1.1.3 Golgi Cells 
Golgi cells are inhibitory interneurons that are found within the granule cell layer 
of the cerebellum. These cells synapse onto the dendrites of granule cells and 
receive excitatory input from mossy fibres, and parallel fibres, that are long 
granule cell axons (Wall, 2003) . This circuitry allows for feed-forward and feed-
back inhibition of granule cells. The Golgi cell acts by altering the mossy fibre - 
granule cell synapse using GABA as its transmitter and is therefore GABAergic. 
1.1.1.4 Stellate/Basket Cells 
Basket cells project to the Purkinje cell bodies whereas stellate cells project to 
the more distant dendritic shafts (Schilling et al., 2008). These cells are 
GABAergic inhibitory neurons. It is thought that basket and stellate cells 
differentiate as follows: the first cells secure highly adhesive Purkinje cell 
territories around the axon hillock and cell body whereas cells which reach 
Purkinje cells later on have to settle for less adhesive distal dendritic shafts 
(Voogd and Glickstein, 1998). Those molecular layer interneurons which arrive 
first in the molecular layer settle in the lower molecular layer (Altman and Bayer, 
1997) and it has been suggested that this is where basket cells reside, cells that 
arrive later in the molecular layer and settle more superficially, attach to more 
distal dendrites i.e. stellate cells. 
1.1.2 Gene products that facilitate the development of the cerebellum 
1.1.2.1 BDNF 
BDNF is a critical neurotrophin that regulates cell differentiation, cell survival, 
neurotransmission, and synaptic plasticity in the CNS (Numakawa, 2010). 
Estrogens stimulate the production of nerve growth factors, such as brain-
derived neurotrophic factor (BDNF) and enhance neuronal survival (Beyer, 
1999). Morrison and Mason (1998) demonstrated the complexities of the 
relationship between BDNF exposure and Purkinje cell development and 
survival. Some extra BDNF may boost survival, but too much BDNF triggers 
excess glutamate production that can become toxic to the Purkinje cells. In the 
current study, BDNF mRNA expression will be evaluated, in order to determine 
whether prenatal androgen over-exposure alters the expression of this gene in 
the fetal cerebellum which may ultimately have consequences on cerebellar 
development. There is also evidence to suggest that neurons that fail to grow or 
migrate to their appointed sites or are unable to make the right synaptic 
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connections can have drastic effects in later life. For example, schizophrenia is 
thought to be a neurodevelopmental disorder with its origin during the critical 
phases of gestational life (Lewis and Levitt, 2002).  
1.1.2.2 FOS 
FOS is involved in cell differentiation including synaptogenesis of granule cell 
dendrites with mossy fibers and parallel fiber contacts with Purkinje cell spines 
(Chen, et al., 1998). Therefore, FOS is a marker of neuronal activation in the 
cerebellum (Chen, et al., 2005). Neal and Wade (2007) demonstrated that 
testosterone exposure negatively regulates FOS expression in the amygdala of 
adult male green anole lizards, which implies that there could be a decline in 
neuronal activity. The current study has investigated whether FOS expression is 
regulated by testosterone in the developing ovine cerebellum. 
1.1.2.3 GAD1 
GABA synthesis in mammals is catalyzed by the two isoforms of glutamate 
decarboxylase (GAD) encoded by the GAD1 and GAD2 genes (Erlander et al., 
1991). Coordinated regulation of the GAD1 and GAD2 genes is essential for the 
proper differentiation of GABAergic neurons. GAD1 is expressed abundantly in 
Purkinje cells of the cerebellum and is a common Purkinje cell marker (Chan-
Palay et al., 1981). In the present study, GAD1 has been utilised as a Purkinje 
cell marker for gene expression studies. 
1.1.2.4 GFAP 
Glial cells are crucial in the development of the nervous system and are 
involved processes such as synaptic plasticity and synaptogenesis (Ullian et al., 
2004). Glial fibrillary acidic protein (GFAP) is a member of the intermediate 
filament family that provides support and strength to cells. Several molecules of 
GFAP protein bind together to form the main intermediate filament found in 
specialized brain cells called astrocytes. Astrocytes are star-shaped cells that 
support the functions of nerve cells in the central nervous system 
(Westmoreland et al., 2001). Testosterone has been shown to down-regulate 
GFAP mRNA expression in facial nuclei of adult male hamsters (Jones et al., 
1997) which implies that this gene can be modulated by steroids. The current 
study will utilise GFAP as a glial marker, in order to determine if there are any 
alterations in gene expression caused by excess testosterone in utero. 
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1.2 The cortex  
1.2.1 Structure and function 
The general function of the cortex is the temporal organisation of actions toward 
biological or cognitive goals, such as the execution of all forms of action 
(somatic movement, eye movement, emotional behaviour, intellectual 
performance and speech (Fuster, 1997). The cortex, the lateral region in 
particular, specialises in the temporal structuring of new and complex goal-
directed series of actions, whether in the form of behaviour, speech, or 
reasoning. Furthermore, the participation of the cortex in the choice between 
alternatives, in decision making, and in executing temporally structured actions 
are the reasons that the cortex has also been considered the “central executive” 
(Fuster, 2002).  
Humans and other primates are characterized by a markedly prolonged period 
of postnatal brain development during which cultural traditions and practices, 
including language, are acquired. In humans, a relatively large proportion of 
brain size growth takes place postnatally, allowing for social and environmental 
factors to powerfully impact the establishment of neural connectivity (Teffer and 
Semendeferi, 2012). Macaque monkeys have been studied most extensively as 
a comparative model of neurodevelopment as they are born with brains that are 
already around 70% of adult mass. In sheep, brain mass has reached 50% 
adult size at birth (McIntosh et al., 1979); whereas in humans, only 
approximately 25% of adult mass is achieved at birth (Robson and Wood, 2008). 
Figure 1.4 depicts a schematic diagram of a developed brain with annotations of 






Figure 1.4:  Schematic diagram of the brain. Here, it depicts the location of the cortex (frontal, 
parietal and occipital lobes). Taken and adapted from CNSForum.com 
1.2.1.1 Cortex layers 
The isocortex consists of up to six well-defined layers of cells (Figure 1.5). The 
outermost molecular or plexiform layer (I) contains nonspecific afferent fibres 
that come from within the cortex or from the thalamus. The external granular 
layer (II) is a dense layer composed of small pyramidal and stellate cells. The 
external pyramidal layer (III) contains pyramidal cells, frequently in row 
formation. The internal granular layer (IV) is usually a thin layer with closely 
packed stellate cells. The internal pyramidal or ganglionic layer (V) contains, in 
most areas, pyramidal cells that are fewer in number but larger in size than 
those in the external pyramidal layer. These cells project to distal structures (eg, 
brain stem and spinal cord). The fusiform (multiform) layer (VI) consists of 
irregular fusiform cells whose axons enter the adjacent white matter.   
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Figure 1.5: Schematic diagram of cytoarchitecture of a developed cortex. This represents the 
cells types that are located in each cortex layer. A) A typical Golgi neuronal stain B) A typical 
Nissl cellular stain. Taken and adapted from McGraw-Hill (2006). 
1.2.1.2 Pyramidal cells 
Pyramidal cells are the output neurons of the cerebrum (Elston et al., 2009). 
They transmit signals to other parts of the central nervous system (CNS). 
Pyramidal cells are tall and conical, triangular in tissue sections. Their apex 
points toward the brain surface and has a thick dendrite with many branches, 
and small, knobby dendritic spines. The base gives rise to horizontally oriented 
dendrites, and an axon that passes into the white matter. Their axons have 
collaterals that synapse with other neurons in the cortex or in deeper regions of 




1.3 Fetal brain development 
The fetal period of human development extends from gestational week (GW) 9 
through to the end of gestation (Stiles, 2008). The gross morphology of the 
developing brain undergoes drastic changes during this time. The human brain 
begins as a smooth structure (lissencephalic) and gradually develops the 
characteristic mature pattern of gyral and sulcal folding. The formation of gyri 
and sulci follows an orderly sequence. Primary sulci are first seen as grooves 
positioned in specifically targeted brain regions, secondary branches then begin 
to form off the primary sulci, followed later by the tertiary branches (Morange, 
2001). The first fissure to form is the longitudinal fissure that separates two 
cerebral hemispheres. Its development begins in rostral regions as early as GW 
8  and proceeds caudally until it is complete at GW 22 (Stiles and Jernigan, 
2010). Different populations of neurons form gray matter structures in many 
regions of the brain including hindbrain and spinal column, cerebellum, midbrain 
structures, deep subcortical nuclei and the neocortex.  
1.3.1 Prenatal period  
Much of brain development in the fetal period centres on the processes of 
neuron production, migration and differentiation. The changes that occur in the 
gross anatomy of the fetal brain reflect dramatic changes occurring at the 
cellular level. 
1.3.1.1 Neuron production 
Neuron production begins in the embryonic period at GW 6, and extends 
through mid-gestation in most brain areas (Stiles and Jernigan, 2010) . At the 
very centre of the brain are a series of interconnected cavities that form the 
ventricular system of the brain. The ventricular system is filled with cerebral 
spinal fluid (Bering, 1955). The ventricular system has a number of important 
functions including cushioning and protection of the brain, removal of waste 
material, and transport of hormones and other substances (Brodal, 2010). 
During brain development the walls of the ventricles are the site of most neuron 
production. Soon after neurons are produced, neurons migrate away from the 
proliferative regions of the ventricular zone (Clancy et al., 2001).  
The first step in neuron production involves increasing the size of the neural 
progenitor cell population. Neural progenitors are a mitotic population of cells, 
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that is, they can divide to form new cells. Neurons are post-mitotic cells; once 
formed they are no longer capable of dividing and producing new cells (Stiles, 
2008) 
1.3.1.2 Neuron migration 
1.3.1.2.1 The cerebellum 
The cerebellum develops over a long time, from the early gestational period 
until the first postnatal years in sheep (Petratos et al., 2000), however ovine 
cerebellar development is not as well characterised as humans, rodents and 
primates. In general, the three key steps involved in the development of the 
cerebellum are: the formation of two proliferative compartments (the ventricular 
zone, VZ, and rhombic lip), inward migration of granule cells from the external 
to the internal granule cell layer, and the formation of cerebellar circuitry (Luo et 
al., 2001). The main cell types of the cerebellum appear at different times of 
development and at different locations. Purkinje cells and the deep cerebellar 
nuclei arise from the VZ of the metencephalic alar plate (Chan-Palay et al., 
1981), Figure 1.6, whereas  granule cells are generated from the rostral part of 
the rhombic lip, known as the upper rhombic lip (Fink, et al., 2006).  
Before migration begins, projections known as parallel fibres arise from granule 
cells. The parallel fibres synapse with Purkinje cells and mossy fibres (the 
axons of the dorsal spinocerebellar, cuneocerebellar, vestibulocerebellar and 
pontocerebellar tracts) and extend further with time as the molecular layer forms 
from the deep external granule layer (EGL) and pre-migratory zone. Another 
type of cerebellar inout comes from climbing fibers which arise from the inferior 
olivary nucleus. In the cerebellum, terminally differentiating granule cell neurons 
express the genes required for migration to the internal granule layer (IGL), 
such as GABRA6 (Wang et al., 2004). Similar genes may be involved in 
determining the cell fate of cortex cell precursors such as Unc5H3, and Netrin-1 




   
Figure 1.6: Mouse cerebellar neurogenesis. A schematic midsagittal section of mouse 
cerebellum at day of birth. The Purkinje cell layer (PCL) is located underneath the EGL and 
secretes Sonic hedgehog (Shh) which is received by EGL cells and drives their extensive 
proliferation such that granule cells become the most abundant neurons in the cerebellum and 
in the entire brain. Upon differentiation, EGL cells migrate through the PCL layer to form the IGL 
of the mature cerebellum. Their trailing axons form, the molecular layer (ML). Purkinje cells 
project into the cerebellar white matter (WM). choroid plexus (CPe) is a nerve complex localized 
in the ventricular system of the brain and form one of the interfaces between the blood and the 
CNS .Taken and adapted from (Millen and Gleeson, 2008). 
After birth, between the second and fourth post-natal days (PND 2–PND 4) in 
mice, a number of signalling pathways promote granule cell precursor 
proliferation (Wechsler-Reya and Scott, 1999). Between birth and the end of the 
second postnatal week, granule cell precursors exit the cell cycle and move into 
the inner regions of the EGL where they extend parallel fibers and migrate 
along the radial fibres of Bergmann glial cells (Edmondson and Hatten, 1987) to 
a position beneath the Purkinje cells, where they form the IGL.  
The development of the cerebellum is a complex process that requires the 
rather precise orchestration of multiple biological processes, such as the 
proliferation, migration, apoptosis, and differentiation of multiple cell types 
(Hatten and Heintz, 1995). The proliferation of external granule cells (EGCs) is 
promoted by factors secreted from Purkinje cells such as sonic hedgehog (Shh) 
(Wechsler-Reya and Scott, 1999) and the migration of Purkinje cells is 
regulated by factors secreted from the EGL, such as Reelin (Jensen et al., 
2002). Therefore, the accurate migration and survival of a subset of Purkinje 
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cells is essential for normal cerebellar development, including the generation of 
sufficient numbers of granule cells. The importance of Purkinje cells in these 
events was demonstrated by Yuasa et al, (1993) and Miyata et al., (1997) 
whereby Reelin null mice exhibited a reduced proliferation of EGCs in the face 
of aberrant Purkinje cell migration.  
1.3.1.2.1.1 Synaptogenesis 
Cerebellar synaptogenesis begins on embryonic day 19 in rodents (Altman and 
Bayer, 1997). The cerebellar cortex receives two classes of excitatory inputs: 
mossy fibres and climbing fibres (Ito, 2006). Mossy fibres originate in the spinal 
cord and brainstem whereas climbing fibres are the axons of inferior olive 
neurons. Mossy fibres convey sensory information from various body parts and 
motor commands from the upper centres. These signals are transferred to 
granule cells via glutamatergic (excitatory) synapses. The axons of granules 
cells (parallel fibres) give off their branches running laterally in the molecular 
layer of the cerebellar cortex (Ito, 2002). Purkinje cells spread huge, flat 
dendritic arbors along the parasagittal planes in the molecular layer. Each 
Purkinje cell receives excitatory synaptic inputs from more than 100,000 parallel 
fibress. Purkinje cells integrate sensory information and motor commands 
through summation of parallel fibre inputs. Parallel fibres also form 
glutamatergic synapses on interneurons in the cerebellar cortex, such as the 
Golgi cell, stellate cell and basket cell (Goto et al., 2006). Golgi cells form 
inhibitory synapses on the synaptic terminals of mossy fibres. The parallel fibre-
Golgi cell-mossy fibre loop circuitry imposes feedback inhibition, which 
attenuates glutamate release by the parallel fibres. Stellate and basket cells 
form inhibitory synapses on Purkinje cells (Kano et al., 2002). Deep cerebellar 
nuclei integrate excitatory synaptic inputs from mossy fibres and inhibitory 
synaptic inputs from Purkinje cells, and send the integrated signals directly to 
the nuclei and indirectly to the primary motor cortex and premotor cortex, via the 
thalamus. The cerebellum influences the regulatory actions of these nuclei and 
cortices on the descending motor system, and thereby contributes to motor 
coordination and motor accuracy. Plasticity at synapses upstream of Purkinje 
cells changes the transferring efficacy of sensory information and motor 
commands to Purkinje cells. Plasticity of synapses on Purkinje cells and deep 
cerebllar nuclei changes the manner of signal integration in these neurons (Ito, 
2001). Cerebellar synaptic plasticity may thereby further improve motor 
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coordination and motor accuracy, and contribute to the acquisition of new motor 
skills. 
 
1.3.1.2.2 The cortex 
The cerebral cortex arises from a sheet of undifferentiated neuroepithelial cells 
that line the lateral ventricle of the dorsal telencephalon. Most neurons are 
produced in the VZ and migrate radially from the VZ in the centre of the brain 
out to the developing cortex (Clancy et al., 2001). Very early in neocortical 
development the distances the neuron must cross are small. Thus the earliest 
produced neurons can use a mode of migration referred to as somal 
translocation (Nadarajah and Parnavelas, 2002). In somal translocation the 
neuron extends a long basal process, which is an extension of the cell body, 
just beyond the edge of the VZ into the outer region of the brain compartment. 
The basal process attaches to the pial surface, the outer surface of the 
developing brain (Miyata et al., 2010). The nucleus of the cell then moves 
through cytoplasm of the basal process. As the nucleus moves up the process 
becomes shorter and thicker but remains attached to the pial surface. At the 
end of somal translocation the nucleus of the cell has moved out of the VZ and 





Figure 1.7: Different modes of neuronal migration to the neocortex. A) Neuron migration by 
somal translocation where cell extends a cytoplasmic process and attaches to the outside of the 
braincompartment (pial surface), and then the nucleus moves up into the brain area. B) Neuron 
migraton radial glial guide. Radial glial provides scaffold for neuron to migrate along. C) Neuron 
migration from second proliferative zone in ganglionic eminences by tangential migration 
(arrows indicate direction of migration for different neuron populations). A and B taken and 
adapted from Nadarajah et al., (2003). C taken and adapted from Stiles (2008). 
 
The earliest produced neurons migrate to the deepest cortical layers. 
Subsequently migrating neurons migrate to successively more superficial layers 
creating an inside out order of migration (Cooper, 2008). The first neurons 
migrate from the ventricular zone (VZ) to form the preplate (PP). The next 
neurons split the PP into the marginal zone (MZ) and the subplate (SP), which 
are both transient brain structures. The mature brain has six well developed 
cortical layers (I-VI), but none of the embryonic structures (MZ, SP, VZ). The 
intermediate zone (IZ) has become a mature white matter layer (WM). The 
neurons that form the neocortex migrate in an orderly fashion forming the six-
layered neocortical mantel. Once positioned in the cortex, neurons begin to 
differentiate producing neurotransmitter and neurotrophic factors, and extending 
the dendritic and axonal processes that form fibre pathways of the brain neural 
networks. 
On arrival in the cortical plate, cells assume progressively more superficial 
positions to form the six layers of the adult cortex in an inside-first, outside-last 
sequence. The laminar identity of deep layer neurons is determined by cues in 
the ventricular zone, just prior to final mitotic division (McConnell and 
Kaznowski, 1991). In humans, the primary sulci of the prefrontal cortex develop 
during GW 25–26 (Stiles and Jernigan, 2010). In the dorsolateral and lateral 
prefrontal cortex, basic features of the dendritic arbors of pyramidal neurons 
emerge during GW 17–25 (Mrzljak et al., 1988). From GW 26 to 34, layer III and 
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V dendrites continue to mature, as spines develop, basal dendritic length 
increases, and interneurons differentiate in layer IV (Mrzljak et al., 1992). 
1.3.1.2.2.1 Synaptogenesis 
The process of synaptogenesis, where new synapses are formed, begins in 
utero at around the 20th gestational week in humans (Stiles and Jernigan, 
2010). The formation and organisation of synapses in the cortex increases after 
birth, reaches a peak, and is followed by pruning and decline. Neurons are born, 
migrate to their appropriate cerebral region, mature, and form synapses. 
Throughout childhood and adolescence, brain development is characterized by 
both growth and then decline in gray matter volume, and increases in white 
matter volume.  
Synaptogenesis occurs later in the cortex than it does in other areas. The 
middle frontal gyrus of the cortex reaches peak synaptic density late in infancy 
at 3.5 years, while auditory and visual cortex attains peak density at 3 months 
(Huttenlocher and Dabholkar, 1997). At the age of 3 months, synaptic density in 
the cortex is less than half of what it will eventually reach, and synapse 
elimination persists throughout adolescence. In humans, peak synapse density 
occurs in mid-childhood around 5 years of age (Huttenlocher and Dabholkar, 
1997), with the pruning of synapses extending into the third decade of life 
(Petanjek et al., 2011). In contrast, in macaques, synapse density peaks during 
infancy at around 3 months of age, and pruning of excess synapses into more 
efficient synaptic configurations, is completed by the end of adolescence (Liu et 
al., 2003). There appears to be no literature that examines this development in 
sheep to date.  
1.3.1.3 Neuron differentiation 
Once the neurons have reached their target region of the brain, the young 
neurons need to become part of information processing networks. In order to 
become integrated into neural networks, the neurons need to develop neuronal 
processes (axons and dendrites) that allow them to communicate with other 
neurons. Axons are the principal means of sending signals from the neuron, 
while dendrites are major sites for receiving input from other neurons. Each cell 
has many dendrites that form dense “arbors” in the immediate vicinity of the cell, 
and a single axon that can extend for some distance away from the cell. During 
development, the tip of each axon is a structure called a growth cone. The 
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growth cone is the site of axon elongation and extension (Brown, 2001). As the 
axon is extended, the growth cone inspects the local environment for guidance 
molecules that direct the axon toward its target. Some guidance cues are 
attractive and signal movement toward a source, whereas others are repulsive 
and guide movement away. Once the axon has reached its target, connections 
called synapses are formed with the target cell. Synapses allow for the 
transmission of electrochemical information which is the essential means of 
communication in the brain. 
1.3.1.4 Regressive events – fetal period 
Neuronal numbers are influenced by two opposing processes: early proliferation 
in germinal centres and apoptosis throughout development and aging. Neuron 
production is adjusted during development via neuronal interactions that select 
a subset of precursor neurons for proper functional development of the central 
nervous system. Evidence of naturally occurring neuronal death during nervous 
system development has been reported in numerous populations of neurons 
(Oppenheim et al., 1999; Pettmann and Henderson, 1998; Williams and Herrup, 
1988). Variations in programmed neuronal cell death patterns have been 
observed within homologous populations in different species and even within 
individual groups of neurons. In addition, environmental, aging, and nutritional 
factors influence the patterns of naturally occurring cell death in the nervous 
system.  
While most neurodevelopmental events involve the proliferation of neurons, two 
important processes involve substantial loss of neural elements. In humans, the 
first process is apoptosis (programmed cell death) involves the normal loss of 
50% or more of the neurons within a brain region (Stiles and Jernigan, 2010). 
The second process in humans involves synaptic exuberance and pruning, in 
which there is massive excess production of connections followed by the 
systematic elimination of up to 50% of those connections. This process tends to 
occur post-natally (Bourgeois and Rakic, 1993).  Both of these processes reflect 
non-pathological events that play an essential role in establishing the complex 





Apoptosis is a distinct form of cell death that comprises a highly regulated 
sequence of physiological events. It involves a cascade of gene expression that 
ultimately results in the breakdown of nuclear chromatin (DNA and support 
proteins) and the fragmenting of the cell (Roth and D'Sa, 2001). All neurons and 
neural progenitor cells have this intrinsic “suicide” program. The set of genes 
involved in the apoptotic cascade is vast, but very specific, with each molecular 
signal triggering the next step in the cascade (Blomgren et al., 2007). A wide 
variety of cell intrinsic and environmental factors can influence the apoptotic 
process. Some trigger cell death, while others protect the cell by preventing the 
cascade. Apoptosis has been documented within all of the neuronal and neural  
progenitor cell compartments in the human brain (Rakic, 2000).  
Apoptosis is a common feature in the development of many types of neurons. In 
vertebrate species, neuronal cell death mechanisms have been associated with 
a variety of developmental roles, including the elimination of errors of axonal 
projection or cell position (Cowan et al., 1984; Denton et al., 1985; Lamb, 1979, 
1981), the target-dependent matching of the sizes of the pre- and postsynaptic 
populations (Lanser and Fallon, 1984, 1987; Tanaka and Landmesser, 1986; 
Vogel et al., 1989), and sculpting of neuronal circuits, both during development 
and in the adult (Bottjer and Johnson, 1992; Finlay, 1992). 
One factor that protects cells against apoptosis is the uptake of neurotrophic 
substances (Levi-Montalcini, 1964; Oppenheim, 1989). Neurotrophic factors are 
produced by target neurons at synaptic sites, and are taken up by the afferent 
neurons that make effective connections with the targets (Huang and Reichardt, 
2001). During development, it is thought that neurons compete for neurotrophic 
resources. Neurons that establish effective connections are able to obtain more 
neurotrophic factor and are more likely to survive (Oppenheim, 1989). Thus, 
one important function of cell death in brain development is its role in regulating 
the establishment of effective and functional neural circuits (Buss, et al., 2006). 
Apoptosis may play as vital a role in the shaping of the adult organism by cell 
division, migration, and differentiation. Furthermore, cell death mechanisms 
must be regulated throughout life as failure to inhibit or promote cell death may 
lead to degenerative diseases, cancer or autoimmune diseases (Bowen 1993; 
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Kerr, et al. 1994). Considerable progress has been made in understanding the 
molecular mechanisms of apoptosis, with the isolation of a number of genes 
associated with apoptosis (Boise et al., 1993; Farrow et al., 1995; Gagliardini et 
al., 1994; Hengartner and Horvitz, 1994; Oltvai et al., 1993; Yuan et al., 1993) 
Because postmitotic neurons cannot replicate, the developing nervous system 
has only two general mechanisms for controlling neuronal cell number, detailed 
by Williams and Herrup (1988):- 1) the regulation of the number of neurons that 
are generated or committed to a particular phenotype or 2) the regulation of the 
extent of programmed cell death. 
1.3.1.5 Postnatal period 
Though the production and migration of neurons are largely prenatal events, 
proliferation and migration of glial progenitors continues for an extended period 
after birth, and the differentiation and maturation of these cells continue 
throughout childhood. There is little doubt that these processes play a critical 
role in the functional maturation of developing neural circuits. Ongoing research 
continues to uncover additional molecular interactions between neurons, 
oligodendrocytes, and astrocytes. The existence of these interactions implies 
that the late maturation of glial populations probably has widespread functional 
implications. 
1.3.1.5.1 Postnatal proliferation and migration 
In the postnatal period, neurogenesis continues to only a very limited degree. 
The subventricular zone (SVZ) serves as a source of neural stem cells in the 
process of adult neurogenesis. This zone harbors the largest population of 
proliferating cells in the adult brain of rodents, monkeys and humans (Gates et 
al., 1995).  
Abraham, et al. (2001) examined cell proliferation in the human cerebellar 
cortex between the 24th gestational week (approximately GD 85 in sheep) and 
the 12th postnatal month. Intensive cell formation has been found in the EGL of 
the human cerebellum, where the highest cell proliferation rate occurs between 
the 28th and 34th gestational weeks (approximately GD 95-110 in sheep). This 
was followed by a gradual decrease that lasts up to the eighth postnatal month. 
As late in development as the fifth postnatal month, 30% of cells of the EGL are 
still proliferating. The width of the EGL remained unchanged from the 28 th 
gestational week to the end of the first postnatal month, when it starts to 
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decrease and completely disappears by the 11th postnatal month. A large 
number of cells labelled with Ki-67, a marker of proliferation, occur in the IGL 
between the 24th and 28th gestational weeks (approximately GD 85-105 in 
sheep). From the 36th week onwards (approximately GD 120 in sheep), the 
labelling index was less than 1%, although a few labelled cells have always 
been found in this layer even in the late postnatal period. Labelled cells are 
distributed in the entire width of the IGL. However, from the 34th gestational 
week (approximately GD 110 in sheep), almost all labelled cells are found 
among and directly below the Purkinje cells. This study has provided insight into 
the typical proliferation of cerebellar cells during development and beyond. 
The development of some peripheral and central nervous system tissue does 
not appear to include a major role for cell removal via apoptosis. In many brain 
subregions, including the cerebellum, the contribution of neuronal cell death 
during maturation remains to be accurately characterized. The central role of 
Purkinje cells in cerebellar development raises questions about the 
mechanisms regulating Purkinje cell organisation and number. Vogel et al. 
(1991) suggested that Purkinje cell number is fixed by a genetic program that 
controls the number of Purkinje cells generated by a small number of founder 
progenitor cells. There is little knowledge about whether prenatal steroidal 
exposure affects apoptosis and/or proliferation in a Purkinje cell population. 
1.3.1.5.2 Myelination 
The efficiency of information transmission in neural pathways is greatly 
enhanced by myelin which acts as a sheath that covers and electrically 
insulates the axons. Myelin is a fatty substance that is white in appearance, 
hence the name white matter (Deoni et al., 2011). In humans, myelination 
begins in the 14th week of fetal development, although little myelin exists in the 
brain at the time of birth. During infancy, myelination occurs quickly, leading to a 
child's fast development, including crawling and walking in the first year. 
Myelination continues through the adolescent stage of life (Dangata & Kaufman, 
1997). Myelination enables nerve cells to transmit information faster and allows 
for more complex brain processes. Thus, the process is vitally important to 
healthy central nervous system functioning. During adolescence, myelination 
mainly occurs in the cortex and aids in cognitive development and in particular, 
it enables better executive functioning (Sowell et al., 2003). Schwann cells are a 
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type of glial cells in the peripheral nervous system that wrap some neuronal 
axons to form the myelin sheath. Oligodendrocytes and Schwann cells indirectly 
assist in the conduction of impulses as myelinated nerves can conduct impulses 
quicker than unmyelinated ones (Bhatheja & Field, 2006). Jung-Testas & 
Baulieu (1998) suggested that Schwann cells, and the other types of glial cells, 
are targets for steroid hormones as they expression steroid hormone receptors 





1.3.1.6 Regressive events occurring post-natally 
1.3.1.6.1 Apoptosis – glial populations 
Brain development involves overproduction of neurons and glial cells, neural 
processes, and synapses. Although neural apoptosis peaks during prenatal life 
in humans, apoptosis in glial cell populations has a time course corresponding 
to the protracted differentiation from glial precursors. During the period of initial 
myelination, many excess oligodendrocytes undergo apoptosis a few days after 
differentiating, and there is evidence that this process depends on signals from 
nearby axons, such that the number of surviving oligodendrocytes matches the 
local axonal surface area (McTigue and Tripathi, 2008). 
1.3.1.6.2 Synaptic pruning 
The major mechanism for generating diversity of neuronal connections beyond 
their genetic determination is the activity-dependent stabilisation and selective 
elimination of the initially overproduced synapses (Changeux and Danchin, 
1976). The largest number of synapses has been recorded in the cerebral 
cortex of human and nonhuman primates. It is generally accepted that synaptic 
pruning in the cerebral cortex occurs at puberty and is completed during early 
adolescence in humans (Huttenlocher, 1979). 
Two features of cerebral development are very important for understanding how 
experiences can modify cortical organisation. Firstly, dendritic spine density, 
which is an approximate surrogate for the number of excitatory synapses on a 
neuron, is two to three-fold greater in childhood than in adulthood. This 
overproduction of synapses is reversed beginning in late childhood, and in the 
cortex, it continues well into the third decade of life (Petanjek et al., 2011). 
Secondly, the overproduction of spines is greatest in the cortex, which then 
shows the slowest rate of synapse elimination (Elston et al., 2009). This 
extraordinarily long period of synapse elimination in the cortex has implications 
for understanding the environmental influences in puberty on adult cognitive 
capacities. Nonetheless, the period of synapse production may be as important 
in understanding adult cognitive and emotional capacities as the later 
adolescent pruning. It has been argued that it is in the period from early 
childhood to kindergarten in which the cortex forms the basic neural circuitry 
that will later underlie higher cognitive functions (Tsujimoto, 2008). Experiences 
early in life can therefore lay down the basic circuitry that is modified in 
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adolescence. Early experiences (aversive or other) set up the cortex trajectories 







1.4.1 Steroidogenesis and hormone receptor signalling  
Estradiol, progesterone, and testosterone are all steroid hormones synthesised 
from cholesterol. These hormones are best known for their role in sexual 
behaviour in adult humans and animals (Roselli et al., 2006). However, they 
also play an active role in the normal development of the CNS (Tsutsui, 2006). 
Steroidogenesis begins when cholesterol is transferred from the outer 
mitochondrial membrane to the inner mitochondrial membrane by the 
steroidogenic acute regulatory protein (StAR) which is the rate-limiting step in 
steroid production (Dean and McCarthy, 2008).  StAR is expressed in Purkinje 
cells of adult rats (Furukawa et al., 1998), suggesting a role in steroid 
biosynthesis in the cerebellum. Once inside the mitochondrion, cholesterol is 
then cleaved to form pregnenolone, a steroid hormone precursor, by the 
enzymatic actions of P450scc (CYP11A1, Stocco and Clark, 1996). P450scc is 
expressed in Purkinje cells of fetal sheep (Petratos et al., 2000), further 
evidence that steroidogenesis occurs in the cerebellum. 
 
Steroid hormone receptors are known to regulate neuronal function and act as 
transcription factors. The classical signalling pathway involves binding of 
hormone to its receptor, resulting in the formation of a hormone-receptor 
complex. This complex then binds to specific DNA sequences known as a 
response element, which in turn regulates the expression of steroid responsive 




1.4.1.1 The aromatase pathway 
Testosterone is the ligand for the androgen receptor (AR). AR signalling has 
been shown to occur in the hypothalamus, and in the granule and Purkinje cells 
of the cerebellum (Chang et al., 1995). An example of AR signalling occurring 
within the cerebellum was detailed by Ahlbom et al. (2001), who found that 
when testosterone binds to AR in cultured cerebellar granule cells, these cells 
were protected against oxidative stress. Testosterone decreased cell death 
induced by hydrogen peroxide, a reactive oxygen species, by increasing 
catalase activity, the enzyme which breaks it down. Ahlbom et al. (2001) also 
examined estrogen treatment, which demonstrated no protective effects against 
oxidative stress and went on to show that flutamide, an AR antagonist, blocked 
the AR-mediated protective effect. Therefore, this study concluded that the 
protective action of testosterone was due to the AR-mediated direct action of 
testosterone. 
 
In the brain, androgens can be metabolised by two different major pathways. 
First is the aromatase (CYP19) pathway (Figure 1.8). This pathway involves the 
conversion of testosterone into estradiol via the actions of aromatase 
(Balthazart and Foidart, 1993), encoded by CYP19 gene. Aromatase is 
expressed in neuronal cells of the cerebellum, amongst other areas of the 
rodent brain (Lephart et al., 1996).  
 
Estradiol acts on the estrogen receptor (ER). There are two isoforms of ER – 
alpha and beta (ERand ER). ERis weakly expressed in the developing rat 
cerebellum with no expression found in the adult (Beyer, 1999). This indicates 
that ER may have a role in the regulation of early prenatal brain differentiation 
and development (Belcher, 1999).  ER is also expressed in the developing 
fetal sheep cerebellum (Schaub et al., 2008). Both isoforms bind to estradiol 
with high affinity however they appear to have different functions. ER mediates 
estradiol-dependant activation of transcription whereas ER, caused inhibition 
of transcription (Paech et al., 1997), thus suggests important differences in the 
gene regulatory functions of these isoforms. Estradiol also impacts on brain 
regions involved in non-sexual motorised and cognitive functions i.e. the 




1.4.1.2 The 5-reductase pathway 
Androgens are also metabolised via the 5-reductase pathway (Figure 1.8).  
Here testosterone (T) is converted into dihydrotestosterone (DHT) and 
progesterone into dihydroprogesterone (DHP). Two isoforms have been 
discovered for 5-reductase – 5-R type 1 and 5-R type 2. SRD5a1 (the gene 
encoding 5-reductase 1) mRNA expression has been found in the cerebellum 
of adult humans (Thigpen et al., 1993) and there is evidence that SRD5a2 (the 
gene encoding 5-reductase 2) is expressed in fetal sheep cerebellum 
(Petratos et al., 2000). 
1.4.1.3 The progesterone pathway 
Progesterone is synthesised from pregnenolone by HSD3 (Figure 1.8; Payne 
and Hales, 2004) which is expressed in granule and Purkinje cells of the 
cerebellum in adult male rats (Guennoun et al., 1995). Progesterone may be 
metabolized further by 5 reductase to 5-dihydroprogesterone (Compagnone 
and Mellon, 2000). Progesterone and 5-dihydroprogesterone can mediate 
effects on the brain through the nuclear progesterone receptor (Belelli and 
Lambert, 2005) and it has been shown that progesterone stimulates cerebellar 
neuronal circuit formation (Tsutsui, 2006).  
 
The progesterone receptor (PR) has two isoforms encoded by a single gene – 
PR-A and PR-B. PR-B is the full length form (155 kDa) whereas PR-A is an N-
terminally truncated, 80 kDa form of the protein (Mulac-Jericevic et al., 2000). 
These are functionally distinct in terms of their ability to activate target genes 
(Tora et al., 1988): PR-B is known to function as a transcriptional activator of 
progesterone responsive genes whereas PR-A is known to function as a 
transcriptional inhibitor of progesterone responsive genes (Tsutsui et al., 2000). 
PR mRNA expression has been detected in the cerebellum of neonatal rats 
(Sakamoto et al., 2001). Progesterone is thought to act directly on Purkinje cells 
through intranuclear receptor-mediated mechanisms to promote dendritic 
growth, spinogenesis and synaptogenesis (Sakamoto et al., 2003). The 
expression of PR is under the control of estrogen, which ultimately increases 
PR expression. PR protein levels are increased after exogenous estrogen 
administration in the mammalian uterus (Milgrom et al., 1973). PR show 
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sensitivity to progestins and evidence has illustrated that progesterone 
decreases PR expression in most target tissues (Leavitt et al., 1977). 
1.4.1.3.1 Non-classical progesterone signalling – GABA  
In addition to classical signalling via nuclear receptors, neurosteroids, such as 
progesterone, exert non-classical rapid actions as allosteric agonists of the 
GABAA receptor, a ligand-gated ion channel.  
GABA is the endogenous ligand for GABAA receptor and is also the major 
inhibitory neurotransmitter in the central nervous system (Compagnone and 
Mellon, 2000). Progesterone can enhance GABAA-induced chlorine currents 
and therefore modulates the inhibitory actions of GABAA (Nicol et al., 1999). 
However, during fetal development and the first post-natal week in rodents, 
GABA, acting via GABAA receptors often exerts excitatory actions on immature 
cortical neurons of the hippocampus (Cherubini et al., 1991). These excitatory 
effects of GABA are due to an elevated intracellular chloride concentration and 
depolarized values of the reversal potential of the GABAA receptor activated 
responses (Owens et al., 1996). 
GABA is the main inhibitory neurotransmitter in the CNS and its action is 
mediated by GABA receptors (GABAR). There are three types of GABARs – 
GABAA, GABAB and GABAC. GABAA and GABAC are ligand gated chloride 
channels (Sieghart and Sperk, 2002) whereas GABAB belongs to the G-coupled 
protein receptor superfamily (Chen, et al., 2005) which open or close ion 
channels via intermediaries. The GABAA receptor binds two GABA molecules at 
the interface between  and  subunits which open the ligand-gated channel 
and produces a chloride current across the membrane (Colquhoun and Sivilotti, 
2004). 19 different subunits for GABAA have been identified - 1-6, 1-3, 1-3, δ, ε, 
π, θ and ρ1-3 (Barnard et al., 1998). GABAA1, GABAA6, GABAA2, GABAA3 
and GABAAare the most abundantly expressed in the cerebellum (Sieghart 
and Sperk, 2002). Laurie et al. (1992) demonstrated that GABRA6 mRNA is 
exclusive to postmigratory granule cells in the IGL of rats, which indicates a 
highly cell-specific control of gene expression. This mRNA could not be 
detected anywhere else in the developing brain or embryo. Therefore, in the 
present study, GABRA6 gene expression was used as a unique indicator for 
cerebellar granule cell development. 
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In long-gestation species such as humans and sheep, the majority of brain 
development occurs before birth. In these species, GABAergic currents are 
excitatory for the first two thirds of gestation before becoming inhibitory by the 
last trimester (Hirst et al., 2009). In the mature brain, GABAA receptor activation 
causes an influx of chlorine ions (Cl−) and membrane hyperpolarization, which 
is due to the electrochemical gradient for Cl−. This results in the inhibition of the 
cell (Wang and Kriegstein, 2009). The excitatory effect of GABA in developing 
neurons is due to an outflow rather than influx of Cl− ions following activation of 
GABAA receptors. This is due to the intracellular Cl
− concentration being higher 




Figure 1.8: The steroid synthesis pathway contains the transporter at the rate limiting step of neurosteroidgenesis (in orange), the steroidal precursors 
(in blue) and the enzymes (in red), involved in this process. This is the pathway through which peripheral steroids are metabolised and how steroids are 
made de novo in the brain. The spike bubbles indicate the GOIs investigated in this study.
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1.4.2 Peripheral steroids 
Peripheral steroids are gonadal hormones that are synthesised in the adrenal 
glands, gonads and placenta (Williams and Meck, 1991). These steroids exert 
biological effects on the nervous system and play a major role in the 
development, growth, maturation and differentiation of the CNS and the 
peripheral nervous system (Mensah-Nyagan et al., 1999). Peripheral steroids 
act on brain tissue through receptor-mediated mechanisms in order to regulate 
the important neuronal functions mentioned above. The metabolism of 
peripheral steroids in brain tissues can result in biotransformation and the 
production of biologically active metabolites (Arnold and Gorski, 1984).  
1.4.3 Neurosteroids 
The brain is capable of responding to steroid hormones synthesised locally 
(neurosteroids) and peripherally (via steroid gland secretion). Baulieu (1991) 
showed that in rat brain, steroids were being synthesised de novo and so 
coined the term “neurosteroids”.  Neurosteroids are defined as steroids that are 
synthesised in the CNS from cholesterol or steroid precursors, such as 
pregnenolone and progesterone that accumulate in the nervous system. These 
steroids are produced separately from steroidogenic gland secretion. The 
metabolism of peripheral steroids in brain tissues can result in biotransformation 
and the production of biologically active metabolites (Arnold and Gorski, 1984). 
This, together with evidence of the expression of steroid receptors in the brain 
demonstrates why the brain is considered to be a steroid target site.  
1.4.3.1 The cerebellum 
The Purkinje cells of the cerebellum have been identified as a major site for 
neurosteroid formation in the brain (Tsutsui, 2006). These neurons produce 
several different neurosteroids, enzymes and precursors, therefore Purkinje 
cells have served as an excellent cellular model for the study of neurosteroid 
actions in the cerebellum (Tsutsui, 2008). During development, Purkinje 
neurons synthesise steroidogenic enzymes (Compagnone and Mellon, 2000). 
Furthermore, steroid hormone receptors have been shown to be localised within 
these cells (Tsutsui et al., 2011). Although steroidogenic enzymes and 
receptors have been shown to be expressed in the cerebellum, the impact of 




1.5 The impact of steroids on brain development 
Animal studies have shown that exposure to steroids during fetal brain 
development can affect neuroendocrine and behavioural functions. This occurs 
via intracellular and cell-surface receptors that regulate changes in protein 
synthesis (Mensah-Nyagan et al., 1999). It has been suggested that steroidal 
hormones play a variety of regulatory functions in the CNS. In particular, during 
prenatal brain development gonadal androgens and estrogens appear to modify 
events related to neuronal survival and synapse formation (Breedlove, 1992). 
The effects of gonadal steroids on neuronal differentiation and survival vary with 
brain region and developmental state (Lauber et al., 1997; MacLusky et al., 
1987).  
Steroids exert many effects on the nervous system and play a major role in the 
development of the central nervous system, for example in the hypothalamus 
and pituitary gland. These brain areas are involved in sexual behaviour and 
have been the focus of most neuroendocrine studies to date. However other 
areas of the brain, including the cerebellum, express proteins that are 
necessary for local steroidogenesis and steroid signalling. In this study, a fetal 
steroid programming model was utilised in order to investigate how gene 
expression in the cerebellum is affected by steroid exposure during 
development - and how this effect subsequently changes the brain‟s 
architecture and function. This approach may yield insight into some of the 
mechanisms that underlie neurodevelopmental disorders. 
1.5.1 The role of androgen in brain development 
Fetal testosterone has been shown to affect the anatomy of the brain, including 
the hypothalamus, limbic system, and neocortex (Breedlove, 1994). Sexually 
dimorphic cognitive skills, such as spatial navigation (Williams and Meck, 1991) 
have been shown to be influenced by fetal testosterone. In the fetal primate 
brain, significant androgen receptor binding occurs in the cerebral cortex, 
cerebellum, mediobasal hypothalamus and corpus callosum in both sexes 
(Naftolin, 1994). There is sexually dimorphic AR binding in males in the cortex 
(Chapman et al., 2006). 
There are two peaks of gonadal testosterone production in human male 
development – during weeks 8 to 24 of gestation and the first six months of 
infancy. The first surge influences behavioural and physical development. 
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However, not a lot is known about the effect of the second surge (Hines and 
Alexander, 2008). The variability in individual prenatal androgen exposure 
influences post-natal behaviour in humans (Hines and Alexander, 2008). For 
example, when pregnant non-human primates and rodents are treated with 
testosterone prenatally, their female offspring demonstrate an increase in 
behaviours associated with males (Herman, et al., 2000).  
Testosterone, and hormones metabolised from this steroid, plays an important 
role in brain development, directing neural development during early life and 
also influencing the underlying organisation of the brain (Arnold and Gorski, 
1984). One of the best known examples of the neural influence of gonadal 
steroids is the sexually dimorphic nucleus of the preoptic area (SDN-POA), a 
sub region of the anterior hypothamlamic/preoptic area (AH/POA) (Arnold and 
Gorski, 1984). Research on the SDN-POA has demonstrated that the early 
hormone environment can influence brain development by determining which 
cells survive, what other neural regions they connect to anatomically and which 
neurotransmitters they use (De Vries and Simerly, 2002). 
Androgens alter the morphology, survival, and axonal regeneration of both 
sexually and non-sexually dimorphic motor neurons. Furthermore, testosterone 
increases expression of nerve growth factor (Tirassa et al., 1997) and mediates 
promotion of neurite growth and interneural communication through branching 
and arborisation during development (Kujawa et al., 1991). There is little 
literature on how testosterone affects cerebellar development but it has been 
suggested that flutamide, a non-steroidal AR antagonist, administered at PND 5 
in mice, does not significantly affect Purkinje cell numbers (Biamonte et al., 
2009), which argues against a role for testosterone and DHT in Purkinje cell 
survival. Another possiblilty is that this effect is not mediated by AR. During the 
rodent perinatal critical period, there is a significantly higher level of estradiol in 
males compared to females, which is thought to act on male brain development 
(Wright et al., 2010). Estradiol has been shown to regulate apoptosis (to 
produce sexually dimorphic cell numbers), dendritic spine formation, neuronal 
migration, and synaptic organization in hypothalamic regions, most of which are 
key regions for regulating male and female sexual functions in the adult brain 
(Zhang et al., 2000; Sakomoto et al., 2003). Another steroid hormone that 
influences brain development is progesterone. This steroid, but not its 
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metabolite allopregnenolone, is thought to act directly on Purkinje cells through 
intranuclear receptor-mediated mechanisms to promote dendritic growth, 
spinogenesis and synaptogenesis (Sakamoto et al., 2003). 
1.5.1.1 How testosterone influences development of different brain 
regions 
Neonatal treatment with testosterone has been reported to alter morphological 
as well as functional development in various regions of the brain and spinal cord. 
For example, testosterone and DHT have been shown to promote survival of 
neurons in the male hippocampus (Spritzer and Galea, 2007). (Wright and 
Smolen, 1983) have illustrated that neonatal testosterone treatment increases 
neuron and synapse numbers in male rat superior cervical ganglion. 
Experiments in male rodents suggest that testosterone is linked to an increase 
in neuron somal size, neuritic growth, plasticity and synaptogenesis in 
motoneurons of the spinal nucleus of the bulbocavernosus (Forger et al., 1992; 
Matsumoto, 1997). Kurz et al., (1986) demonstrated that a decrease in 
androgen levels after castration produced dramatic structural changes, 
decreasing the dendritic length and soma size of motoneurons in male rats. 
These changes were reversed by androgen replacement whereby dendritic 
arbor and soma size were restored to typical levels. This suggests that 
androgens may regulate neuronal function in adulthood by influence on length 
and size of dendrites of motoneuronal somas. These studies contrast the 
findings of Biamonte et al., (2009), who implied that testosterone and DHT do 
not influence Purkinje cell survival.  
1.5.2 Clinical implications 
1.5.2.1 Sexual differentiation 
Sexual differentiation is the process by which the central nervous system 
becomes structurally and functionally male or female. Structural sexual 
dimorphisms are typically manifested as sex differences in cell group volume, 
neuron or glial cell number, soma size, dendritic arborizations, dendritic spine 
density, degree of myelination, or a combination of these features (Juraska et 
al., 2013). Phoenix et al. (1959) was the first to demonstrate that the expression 
of male and female sexual behaviour in adulthood could be masculinised and 
defeminised by manipulating exposure to testosterone during prenatal 
development. This group had suggested that these early developmental effects 
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of androgens on later adult behaviour must be based on organisational effects 
of these hormones on the structure of the developing nervous system. 
From investigations in rodents, three different paths of sexual differentiation 
have been proposed. First, the critical window for hormonally mediated sexual 
differentiation of brain extends through to the adolescent period of development. 
Second, ovarian hormones, i.e. estrogens, play an active role in the 
feminisation of the brain during puberty. Lastly, hormonally mediated sex 
differences in the addition of new neurons and glial cells and sex differences in 
neuronal survival, contribute to sexual differentiation of hypothalamic, cortical 
and limbic regions during adolescence (Juraska et al., 2013). 
Structural sex differences in the cerebral cortex are not as visually prominent or 
as large in magnitude as those in the hypothalamus. Nevertheless, there are 
sex differences in the cortex and in its connections. Notably, many of the sex 
differences emerge during puberty as the result of exposure to ovarian 
hormones in females. Reid and Juraska (1992) found that adult male rats had a 
thicker cortex than adult females. The cortical thickness was examined in four 
locations: the primary motor cortex, the forelimb area of the sensorimotor cortex 
and the monocular and the binocular areas of the visual cortex and each 
showed sex differences. The investigation on the cellular basis for this indicated 
that it was not due to the number of synapses per neuron, as the number of 
synapses per neuron was not different between the sexes (Reid and Juraska, 
1995) but was due to a 17% increase in the number of neurons in the in adult 
male rats, when compared to females (Reid and Juraska, 1992). 
The sex difference in neuron number in the adult rat cortex occurs during 
puberty and is probably due to cell death-promoting influences of ovarian 
hormones in females. Similarly, synaptic pruning occurs during adolescence in 
the cortex, but less pruning occurs in female rats ovariectomised at PND 30 
compared with intact female rats (Munoz-Cueto et al., 1990). Thus, the findings 
for the cortex are similar to those sexually dimorphic regions such as 
anteroventral periventricular nucleus (AVPV) and SDN-POA, in the way that 




1.5.2.1.1 Gene expression and sexual dimorphism 
Dewing,, et al., (2003) explored the hypothesis that genes, by directly inducing 
sexually dimorphic patterns of neural development, can influence the sexual 
differences between male and female brains. The group performed microarray 
analysis on GD 10.5 male and female mice to evaluate any differences in gene 
expression between genders prior to gonadal formation. The majority of the 
genes that exhibit gender differential expression are known to be involved in 
cellular differentiation and proliferation, transcriptional regulators and cell 
signalling. This suggests that genetic factors may play a part in influencing brain 
sexual differentiation in the identification of genes differentially expressed 
between male and female brains prior to gonadal formation. 
1.5.2.2 Congenital adrenal hyperplasia 
Findings have arisen from clinical syndromes during early life. Congenital 
adrenal hyperplasia (CAH) is an autosomal recessive disorder that is caused by 
a 21-hydroxylase (21-OH) deficiency. This enzyme is needed to produce 
cortisol, also synthesised from cholesterol, and 21-OH deficiency results in 
cortisol precursors being shunted into the adrenal androgen pathway, and so 
testosterone is over produced. Males appear normal but they display virilised 
behaviour. However in females the testosterone level is elevated which results 
in masculinised or ambiguous genitalia (Meyer-Bahlburg et al., 2004).  
There is evidence to suggest that prenatal androgen exposure also influences 
brain development and therefore behaviour. For example 3-8 years old CAH 
female children show increased interest in toys associated with males and a 
reduced interest in dolls. These females also prefer rough, active play states 
found in young males (Hines and Kaufman, 1994). Maternal testosterone levels 
during gestation are correlated positively to masculine behaviours seen in their 
young female offspring (Hines et al., 2002). This implies that prenatal androgen 
exposure can have a profound effect on behaviour and personality later on in 
life.  
1.5.2.3 Neurodevelopmental disorders 
Neurodevelopmental disorders are a group of conditions with onset during early 
childhood. The disorders typically manifest early in development and are 
characterized by developmental deficits that produce impairments of personal, 
social, academic, or occupational functioning. The range of developmental 
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deficits varies from very specific limitations of learning or control of executive 
functions to global impairments of social skills or intelligence. For some 
disorders, the clinical presentation includes symptoms of excess as well as 
deficits and delays in achieving expected milestones. For example, autism 
spectrum disorder is diagnosed only when the characteristic deficits of social 
communication are accompanied by excessively repetitive behaviours and 
restricted interests (Karlsson, 2014).  
1.5.2.3.1 Structural cerebellar abnormalities in neurodevelopmental 
disorders 
The cerebellum has a role in motor function e.g. voluntary limb movements and 
there is also evidence to suggest that the cerebellum contributes to cognitive 
function e.g. executive function (planning, abstract reasoning and working 
memory) and spatial cognition (visual spatial organization and memory; 
Diamond, 2000). Purkinje cells of the cerebellum play a key role in modulating 
the output from the cerebellum to the cerebral cortex, because they provide 
input to the deep nuclei such as the dentate nucleus. The deep nuclei in turn 
provide the sole output from the cerebellum to the cerebral cortex. It has been 
repeatedly shown that the cerebellum is activated in a variety of mental 
activities, even when motor activity is well-controlled, including facial recognition, 
emotion attribution, directed attention, and many types of memory (Allen et al., 
1997; Decety and Ingvar, 1990; Kim and Thompson, 1997; Seidler et al., 2002). 
There has been extensive research into the pathology of the cerebellum in 
autism. In general, there seems to be a consensus that there is a reduction in 
the number of Purkinje cells in adult male humans that suffer from autism 
(Bauman and Kemper, 1985; Fehlow et al., 1993; Kemper and Bauman, 1993; 
Ritvo et al., 1986). Fatemi et al. (2002) also illustrated that the size of Purkinje 
cells was reduced by 24% in autistic adult male humans, as did Bauman and 
Kemper (1985).  
The growing recognition that the cerebellum is engaged in basic cognitive 
functions such as timing and associative learning, has led to an emerging 
interest in the role of the cerebellum in schizophrenia. However, there is less-
well documented evidence that there are cerebellar alterations in patients with 
schizophrenia. Reyes and Gordon (1981) demonstrated that the linear density 
of Purkinje cells was reduced in schizophrenic males and Tranet al., (1998) 
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reported that Purkinje cells were smaller by 8.3%. These findings are similar to 
the ones found in autistic males (Fatemi et al., 2002; Bailey et al, 1998), which 
may suggest that Purkinje cell alterations play a role in the onset of 
neurodevelopmental disorders. The literature points to a sex bias for both 
autism and schizophrenia, which suggests androgens play a role in the 
aetiology of neurodevelopmental disorders. 
There is mounting evidence that gender and the level of steroid hormones 
during development, in particular androgens, are risk factors and may contribute 
to neurodevelopmental disorders such as autism and schizophrenia (Baron-
Cohen, 2002; Rees and Harding, 2004). Previous literature has further 
demonstrated that in neurodevelopmental disorders such as autism and 
schizophrenia, there is abnormal cytoarchitectural development in the 
cerebellum (Bailey et al., 1998; Bauman and Kemper, 1985; Reyes and Gordon, 
1981; Tran et al., 1998). This suggests that defects in neuronal maturation and 
cortical organisation may be responsible for some of the neurological problems 
seen in autism. A candidate gene is one which is thought to cause or contribute 
to a particular disorder or disease. Candidate genes can be identified by several 
methods, including prior knowledge of the biological pathway, linkage studies, 
expression studies, and genome wide association studies (GWAS). The 
identification of single nucleotide polymorphisms (SNPs) within a gene can also 
be used to narrow the region of investigation (Weiss et al., 2009). 
1.5.2.3.2 Autism 
Autism is a severe neuropsychiatric disorder that predominantly affects male 
individuals with a 4:1 male:female ratio (Manning et al., 2001). It has been 
suggested that the second to fourth digit ratio (the second being the index finger 
and fourth being the ring finger), is affected by prenatal exposure to excess 
testosterone and that this ratio can be considered a crude measure for prenatal 
androgen exposure. Indeed, Manning et al., (1998) showed that low second to 
the fourth digit ratio negatively correlates with a high prenatal androgen 
exposure. Further evidence to suggest that excess prenatal testosterone levels 
are a contributing factor in the occurrence of autism is that the second to the 
fourth digit ratio is low in autistic individuals (Manning et al., 2001). Baron-
Cohen (2002) described the “extreme male brain” theory in which the behaviour 
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seen in autism is an exaggeration of typical sex differences, and that exposure 
to high levels of prenatal testosterone may be a risk factor.  
Several candidate genes have been identified in autism. One of these genes is 
the RELN gene, which encodes for the Reelin protein, and has a major role in 
neuronal migration and in prenatal development of neuronal connections 
(D'Arcangelo et al., 1995). Reduced Reelin expression in the cerebellum of 
adult humans has been found to be associated with autism (Fatemi et al., 2005). 
Another candidate gene is RORA (retinoic acid-related orphan receptor alpha) 
which activates genes in the cerebellum that stimulate proliferation of granule 
cell precursors in the external granule layer whilst also regulating a set of genes 
in Purkinje cells involved in processing neurotransmitter signalling (Gold et al., 
2003). Sarachana et al. (2011) also demonstrated that RORA expression was 
increased in the human neuroblastoma cell line, SH-SY5Y, upon estradiol 
treatment but down-regulated with DHT treatment. This suggests that RORA is 
responsive to steroid hormone levels. 
1.5.2.3.3 Schizophrenia 
Schizophrenia is thought to be a neurodevelopmental disorder with its origin 
during the critical phases of gestational life (Lewis and Levitt, 2002) when 
neurons fail to grow or migrate to their appointed sites or are unable to make 
the right synaptic connections. There has been extensive research on structural 
abnormalities of the frontal and temporal cortex in schizophrenia.  Examples 
include: decreased dendritic spine density in the prefrontal cortex (Glantz and 
Lewis, 2000); increased ventricular volume and decreased hippocampal volume 
in affected children (Gogtay et al., 2004); and a reduced volume of the rostral 
hippocampal formation in the affected twin in most discordant monozygotic twin 
sets (Suddath et al., 1990), which also implies that an environmental factor may 
be involved.  
Several candidate genes have also been identified in schizophrenia. Brain-
derived neurotrophic factor (BDNF) is a nerve growth factor that enhances 
neuronal survival (Beyer, 1999). BDNF is abnormally regulated in the CNS of 
animal models of schizophrenia (Fiore et al., 2002) and human schizophrenic 
patients have reduced number of BDNF-positive neurons and BDNF in the 
serum (Toyooka et al., 2002). Durany et al., (2000) also demonstrated that 
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there was a significant decrease in BDNF concentrations in cortical areas and 
the hippocampus of human post-mortem tissue from schizophrenic patients. 
Therefore, all this evidence taken together would imply that BDNF may be a 
candidate gene for schizophrenia and so BDNF mRNA levels were measured 
and evaluated in the present study, in order to determine whether there were 
any changes in gene expression after prenatal androgen exposure.  
DISC1 has been identified as a susceptibility gene for schizophrenia due to the 
link between major psychiatric disease in a large Scottish cohort and being a 
carrier of the DISC1 gene that has been mutated by a translocation (Millar et al., 
2000). Schurov et al., (2004) demonstrated that DISC1 expression is 
developmentally regulated with two major peaks at GD 13 and PND 35 
(approximately GD 20 and one postnatal month in sheep, respectively) in the 
cortex and hypothalamus of mice. These time periods are critically important in 
the development of rodents and correspond to the period of neurogenesis in the 
developing brain (Schurov et al., 2004). The cortex is strongly implicated in 
schizophrenia and it has been previously reported that the density of DISC1 
positive neurons was significantly reduced in certain layers of the cortex of 
schizophrenics (Millar et al., 2000).  It was proposed that the appearance of 
diagnostic symptoms was linked to the normal maturation of brain areas 
affected by the early developmental pathology, particularly the dorsolateral 
cortex (Buchanan  et al., 1998).  
Pickard et al., (2005) demonstrated that NPAS3 expression is disrupted in 
schizophrenia. Further evidence to support this came from Pieper et al., (2005) 
who saw reduced neurogenesis in the hippocampus of NPAS3 knockout mice 
and went on to suggest the possibility that impaired hippocampal neurogenesis 
may be relevant to some aspects of hippocampal pathology that are associated 
with schizophrenia. The genes mentioned above have been selected as genes 
of interest in our study and their mRNA expression was determined and then 
compared between the control and treated groups. 
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1.6 Gene expression 
1.6.1 Nuclear receptor signalling  
Nuclear receptors may be classified into four types based on their dimerisation 
and deoxyribonucleic acid (DNA) binding properties. Steroid hormone receptors 
bind to DNA as homodimers either to simple response elements comprising 
short palindromic sequences or to composite response elements with other 
transcription factors. Estrogen response elements consist of inverted repeats of 
the sequence A/ GGGTCA separated by three nucleotides, whereas the 
receptors for androgens, glucocorticoids and progestins bind to inverted repeats 
of the sequence AGA/GACA, also separated by three nucleotides.  
 
 
Figure1.9: A) Organisation of functional domains in nuclear receptors. DBD = DNA binding 
domain.  LBD = ligand binding domain. AF1 and AF2 = transactivational domains. B) Schematic 
representation of steroid hormone receptor binding to DNA. The receptors bind as homodimers 
to palindromic sequences. The specific sequences of simple response elements for steroid 
hormone receptors are shown. Taken from (White and Parker, 1998) 
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Receptors are characterised by a highly conserved DNA binding domain and a 
moderately conserved ligand binding domain which also functions in dimer 
formation and transcriptional activation, Figure 1.9 A (Mangelsdorf et al., 1995; 
Parker, 1993). Transcriptional activation by steroid receptors is mediated by at 
least two distinct activation functions; AF1, is located in the N-terminal domain 
and is a strong regulator of transcription and AF2, is in the hormone binding 
domain which is dependent on ligand-binding (Lee, et al., 1989). A number of 
studies have shown that this AF1 is a target for phosphorylation by other 
signalling pathways (Bunone et al., 1996). The second activation function, AF2, 
is induced by hormone binding and a short sequence encoding an amphipathic 
a-helix in the C-terminal part of the ligand binding domain, which is conserved in 
all transcriptionally active nuclear receptors, has been shown to be essential in 
receptor function (Durand et al., 1994). 
When activated by hormone binding, the receptors may act directly as 
transcription factors by binding to specific DNA sequences, termed hormone 
response elements, found in the vicinity of target genes, Figure 1.9 B, (Beato, 
1989). Composite response elements have also been identified which bind 
receptors in addition to other transcription factors such that the binding of one 
influences, either positively or negatively, the activity of the other (Diamond et 
al., 1990). In addition, it is evident that nuclear receptors are also capable of 
regulating the transcription of genes that lack hormone response elements by 
modulating the activity of other transcription factors such as AP-1 (Webb et al., 
1995). 
In the absence of hormone, steroid hormone receptors exist as inactive 
oligomeric complexes with a number of other proteins including chaperone 
proteins, namely the heat shock proteins Hsp90 and Hsp70 and cyclophilin-40 
and p23 (Smith and Toft, 1993). The role of Hsp90 and other chaperones may 
be to maintain the receptors folded in an appropriate conformation to respond 
rapidly to hormonal signals. Whether different types of receptor complexes 
occur in cells, each containing a subset of chaperones and able to respond to 
different types of signal, or whether receptors are folded into a mature complex 
containing chaperones in an assembly line type of process is as yet unclear 
(Bohen et al., 1995). Following hormone binding, the oligomeric complex 
dissociates allowing the receptors to function either directly as transcription 
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factors by binding to DNA in the vicinity of target genes or indirectly by 







1.7 Fetal programming 
Barker postulated the hypothesis that exposure of a fetus to environmental 
insults at critical periods of development could programme long term changes in 
gene expression that manifest in adulthood (Barker, 1998; Barker et al., 1990). 
This mode of inheritance may therefore be transferred from mother to fetus 
through nutrition, stress, hormonal imbalances, exposure to environmental 
toxins and so forth that could have adverse effects on fetal development 
(Symonds et al., 2009).  
There is a vast amount of literature that highlights fetal programming. One of 
the most well-known studies examined the long-term metabolic effects and 
cardiovascular disease in offspring of women that were pregnant during the 
Dutch hunger winter in 1944-45 (Schulz, 2010). The low calorie intake and 
under nutrition during pregnancy resulted in a cohort of offspring that were born 
with low birth weights and were susceptible to diabetes, pulmonary disease and 
cancers in adult life, which was particularly prevalent if starvation occurred 
during the third trimester of pregnancy (Roseboom et al., 2006). Interestingly, 
obesity was more common in those individuals whose mothers were starved 
during early pregnancy and early exposure to undernutrition has also been 
associated with schizophrenia and personality disorders (Hoek et al., 1996; 
Neugebauer et al., 1999). Other studies have indicated that fetal adaptation to 
an unfavourable environment in utero can result in poor sensitivity to a plentiful 
post-natal environment. This is commonly reflected by rapid post-natal catch-up 
growth which itself has been associated with the onset of obesity, diabetes and 
cardiovascular disease (Hales and Barker, 2001).  
1.7.1 PCOS 
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects 
women in their reproductive years. PCOS affects the endocrinic, reproductive 
and metabolic systems. This syndrome is characterised by the cessation of 
maturation of the ovarian follicle prior to complete development which ultimately 
leads to an increased number of larger follicles in the ovary (Franks et al., 2008). 
Other associated reproductive alterations include increased risk of miscarriage 
and hyperandrogenism, which includes hisuitism and acne (Ehrmann et al., 
1999). The metabolic disorders are typically insulin resistance, obesity and 
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impaired pancreatic -cell insulin secretion that results in type II diabetes 
(Abbott et al., 2002). 
It has been suggested that there is a genetic basis of PCOS as there is a high 
prevalence of family members afflicted with symptoms that are characteristic to 
PCOS (Sam et al., 2008). Familial aggregation of PCOS has been evidenced by 
sisters of women with PCOS. Approximately 40% of these sisters also have 
hyperandrogenaemia and metabolic disorders (Legro et al., 1998). The male 
phenotype of PCOS has been evaluated and Legro (2000) suggested that 
premature balding and insulin resistance were characteristics. Recabarren et al., 
(2008) performed a longitudinal study and observed that sons born to women 
with PCOS exhibited a greater body weight and insulin resistance in adulthood, 
compared to sons born to women without PCOS. 
Intrauterine growth retardation (IUGR) in humans has been linked to the 
development of hyperandrogenism (Ibanez et al., 2002) and PCOS (Cresswell 
et al., 1997). Sir-Petermann et al., (2002) showed that pregnant women with 
PCOS had an increased level of testosterone, compared to normal, pregnant 
women. Prenatal androgen excess exposure has been recognised as a factor in 
the re-programming of organ systems in PCOS animal models (Abbott et al., 
1997; Hogg et al., 2011; Connelly et al., 2013; Rae et al., 2013). There are 
already established PCOS sheep models known (Hogg et al., 2011; Connelly et 
al., 2013; Rae et al., 2013), which have ultimately lead to a firmer understanding 
of fetal programming in the gonads, pancreas, liver and adrenal glands. Two 
models have been designed – one whereby the pregnant ewe is injected by 
testosterone propionate (TP, an androgen) which would allow the placental 
aromatisation of androgen to estrogen to be passed onto the fetus. The second 
is a unique fetal programming model by which the fetus is directly injected, thus 
bypassing any placental aromatisation and any maternal effects of androgens 
(Hogg et al., 2011; Connelly et al., 2013; Rae et al., 2013). 
1.7.2 Maternal stress 
In addition to nutritional stress, maternal emotional stress, anxiety or depression 
can have adverse effects on fetal neurodevelopment (Nicoletto and Rinaldi, 
2011). Maternal stress is a risk factor for ADHD (Talge et al., 2007) and 
depression (Markham and Koenig, 2011).  A consequence of these types of 
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environmental stress is fetal overexposure to glucocorticoids (Pryce et al., 
2011).  Fetal over-exposure to glucocorticoids may also occur as a result of 
treatment for gestational disease of the mother or fetus and is a routine 
treatment for those at risk of preterm delivery (Pryce et al., 
2011).  Dexamethasone (DEX) is a synthetic glucocorticoid, and the 
behavioural consequences of prenatal dexamethasone administration are 
similar the effects of prenatal stress, causing a reduction in social play and 
skilled motor behaviour in marmosets (Pryce et al., 2011).  Prenatal exposure to 
DEX also delays neuronal maturation and leads to degeneration of hippocampal 
volume in adolescent rats, this correlates with hippocampal changes seen in 
adult primates subjected to prenatal stress and with changes seen in psychiatric 
patients (Pryce et al., 2011).   
The literature in regards to stress and cortical development is vast, however 
there is little evidence for androgens affecting cortical developent. Chronic 
stress is associated with increased risk of illness, the development of a variety 
of psychological disorders, and changes in cognition. Stress has also been 
hypothesized to play a causal role in several psychological disorders. For 
instance, stressful life events appear to increase the probability of a psychotic 
episode in schizophrenics (Ventura et al., 1989). Animal studies have also 
demonstrated detrimental effects of stress on cognitive function such as stress-
induced deficits in a variety of cognitive tasks, including shuttle escape 
(Seligman and Maier, 1967), water maze (Altenor and DeYoe, 1977), food-
motivated operant conditioning (Rosellini et al., 1984), and radial maze tasks 
(Luine and Rodriguez, 1994).  
The cortex is a target for glucocorticoids, which are involved in stress response 
- DEX binds to receptors in the cortex. In addition, DEX binding in the cortex is 
altered by both corticosterone treatment and adrenalectomy, which indicates 
the presence of endogenously regulated corticosterone receptors (Meaney and 
Aitken, 1985). Furthermore, the cortex is also involved in many of the tasks that 
are influenced by chronic elevations of circulating glucocorticoids. Lesions of 
the cortex in rats impair spontaneous alternation, radial maze performance, and 
passive avoidance (Dias et al., 1996). Therefore, potential alterations in the 
cortex may mediate some corticosterone-induced behavioural changes. 
Wellman (2001) demonstrated that chronic corticosterone administration 
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dramatically reorganised apical arbors of layer II-III pyramidal cells of the cortex, 
with an increase of 21% in dendritic size proximal to the soma, along with a 
decrease of up to 58% in dendritic size distal to the soma.  
1.7.3 Alterations in the in utero endocrine environment  
Exposure to an atypical endocrine environment during fetal development leads 
to an alteration in behaviours such as empathy and aggression presumably 
because of the effect on brain organisation and development (Hines, 2008; 
Meyer-Bahlburg, 2011).  Indeed, there is a correlation between the levels of 
testosterone in maternal blood or amniotic fluid samples and the masculinity of 
behaviour of young girls and boys (Chapman et al., 2006; Hines et al., 2002).  
Another important source of information concerning the effects of abnormal 
hormone exposure on human physiology are studies on a group of people born 
between 1948 and 1971 whose mothers had been administered 
diethylstilbestrol (DES) during pregnancy to prevent abortion and treat morning 
sickness.  In addition to reproductive disorders, female offspring also had 
disorders of the immune system and depression (Colborn et al., 1993).  Similar 
studies into people exposed to endocrine disruptors during development 
indicate that exposure results in delayed psychomotor development, poor visual 
recognition, problems with short-term memory and growth retardation (Colborn 
et al., 1993).  Interestingly, it was estimated in the 1990s that at least 5% of the 
infants born in the United States were exposed to sufficient quantities of 
endocrine disruptors to cause neurological effects (Tilson, 1990).In rat models, 
it has been shown that a single exposure to an endocrine disruptor at a critical 




1.8 Why sheep are a good model for human pregnancy 
Most neurological studies have been performed on rodents, but this has its 
limitations as they are short lived animals. The life expectancy of rodents is 
between 2 to 3.5 years (Pass and Freeth, 1993). Rodents also lack a developed 
forebrain which is a major anatomical characteristic of the human brain (Morton 
and Avanzo, 2011). The cognitive function of sheep is poorly characterised yet 
sheep are a model for research into brain function and behaviour. Morton and 
Avanzo (2011) demonstrated that sheep could perform well in sensitive tests of 
cognitive dysfunction in humans which implies that sheep do have a capacity for 
executing cognitive tasks (e.g. discrimination learning, reversal learning, 
attentional set-shifting, intradimensional and extradimensional set-shifting tasks). 
Sheep have large brains with human-like basal ganglia, and well developed 
convoluted cerebral cortices (Jacobsen et al., 2010). These animals are longer 
living (than rodents) and so they have a more human-like biological timeframe. 
Like humans, sheep demonstrate a good capacity for learning and memory with 
the ability to remember faces of other sheep (Kendrick et al., 2001). Therefore 
to some degree, sheep have similar cognitive abilities to humans.  
The gestation period for sheep approximately 145 days and for humans, is 
around 270 days (nine months), whereas for rodents, the gestional period is 
between 20 and 22 days (Barry and Anthony, 2008). Sheep make a better 
pregnancy model for humans for a variety of reasons. Rodents do not have a 
breeding season and females of breeding age come into their estrus cycle all 
year-round, approximately every four to five days. On the other hand, sheep do 
have a breeding season, typically in autumn and ewes enter their estrus cycle 
every seventeen days (Thompson and Meyer, 1994).  The typical litter for a ewe 
is one or two lambs, which is a stark contrast to the ten to twelve pups in a 
rodent litter. In sheep, the placenta is attached to the wall of the ewe's uterus by 
about 80 small buttons, the cotyledons. It is through these and the placenta that 
the developing lamb has received nutrients from the ewe's blood supply. The 
placenta with the cotyledons will be expelled as the afterbirth. Each lamb has a 
separate placenta, which is the same as rodent pups (Gimenez and Rodning, 
2007). One limitation of using sheep as model is that the whole ovine genome 
was not yet fully sequenced and annotated until after the experiments in this 
project were performed (Jiang et al., 2014). Figure 1.10 shows a comparison of 
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the sheep, rat and human cerebellar development timeline. No animal model 
truly recapitulates human pregnancy; however the pregnant sheep are an 
established model to investigate maternal-fetal interactions (Hogg et al., 2012; 
Hogg et al., 2011) and fetal programming (Rae et al., 2013).  
 
Figure 1.10: Comparison of timing of cerebellar development for rat, human and sheep. Key - 
gestational day (GD), embryonic day (E), postnatal day 0 (P0), gestational weeks (gw), 
postnatal weeks (pnw), Purkinje cells (PC), granule cells (gc), external granule cells (egc). . 
Taken and adapted from (Biran, 2011). The sheep cerebellar development timeline is 
incomplete due to lack of literature. Sheep timeline composed from findings from: (Potter et al., 
1982), Rees and Harding (1988) and Roselli et al.. (2006).  
The fetal sheep brain has the capacity to aromatize androgens to estrogens on 
GD 64 (Roselli et al., 2003). This is the time point that falls in the middle of the 
critical period of sexual differentiation of the brain and gonads (Roselli et al., 
2003). The samples used in the present study were injected with 20mg TP at 
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GD 62 and 82, which is well within the GD 50-80 critical window for the effects 
of androgen on sheep behaviour, yet after the critical window for gonadal 




1.9 Focus of study 
Previously literature has shown that fetuses are exposed to elevated levels of 
androgens in utero condtions such as polycystic ovary syndrome and congenital 
hyperplasia (Abbott, et al., 1997; Hogg, et al., 2011; Connelly, et al., 2013; Rae, 
et al., 2013; Recabarren, et al., 2008; Ibanez, et al., 2002; Meyer-Bahlburg, et 
al., 2004; Hines and Kaufman, 1994) and that the effects of this can be 
detrimental in later life. Elevated levels of androgens have also been implicated 
in neurodevelopmental disorders such as autism and schizophrenia (Baron-
Cohen 2002; Lewis and Levitt, 2002). 
Steroids exert effects on the nervous system and play a major role in the 
development of the CNS, e.g. in the hypothalamus and pituitary gland (Feist 
and Schreck, 1996; Mong et al., 1999; Toran-Allerand et al., 1980). These brain 
areas are involved in sexual behaviour and have been the focus of most 
neuroendocrine studies to date. However, it is known that other areas of the 
brain, e.g. the cerebellum and cortex, the brain regions involved in cognitive 
function, express those proteins necessary for local steroidogenesis and steroid 
signalling. A steroidal fetal programming model was utilised in order to 
investigate how gene expression in these two brain regions is affected by 
steroid exposure during development, and how this may lead to a change in 
brain architecture and function.  
1.9.1 The cerebellum 
The cerebellum expresses proteins for local steroidogenesis and steroid 
signalling (Baulieu, 1998), however the impact of steroids on cerebellar 
development has yet to be investigated. Cerebellar Purkinje cells are a major 
site of neurosteroid formation (Tsutsui et al., 2003), implying that these cells 
may be affected by developmental androgen exposure. How cerebellar gene 
expression is affected by androgen exposure during development - and how 
this subsequently changes the brain‟s cytoarchitecture and function are 
discussed in Chapters 3, 4 and 5.  
 Aim 1 - identify changes in the expression of genetic markers of steroid 
metabolism and signalling, neuronal activity and cell markers in the 
cerebellum of male sheep that results from exposure to testosterone 
propionate (TP) during development, using quantitative real-time 
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polymerase chain reaction (qRT-PCR).  
Many enzymes involved in steroidogenesis have been described in the 
cerebellum but the impact of steroids on its development has yet to be identified.  
 Aim 2 - detect any alterations in the cerebellar cytoarchitecture, in 
response to androgen over-exposure. 
The cerebellum has a clear developmental pathway and an established 
cytoarchitecture that will enable us to more easily identify effects of TP 
treatment on the development of the brain. To verify the mRNA expression data 
at the protein level, histological and immunohistochemical techniques were 
performed in order to determine whether there are any structural effects of TP 
treatment of the cerebellum, such as differences in cell numbers expressing a 
particular protein which may result from the gene expression changes outlined. 
Western blotting was attempted to verify and quantify protein expression 
alteration as a result of TP administration.  
 Aim 3 - ascertain if there is a difference in EGL:IGL ratio between the 
control and TP-treated groups using Nissl staining (Chapter 4).  
The cell density thickness of the EGL and IGL layers will be calculated (using 
Image J software) for the control and TP-treated samples and then the ratio of 
EGL:IGL was investigated to confirm if TP administration has an effect on 
granule cell migration in the cerebellum. Also in, Chapter 4, further examination 
of structural differences in Purkinje cell morphology was performed using 
immunohistochemistry. The Purkinje soma diameter, number, and Purkinje cell 
layer width were measured and compared between the control and TP-treated 
groups, so that any dyregulation in Purkinje cell development and migration due 
to prenatal androgen over-exposure, could be established. 
Due to the vast amount of literature that suggests androgen levels can influence 
the likelihood that a fetus will have a neurodevelopmental disorder, several 
neurodevelopmental candidate genes for autism and schizophrenia were 
examined by means of qRT-PCR (Chapter 5).  
 Aim 4 - determine whether these candidate genes were altered due to 




If any significant changes were observed, this would explain the role of 
testosterone in brain development and may ultimately give insight into a variety 
of neurodevelopmental disorders. 
1.9.2 The cortex 
Similar to the cerebellum, the cortex expresses proteins involved in 
steroidogenesis.  
 Aim 5 - identify changes in the expression of 15 000 genes in the cortex 
of male sheep that results from exposure to testosterone propionate (TP), 
diethylstilbestrol (DES) and dexamethasone (DEX) during development, 
using microarray analysis.  
Chapter 6 focuses on the results between the comparision of the control and 
TP-treated groups. Microarray data was generated in order to detect gene 
expression alterations in the cortex, between the control and TP-treated groups. 
This data allowed for, with the aid of bioinformatics, the determination of which 
genes have been affected as a result of in utero TP administration.  
 Aim 6 – Verify the microarray data using qRT-PCR. 
Histology was performed to determine whether these changes can be validated 
at the mRNA and protein level.   
We would like to establish if there is a connection between the changes 



















This chapter details the general materials and methods that were employed in 
this thesis. The animal husbandry, the administration of injections was 
performed by collaborators from the University of Edinburgh whereas as tissue 
collection was performed by Dr. Claire Garden or Miss Lisa-Marie Wilson. Any 
work that was carried out in conjunction with others is duly acknowledged in the 
chapters in which the specific work was presented.  
2.1.1 Animal husbandry 
A flock of Scottish Greyface ewes were purchased for these studies and housed 
and cared for at the Marshall Building, Roslin, Midlothian under the regulations 
authorised by UK Home Office Project Licence Number 60/3744. Ethical 
approval was reviewed by the University of Edinburgh Animal Research Ethics 
Committee. The current study specifically focuses on the fetal injection cohort 
GD 90, outlined below and in Connolly et al., (2013). The current study was part 
of a much larger study and therefore various cohorts were utilised, with 
pregnant ewes randomly assigned to control and treatment groups.  
2.1.1.1 Mating and pregnant ewe husbandry 
Ewes with good body conditioning scores of 2-3 (Thompson and Meyer, 1994 ) 
were mated with Texel rams under natural seasonal breeding conditions from 
November to January. Prior to mating, estrous cycles were aligned in two 
separate groups that were staggered over two weeks to achieve pregnancy at 
the same time for the majority of animals within each group. Chronogest CR 
sponges impregnated with 20mg flugstone acetate (Intervet U.K. Ltd., 
Buckinghamshire, U.K.) were inserted into the vagina for 10-12 days. At sponge 
withdrawal animals were given 0.5ml prostaglandin estrumate (intramuscular; 
Schering Plough Animal Health, Welwyn Garden City, U.K.) to terminate the 
luteal phase. Ewes not carrying a reference paint marker on their hind to 
indicate ram-ewe contact, were considered not mated, and were returned for 
mating a second time. Pregnancy was confirmed by ultrasound scan and ewes 
placed into treatment groups according to the number of fetuses (singleton, twin 
or triplet pregnancies). Pregnant ewes were housed in groups in spacious 
enclosures and fed hay ad libitum, supplemented with Excel Ewe Nuts (0.5-1.0 
kg daily; Carrs Billington, Lancashire, U.K.) and Crystalyx Extra High Energy 
Lick (Caltech Solway Mills, Cumbria, U.K.). To avoid dominant females from 
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over-feeding at the expense of smaller ewes, these animals were housed in 
separate pens. All ewes were boosted against Clostridial diseases and 
Pasteurellosis 4-6 weeks before lambing by treatment with Heptavac P Plus 




2.1.1.2 Treatment regimes 
Treatment regime began at GD 62 of an average 147 day gestation and 
repeated at GD 82. TP (AMS Biotechnology (Europe) Ltd., Abingdon, U.K.) was 
dissolved in vegetable oil (Sainsbury‟s SO organic range) and 5% ethanol to a 
concentration of 100mg/ml and stored in an incubator at 37°C, to prevent crystal 
formation, until ready to use. DES (Sigma Aldrich, U.K.) was dissolved in 
vegetable oil and 5% ethanol to a concentration of 250g/ml and vehicle 
controls (C) consisted of vegetable oil and 5% ethanol and was stored in the 
same way. The final injection dose for TP and DES was 20mg and 50g, 
respectively (Connolly et al., 2013). Fetal injections were carried out following 
anaesthesia of the mother. Ewes were sedated using 10mg Xylazine 
(intramuscular; Rompun; Bayor Plc Animal Health Division. Berkshire, U.K.), left 
to settle for 10 min, then given 2.0mg/kg ketamine (intravenous; Keteset; Fort 
Dodge Animal Health, Southampton, U.K.). Ewes were additionally 
administered a post-operative dose of antibiotics (1ml/25kg; intramuscular; 
Streptacare; Animalcare Ltd., York, U.K.). Under surgically sterile conditions, 
injections were performed with the guidance of ultrasound using a vaginal probe 
fitted with a needle guide at GD 62 and then again at GD 82. This is within the 
GD 50-80 critical window for the effects of androgen on sheep behaviour, yet 
after the critical window for gonadal differentiation (GD 30-35; Roselli et al., 
2006).  A 20G Quincke spinal needle (BD Biosciences, Oxford, U.K.) was 
inserted through the uterine wall and into the flank of the fetus. Delivery of fluid 
into the peritoneal cavity (200μl) was monitored by ultrasound and any anomaly 
such as leakage into amniotic fluid or uptake into the fetal circulation was 
recorded. Ultrasound was performed by Dr Colin Duncan and fetal injection 
carried out by Dr. Mick Rae, Dr. Kirsten Hogg or Dr. Fiona Connolly, according 




(sacrificed at GD 90) 
 Control TP DES 
Male  11 6 11 
Female 6* 6 4* 
Table 2.1: The resulting offspring from fetal injections at GD 62 and 82. This table shows a 
breakdown of various treatment cohorts. (*differences in numbers of fetuses used are 
attributable to constraints of tissue available for each analysis). 
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In the current study, the ovine fetuses were subjected to two bolus injections of 
20mg TP (one at GD 62 and another at GD 82) which meant that the androgen 
levels in the blood were significantly elevated (23093 IU), compared to the 
control samples (192.5 IU, Connolly et al., 2013). The does of TP (20mg) was 
chosen to reflect androgen levels of a polycystic ovarian syndrome (PCOS) 
model. The level of peripheral androgen that crosses the blood-brain barrier to 
the cerebellum remains unclear. It would have therefore been useful to the 
current study to measure testosterone levels by utilising techniques such as 
radioimmunoassay or luminescence immunoassay. However, this was beyond 




2.1.1.3 Animal sacrifice and collection of specimens 
2.1.1.3.1 Fetal, lamb and adult animal sacrifice 
Pregnant ewes were euthanised at GD 90 of and their fetus(es) immediately 
collected. Euthanasia was carried out in accordance with the regulatory outline 
of Schedule 1: Appropriate Methods of Humane Killing of the Animals (Scientific 
Procedures) Act 1986. A single lethal injection of pentobarbitone sodium 
(150mg/kg; intravenous.; Euthetal; Merial Animal Health Ltd., Essex, U.K.) was 
administered to the animal. 
2.1.1.3.2 Tissue collection 
A range of tissues were collected from animals for ongoing studies in Dr. Colin 
Duncan‟s laboratory, as well as for the studies outlined in this thesis. Weights of 
postnatal cerebellar tissue were recorded immediately following dissection. The 
brain was bisected along the midline and one half (a hemisphere and half the 
cerebellum) were stored in neutral buffered formalin to prevent tissue 
degradation and maintain tissue integrity. The other half which included the 
cerebellum, hippocampus and prefrontal cortex, were snap frozen in dry ice 
followed by storage at -80°C, to prevent RNA degradation. Other tissues 
dissected included fetal ovaries, testes, adrenal glands, liver and fat, were 





2.1.2.1 RNA isolation 
RNA from fetal ovine cerebellar tissue was isolated from frozen tissue from four 
male control animals and four TP-treated animals using the Trizol method  
(Chomczynski, 1993). RNA from fetal ovine cortex tissue was also isolated 
using this method but the sample numbers were different - six male control 
animals and six TP-treated animals. DES-treated cerebellar RNA isolation was 
performed by an Honour‟s student (n=4). The variance in sample numbers for 
cerebellar and cortex tissue is due to poor quality RNA in two cerebellar 
samples. Each tissue sample was ground into a fine powder in liquid nitrogen, 
then homogenised in TRIsure (100mg tissue powder per ml, Bioline, U.K.) and 
then transferred into 1ml eppendorf tubes. 200l of chloroform per 100ml of 
tissue (Sigma Aldrich, U.K.) was then added to each tube and centrifuged at 
4oC for 10 minutes at 10 000 x g. This left a clear, aqueous phase at the top 
which contained total RNA. The interphase contained proteins and genomic 
DNA. The aqueous phase was transferred into clean tubes and 500l of cold 
isopropanol (Sigma Aldrich, U.K.) was added. This was centrifuged as before. 
The supernatant was discarded and the pellets were left to air dry, ensuring the 
pellets were not over-dried. The pellets were then solubilised in 50l of RNAse 
free water (Bioline, U.K.). 5l of 4M sodium chloride (NaCl) and 150l of 100% 
ethanol (Sigma Aldrich, U.K.) was added to the pooled pellets and incubated at 
-20oC for 1 hour. Meanwhile, the tubes containing the interphase had 300l 100% 
ethanol added to them and stored at -20oC for future protein studies. The total 
RNA was then centrifuged as previous, the supernatant discarded and the pellet 
left to air dry. 50l of RNAse free water, 5l of 4M sodium chloride (NaCl) and 
150l of 100% ethanol was added to the pooled pellets and incubated at -20oC 
for 1 hour. This incubation occurred in total, three times. After the final 
centrifugation, the pellet was washed in 300l 75% ethanol and centrifuged at 
10 000 x g for 5 minutes. This ethanol precipitation method is a widely used 
technique to purify or concentrate nucleic acids. This is accomplished by adding 
salt (in this instance, 4M NaCl) and ethanol to a solution containing RNA. In the 
presence of NaCl, ethanol efficiently precipitates nucleic acids, such as total 
RNA. The supernatant was discarded and once the pellet had dried, 50l of 
RNAse free water was added to solubilise the pellet and then stored at -80oC. 
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2.1.2.2 Determining RNA integrity 
Denaturing paraformaldehyde gel electrophoresis was used to monitor the 
integrity of the RNA isolated. A 1% paraformaldehyde gel was made using 1g of 
agarose (Bioline, U.K.), 72ml RNAse free water, 10ml MOPS-EDTA-sodium-
acetate buffer (Sigma Aldrich, U.K.), 18ml formaldehyde (Sigma Aldrich, U.K.). 
5l of SafeView (NBS Biologicals, U.K.) was added to the mixture just before 
pouring. This was used instead of ethidium bromide. 6l of loading buffer 
(Sigma Aldrich, U.K.) was added to 3l of RNA ladder (Transcript RNA Markers 
0.2-10 kb, Sigma Aldrich, U.K.) and 3l of total RNA (in separate tubes). All 
samples and markers were denatured at 65oC for 10 minutes, placed on ice and 
then loaded onto the gel. The gel was electrophoresed at 50 volts for 3-4 hours 





2.1.2.3 DNAse treatment and determining RNA concentration 
The samples were DNase treated using the DNase I amplification grade kit 
(Sigma Aldrich, U.K.) to eliminate any DNA contamination in the RNA sample. 
In short, 1 unit/l of DNase I and 1l 10X reaction buffer was added to 1g/ml 
RNA and incubated at room temperature for 15 minutes. 1l of stop solution 
(binds calcium and magnesium ions to inactivate the DNase I) was then added 
to the tubes and incubated at 70oC for 10 minutes. This denatured the DNase I 
and RNA. The samples were then placed on ice for 5 minutes. 
Spectrophotometer readings were used to determine the concentration of total 
RNA for each sample. The RNA was diluted 1:1000 in RNAse free water and 
read at 260nm and 280nm to obtain an absorbance measurement on the 
BioMate 3 Thermo Spectronic spectrophotometer (U.K.). These measurements 
were used in the Beer-Lambert Law to give the RNA concentration;- 
                                                         A=CL           
Where A= absorbance, = molar extinction coefficient ((μg/ml)-1 cm-1), C= 
concentration (M) and L= path length (cm). RNA has a molar extinction 
coefficient of 0.025 (μg/ml)-1 cm-1 and the path length for the instrument used 
was 1cm. 
RNA was stored in 4g aliquots at -80oC for cDNA synthesis. 2g of RNA was 
used to synthesise cDNA using a cDNA Synthesis reverse transcriptase kit 
according to the manufacturer‟s instructions (Bioline, U.K.). Each sample also 
had a negative control (water substituted for reverse transcriptase enzyme – 
thereafter referred to as „no RT‟), where no reverse transcriptase was added. 




2.1.3 qRT-PCR optimisation 
2.1.3.1 Genes of Interest identification  
The genes of interest (GOI) that were scrutinised in GD 90 male ovine 
cerebellar tissue were AR, CYP19, ER and ER Cyp11A1, Cyp17, HSD3B1, 
STAR, BDNF, DISC1, GABRA6, GAD1, FOS, NPAS3, RELN, RORAGFAP, 
PR, SRD5a1 and SRD5a2 (see Table 2.2). This panel of genes were chosen for 
examination as they are involved in steroid signalling and metabolism, 
candidate genes for neurodevelopmental disorders or are markers for specific 




Table 2.2: A list of all the initial genes of interest that were tested. These were selected for three 
suitable categories that will allow the hypotheses of this study to be tested – cell marker, 
steroidal genes and disorder markers. The primary focus of this study is to identify changes in 
the cerebellar expression of genetic markers of steroid metabolism and signalling that result 
from exposure to testosterone propionate (TP) during development in sheep. 
Gene Name Classical Name Reason for being GOI Reference 
AR Androgen receptor To investigate T signalling Chang et al., 
(1995) 
CYP19 Aromatase Enzyme that converts T into E Naftolin (1994) 
BDNF Brain-derived neurotrophic 
factor 
Modulated by steroids, 
associated with disease 
Numakawa 
(2010) 
DISC1 Disrupted in schizophrenia 1 Altered in schizophrenia Millar et al., 
(2000) 
ER Estrogen receptor  To investigate E signalling Belcher (1999) 
ER Estrogen receptor  To investigate E signalling Belcher (1999) 
GABRA6 Gamma-aminobutyric acid A 
receptor, alpha 6 
Altered in autism, target for 
schizophrenia treatment. 
Dean et al., 
(2005); Fatemi et 
al., (2010)  




Immediate early gene Marker for neuronal activity in 
neuroendocrine systems 
Hoffman et al., 
(1993) 
NPAS3 Neuronal PAS domain protein 3 Altered in schizophrenia and 
regulates glucose metabolism 
Pickard et al., 
(2005) 
CYP11A1 P450scc Converts cholesterol to 
pregnenolone. 
Baulieu (1998) 
PR Progesterone receptor To investigate progesterone (P) 
signalling 
Sakamoto et al., 
(2003) 
RELN Reelin Autism marker Serajee et al., 
(2006) 
RORA Retinoid-related orphan 
receptor alpha 
Autism marker modulated by 
steroids 
Sarachana et al., 
(2011) 
SRD5a1 5 - reductase 1 Converts T and P into DHT and 
DHP 
Mensah-Nyagan 
et al., (1999) 
SRD5a2 5 - reductase 2 Converts T and P into DHT and 
DHP 
Mensah-Nyagan 
et al., (1999)   
STAR Steroidogenic acute regulatory 
protein 
Rate-limiting step in 
steroidogenesis 
Stocco and Clark 
(1996) 
GFAP Glial fibrillary acidic protein Microglial marker Eng et al., (2000) 
HSD3B1 3 hydroxysteroid 
dehydrogenase 
Key enzyme in steroidogenesis Payne and Hales 
(2004) 




2.1.3.2 Primer design  
Initially for each GOI, the ovine DNA sequence (if available) was obtained using 
CLC sequence viewer software (http://www.clcbio.com/index.php?id=28). 
Because the whole ovine genome was not yet fully sequenced and annotated 
during this part of the project, the bovine DNA sequence was utilised where 
applicable. There were some ready-made primers on the market available to be 
tried e.g. TaqMan by Applied Biosystems (ABI, U.K.). If the ready-made primers 
were unsuitable, e.g. no amplification in qRT-PCR, custom-made primers were 
designed. This was done for AR, BDNF, DISC1, ER, ER, GABRA5, NPAS3, 
PVALB and ROR If there was no ovine sequence, then the bovine, human 
and murine sequences were compared and primer sets were designed over an 
exon boundary that had the best homology using Primer Express software (ABI, 
U.K.). When designing custom primers, it was essential that the GC content 
was between 50 and 60%, amplicon length was 50 to 150 bases long and there 
were minimal secondary structures e.g. primer dimers and hairpin loops. The 
melting temperature of primers is also a crucial factor in primer design. Primers 
with melting temperatures in the range of 52-58°C generally produce better 
results than primers with lower melting temperatures. While the annealing 
temperature can go as high as 72°C, primers with melting temperatures above 
65°C have a higher potential for secondary annealing (Bustin et al., 2009). 
These sequences were then put through NCBI‟s BLAST website (U.S.A) to 
ensure that the primer pairs are specific to the GOI. The custom-made primers 




2.1.3.3 Optimising Custom-Made Primers 
According to the Minimum Information for Publication of Quantitative Real-Time 
PCR Experiments (MIQE) guidelines (Bustin et al., 2009) all custom-made 
primers must be optimised and validated. One way to do this was to create a 
standard curve using DNA copy number (Wong and Medrano, 2005). The PCR 
product for AR, was ligated into the vector pCR2.1 (Sigma Aldrich, U.K.) and 
then transformed into -select chemically competent cells (Bioline, U.K.). These 
cells were then plated onto a Luria broth (LB) plates with 50g/ml kanamycin 
and incubated at 37oC overnight. Then, colony PCR was performed to see if 
any of these PCR products had successfully been cloned into the vector. For 
the successful colonies, a Miniprep of plasmid DNA (Sigma Aldrich, U.K.) was 
carried out, as per manufacturer‟s instructions, and then the plasmid DNA 
concentration was determined. From this, the DNA copy number was 
established using a calculation program 
(http://endmemo.com/bio/dnacopynum.php). In summary and a brief example, 
the DNA concentration (e.g. 0.04g/l) was calculated and converted to M (e.g. 
0.000946M). These figures were entered into the above website and converted 
into the DNA copy number (e.g. 569, 940, 828, 402). The next step was to 
calculate the concentration of DNA that would hold 10 000 000 DNA copies. 
This was achieved as follows:- 
1. 0.04g/l = 40ng/l = 569, 940, 828, 402 DNA copies 
2. 1/1000 = 40pg/l 
3. 1/57 = 0.7pg/l = 10 000 000 DNA copies 
Serial dilutions were prepared in order to obtain a standard curve that ranged 
from 10 million DNA copies to 100 DNA copies. qRT-PCR was then performed 
in triplicate. The cloned vector was sequenced (by Eurofins MWG Operon, 





2.1.3.4 Optimising Primer Concentration 
With all primers used, it was imperative that the optimal concentration for each 
primer for qRT-PCR was established.                                        
                   
 
   Figure 2.1: Shows a primer concentration matrix. 
Concentrations of the AR forward and reverse primers were set up as Figure 
2.1 SYBR green qRT-PCR was performed with 25ng of cDNA (from a male 
control sample) and the Ct values and melt curves were compared to establish 




2.1.3.5 Melt curve analysis  
Using SYBR green qRT-PCR assay means that melt curve analysis must be 
performed. The purpose of this analysis is to check that primers are giving a 
specific PCR product and there is no non-specific amplification e.g. primer 
dimers. All SYBR green assays were checked in this way and the assays that 
displayed a single peak were used for further qRT-PCR analysis and the assays 
that demonstrated multiple peaks were discarded and their use was 
discontinued and the primers were redesigned. Figure 2.2 A is a typical image 
for primer sets that had an optimal melt curve pattern whereas any melt curve 
patterns that resembled Figure 2.2 B were discarded. 
 
 
     
Figure 2.2: A) A melt curve with one single peak shows a good affinity between primer and 






2.1.3.6 Optimising and validating custom-made primer sets 
Due to the large number of genes chosen for investigation, it was not possible 
to design, optimise and validate each set of primers due to time constraints. 
Therefore certain primers sets were synthesised from previously published and 
validated sequences (Hogg et al., 2011). The remainder of primer sets used in 
the current study were designed by PrimerDesign (U.K.), who optimised each 
primer set.  
Confidence of the specificity of a primer set can be gleaned from analysis of the 
melt curve that can be generated after SYBR green qRT-PCR (Tindall et al., 
2009). Figure 2.2 A depicts a melt curve with one large peak. This shows good 
design of a particular primer set as the peak represents product with no other 
inferences. Figure 2.2 B illustrates a primer set that has been designed with 
poor consideration of the forward and/or reverse primers as more than one 
peak in a melt curve would imply that there are secondary structures being 
created during qRT-PCR, as well as product. Melt curve analysis was 
performed on all the primer sets used in this study and confirmed product 
specificity, giving confidence that each primer set was amplifying the correct 
amplicon. The primer sets (DISC1 and RORA) that were designed within our lab 
were discarded due to the observation of secondary structures during melt 
curve analysis and because the cloning and sequencing of these PCR products 




2.1.4.1 Pre-validated assays for cerebellar gene expression studies 
Due to time constraints, there was difficulty validating every GOI primer set. 
Pre-validated SYBR green primers were therefore made by PrimerDesign 
(Table 2.3) or published primer sequences, that have been used on sheep 
tissue and been successful, were used (Hogg et al., 2011). Melt curve analysis 
was also performed on these primers in order to detect and artefacts or 
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Table 2.4: Primer sequences that have been published for use in ovine tissue. All primers sets 




2.1.4.2 Pre-validated assays for cortex gene expression studies 
Published primer sequences, that have either been used on sheep tissue, or 
shared close homology with the ovine sequence and been successful, were 
used. Table 2.5 shows the GOI, its primer sequences and the publication where 







(5’ – 3’) 
 





























Hogg et al., 
(20110 
ERBA BETA 1 
(NM_0011903
91) 









































Attia et al., 
(2009) 





2.1.4.3 qRT-PCR Assay set up 
SYBR green Quantitative PCR (qRT-PCR) was performed on the cDNA 
samples from the male control group and the TP-treated male group. One 
Taqman qRT-PCR primer and probe set was used for one gene of interest 
(GFAP). The cDNA concentration that was used for all qRT-PCR experiments 
after optimisation was 12.5ng per reaction. 
Gene expression of each GOI was evaluated using qRT-PCR analysis. There 
were eight samples in total for the cerebellar tissue - four in the control group 
and four in the TP treated group whereas for the cortex samples, there were six 
in each group (twelve in total). Each sample was analysed in quadruplicate and 
had two negative controls – a no template (water only) and a no reverse 
transcriptase (no RT). When a master mix was prepared, it was prepared for 
fifty reactions to take into account potential pipette accuracy deviations and 
ensure sufficient mix for the analysis. PrecisionBlue Precision MasterMix with 
ROX with SYBRgreen (Primer Design, U.K.) was used in all SYBR green 
assays whereas TaqMan Universal PCR Master Mix (without UNG, Life 
Technologies, U.K.) was used for the Taqman assay. SYBR green assays 
made by PrimerDesign (U.K.) and the one Taqman assay were performed in 
the following way:- 
Mastermix For 1 reaction (l) 
Primer set 1 
Mastermix 10 
Water 4 
TOTAL VOLUME 15 
Table 2.6: This table shows the volumes needed for mastermixes for PrimerDesign and Taqman assays. 
The PrimerDesign primers had a stock concentration of 30 micromolar (m) and the Taqman primer and 
probe set had a stock concentration of 25 m. Therefore the final concentrations for each primer by 
PrimerDesign was 300nm and by Taqman, 250nm.  
                                    
For the above assays (Table 2.6), the forward and reverse primers were 




In the case of assays where primer sets were separate forward and reverse 
(Tables 2.4 and 2.5), Table 2.7 details the reaction mix constituents: 
 
Mastermix For 1 reaction (l) 
Forward primer 1 
Reverse primer 1 




TOTAL VOLUME 15 
Table 2.7: This table shows the volumes needed for the mastermixes for the published assays. Each 
primer had a stock concentration of 25m and a final concentration of 250nm.                                                                                                
 
Once the mastermix was prepared, 15l was added to the correct number of 
wells of a 96-well plate. Then, 5l of water, no RT or 2.5ng/l cDNA was added 
into the appropriate wells. The StepOnePlus Real-Time PCR system (ABI, U.K.) 
was used as follows; the holding stage (95.0oC for ten minutes) and the cycling 
stage (95.0oC for fifteen seconds then 60.0oC for one minute) for forty cycles. 
With the SYBR green assays, melt curve analysis was also performed at the 
end of the cycling profile by heating to 60.0oC for one minute, then gradually 
increasing the temperature in 0.3oC increments until 95.0oC. At each 
temperature increment, a measurement was taken permitting a curve to be 
formed. CT values were obtained in order to calculate the fold difference for 
each sample.  Threshold setting was automatically generated by the machine 
software, but checked visually in each case. The fold difference was calculated 





2.1.4.4 Reference gene selection 
The expression levels of a panel of 12 candidate reference genes from Primer 
Design were determined using geNorm analysis (Vandesompele, 2002) in order 
to select the most appropriate (stable over all treatments) reference genes. This 
is a software program that establishes which genes are the most stable to use 
as a reference gene(s) in the sample tissue (Bustin et al., 2009). For cerebellar 
gene expression studies, beta-2 microglobulin (B2M) and ribosomal protein L19 
gene (RPL19) were selected as the reference genes as they were the most 
stable in the male control and TP treated groups. For cortex gene expression 
studies, malate dehydrogenase 1 (MDH1) and ribosomal protein S2 gene 
(RPS2) have been selected as the reference genes. Reference gene selection 
was performed using  SYBR green qRT-PCR as Table 2.6. 
  
2.1.4.5 Melt curve analysis 
With the SYBR green assays, melt curve analysis was also performed. This 
allowed the determination of whether there were secondary structures i.e. 
primer dimers. A good melt curve should have one single peak (Figure 2.2 A) 
whereas a melt curve with multiple peaks indicates secondary structures were 
formed (Figure 2.2 B). 
2.1.4.6 Calculating CT  
Each assay was done in quadruplicate for each sample and the three closest CT 
values were used for the 2-CT method (Table 2.8). Reference genes are 
needed in qRT-PCR as „no change‟ comparators for the purposes of 
normalisation. The geometric reference mean was calculated using reference 
genes CT values (Vandesompele et al., 2002) This was acheived by taking a 
mean of three CT values for each of the two reference genes and then 
multiplying the two means together. Then the square root of that was calculated 
to derive the geometric reference mean. This was done for each sample. CT 
was calculated by subtracting the mean CT value for each particular GOI away 
from the geometric reference mean value. Then, CT could be calculated by 
subtracting the CT value from one of the samples i.e. the reference sample. 
For this study, sample number 204/1 was chosen as the reference sample. This 
was because it was the first control sample when placed in numerical order. 
This sample was kept constant in all the calculations and was chosen because 
it was the first control sample in ascending numerical order (sample 204/1). The 
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fold difference was then calculated by 2CT*(-1). Fold changes that were less 
than two were considered to not illustrate any change in gene expression and 
not reported. 
A) 
 Sample 204/3 
Mean B2M CT 26.6633 
Mean RPL19 CT 20.904 
Multiply means (26.6633 X 20.904) 557.36962 
Square root of 557.36962 (Geo ref mean) 23.608676 
B) 
Sample Treatment CT CT 
Mean 
CT S.D. Geo. 
Ref. CT 
 CT  CT Fold 
Difference 
204/3 Control 20.635 20.657 0.0197 23.609 -2.952 -0.152 1.111 
204/3  20.673       
204/3  20.663       
Table 2.8: Worked example A) Geometric reference mean calculation B) The fold difference calculation for 
one sample in a StAR assay. Sample – Sample number of the sheep. Treatment – Whether the sample 
received control or TP vehicle. CT – Threshold cycle, determined by qRT-PCR. CT mean – The mean of the 
three CT values per sample. CT S.D. – Standard deviation of the three CT values. Geo. Ref. CT – Geometric 
reference mean CT value. CT – Normalisation of CT obtained by subtracting the Geo. Ref. CT: (ΔCT =CT – 
Geo. Ref. CT). CT – Identifies relative quantification between sample and a replicate sample (CT = 
CT - CT sample 204/1). Fold difference – fold change between sample and replicate sample (Fold 
change = 2CT*(-1)). 
2.1.4.7 Statistical analysis 
Each individual sample therefore generated a single data point, which was 
derived from a fold change over/below the reference.  These data points are 
then the gene expression score for that particular sample. The results from the 
male control group and the male TP treated group were compared to determine 
differences in gene expression, if any, using a two tailed, unpaired t test 
(GraphPad Prism software, U.S.A.).  
Fold change shift in TP-treated group was calculated using: - TP/Control mean 
fold change 





2.1.5 Protein Preparation 
2.1.5.1 Protein Dialysis 
The protocol for optimising protein preparation from samples used to extract 
RNA was followed from Hummon et al., (2007). Due to the limited number of 
samples, the protein fraction was obtained during RNA isolation. The sample 
was loaded onto a 2K molecular weight cut-off (MWCO) Slide-A-Lyzer dialysis 
cassette (Thermo Scientific. U.K.) with 1% SIGMA FAST protease inhibitor 
cocktail solution (Sigma Aldrich, U.K.) and dialysed through three changes of 
0.1% sodium dodecyl sulphate (SDS, Sigma Aldrich, U.K.) in distilled water at 
4oC. The supernatant was removed from the cassette and placed into a tube. 
The globular mass in the cassette was also placed into a tube and both were 
stored at -20oC. 500l of the supernatant and the globular mass were placed 
into separate concentrator tubes (15ml, Thermo Scientific, U.K.) and 11.5ml 0.1% 
SDS was added to each tube and centrifuged at 6000 x g. The liquid that had 
not been drawn down into the collecting part of the tube i.e. the concentrated 
supernatant and globular mass, was used for the subsequent step. 
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2.1.5.2 Protein extraction optimisation 
In order to allow further analysis to identify whether the protein required 
concentration and to determine the optimum buffer requirements for 
solubilisation, the globular mass concentrated protein fraction was added to 
either 1% SDS, 8M Urea and Tris or a combination of the two solvents (equal 
volumes) and stored at -20oC (Figure 2.3).  
 
Figure 2.3: A diagram to show the process and conditions of protein preparation to find the 
optimal condition for protein analysis. 
2.1.5.3 Determining Protein Concentration 
The bicinchoninic acid (BCA) assay was used to determine protein 
concentration for all samples, using bovine serum albumin (BSA, Sigma Aldrich, 
U.K.) as the standard. BSA standards, made up from 10mg/ml BSA solution, 
were 0, 0.2, 0.4, 0.6, 0.8 and 1.0mg/ml. The working solution was made up with 
bicinchoninic acid and copper (II) sulphate pentahydrate 4% solution (solutions 
supplied together by Sigma Aldrich, U.K.). In a 96-well plate, each standard was 
added into the appropriate wells and the protein samples were diluted to a 1:5 
dilution, using dH2O. The working solution was added to each well and 
incubated at 37oC for 30 minutes. The plate was then read by LT-5000 MS 




2.1.6 Western Blotting as a protein detection method  
Western blotting refers to the immunological detection of a protein, using 
specific antibodies. Proteins of different molecular weights (kDa) will separate 
accordingly via SDS-PAGE gel electrophoresis, the gel is then transferred to a 
more stable membrane i.e. nitrocellulose and then the membrane is probed for 
the protein of interest. 
Enhanced Chemiluminescence (ECL) was used for signal detection because it 
is highly sensitive, so even the weakest band, if any, should be observed. A 
charged couple device (CCD) camera is used to capture the ECL signals on a 
blot and is highly dependent on timing and exposure. This method of imaging 
gives a broader linear dynamic range whereas using an alternative method 
such as X-ray film exposure is inaccurate for quantifying results, because of its 
lower dynamic range (Elbaggari, 2008). A broad, linear dynamic range allows 
comparision of weak and strong bands on the same blot. ECL exposure times 
can be cut drastically because CCD imaging is more sensitive than X-ray 
imaging (Elbaggari, 2008).   
Western blotting is often used for semi-quantification of protein levels. This 
requires the digitisation of a probed immunoblot and subsequent analysis of the 
gray values of the bands in the resulting images. In principle, the quantification 
procedure consists of acquiring an image of the immunoblot, the bands 
detected are then selected and using computer software, the optical density 
(OD) can be determined (Gassmann, et al., 2009). This would allow us to 
determine the amount of the protein of interest in the TP-treated group, relative 




2.1.6.1 SDS-PAGE electrophoresis 
The absorbance read for each of the unknown protein samples was then 
converted into a concentration (mg/ml). From this, 50g of each protein sample 
was used in for Western blotting analysis. 2X Laemmli buffer (4% SDS, 20% 
glycerol, 10% 2-mercaptoethanol, 0.004% bromphenol blue and 0.125 M Tris 
hydrogen chloride, Sigma Aldrich, U.K.) was added to each sample, which were 
then boiled at 100oC for 5 or 10 minutes (Kurien and Scofield, 2009), in order to 
denature the higher order structure, while retaining sulfide bridges. Denaturing 
the protein ensures that the negative charge of amino acids is not neutralised, 
enabling the protein to move in an electric field applied during electrotransfer 
(Mahmood and Yang, 2012). The samples were then loaded onto a SDS-PAGE 
gel, along with Page Ruler 10-250kDa ladder (Thermo Scientific, U.K.).   Tables 
2.9 and 2.10 refer to the volumes of reagents used to make one gel.                
Reagent Volume Volume 
 10% 12% 
H2O 6ml 4.8ml 
30% Acrylamide 3.8ml 3.9ml 
1.5M Tris (pH8.8) 5ml 6ml 
10% SDS 150l 150l 
10% APS 150l 150l 
TEMED 10l 10l 








Table 2.10: The reagents and volumes used to make a 5% stacking gel for SDS-PAGE. 
Reagent Volume 
H2O 2.7ml 
30% Acrylamide 500l 
1.5M Tris (pH8.8) 670l 
10% SDS 40l 




2.1.6.2 Primary antibody selection 
Primary antibodies were selected by determining which antibody was most 
suitable for use on ovine tissue. Some of the antibodies available on the market 
stated they were suitable for use on ovine tissue; others did not. Therefore we 
aligned the protein sequences for ovine, bovine, human and murine to 
determine the homology of a particular target, using CLC sequence viewer 
software (http://www.clcbio.com/index.php?id=28). The results for the sequence 
alignment, together with liaising with the antibody manufacturers (Abcam and 
Santa Cruz), allowed us to determine that all the antibodies initially chosen, 
were suitable for this investigation. To determine which was the most suitable 
dilution for each primary antibody, titration optimisation experiments were 
performed (Table 2.11). StAR and 5-reductase 1 antibodies were predicted to 
react to the bovine protein sequence, which is very similar to the ovine protein 
sequence. The PR and 5-reductase 2 antibodies did not specify whether they 
would react on ovine or bovine tissue but after contact with the suppliers, they 
suggested they could. Due to the limited demand and supply of antibodies 
reactive to ovine tissue, these were the most suitable antibodies to test.  Lamb 
adrenal gland tissue was used as a positive tissue control in order to validate 
the antibodies, as it is known to express high levels of the proteins of interest 
(Nussey and Whitehead, 2001). IgG serum, specific to which species each 






















































2.1.6.3 Western Blotting 
50g protein was loaded and resolved on a SDS-PAGE gel (see Tables 2.9 and 
2.10) at 200V for 45 minutes and then transferred onto a nitrocellulose 
membrane (Thermo Scientific, U.K.) via two methods of transfer. For semi-wet 
transfer, three pieces of filter paper (the same size as the gel) were soaked in 
cold transfer buffer (100mM tris, 130mM glycine and 10% methanol which was 
added fresh each time) and placed onto the transfer apparatus, ensuring no air 
bubbles were formed. The nitrocellulose membrane was also soaked in transfer 
buffer and placed on top of the filter paper. Another three pieces of filter paper 
soaked in transfer buffer was added on top of the membrane, again removing 
any air bubbles. The Trans-Blot SD Semi-Dry Transfer Cell (Bio Rad, U.K.) was 
then set to 15 volts for 60 minutes. For wet transfer, the same gel sandwich was 
made, then fully submersed in cold transfer buffer in a transfer tank at 100 volts 
for 60 minutes. 
To check for sufficient transfer, the protein bands were visualised with 
Memcode Reversible Stain kit (Thermo Scientific, U.K.) or 0.1% Ponceau S 
buffer (Sigma, U.K.). The membrane was then blocked in 5% non-fat milk (NFM) 
or 5% BSA in tris-buffered saline (TBS: 50mM Tris base, 150mM sodium 
chloride, pH 7.4) at 4oC for 2 hours on a rocker.  
Each antibody (Table 2.11) was diluted in 5% NFM or 5% BSA in TBS buffer 
which was added to the blot and left at 4oC overnight on a rocker. The blot was 
then washed in TBS-0.1% Tween (TBS-T) four times for five minutes each. The 
blot was then incubated with the correct secondary antibody (see Table 3) for 1 
hour at room temperature on a rocker and washed as before. Pierce Enhanced 
chemiluminescence (ECL, Thermo Scientific, U.K.) detection was used to 
visualise the bands on the BioRad Chemidoc XRS image analyser (U.K.). The 
substrate was applied to the blot for 5 minutes before exposure times began at 






2.1.7.1 Sample Processing 
Ovine cerebellar and cortex tissues from the control and TP treated groups (GD 
90 fetal injection) were fixed and stored in neutral formalin buffer. Samples were 
processed in an automated Leica TP1050 tissue processor (Leica 
Microsystems, Milton Keynes, UK). In summary, the tissues were then 
dehydrated using standard protocols with ethanol and xylene and paraffin wax 
was used to stabilise the fixed tissue (Table 2.12). The tissue was then 
embedded in heated liquid paraffin wax and cooled into blocks for long term 
storage at room temperature. 


























Ambient Ambient 120 On 
Absolute 
Ethanol 
2hr Ambient Ambient 120 On 
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2hr Ambient Ambient 120 On 
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Xylene 1hr Ambient Ambient 120 On 
Xylene 1hr Ambient Ambient 120 On 
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1hr 60oC P/V 120 On 
Paraffin 
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The wax-embedded tissue was sectioned in 50m intervals to 5m thickness 
using a Leica RM 2135 microtome and wax ribbons were transferred to a pre-
heated water bath (55°C), to float the sections to remove creases in the tissues  
and then mounted onto charged slides (Superfrost Plus Gold slides, Thermo 
Scientific, Germany). The slides were then placed in an incubator at 50°C 
overnight to dry. The slides were dewaxed in xylene (Sigma Aldrich, U.K.) and 
then gradually rehydrated in ethanol at concentrations of 100%, 95% and 70% 




2.1.7.2 Haematoxylin and Eosin Staining 
The slides were immersed in haematoxylin (Harris modified, Vector 
Laboratories, U.K.) for four minutes with gentle agitation at room temperature 
and then rinsed with running tap water for one minute. Then the slides were 
placed in 0.1% acetic acid for one minute at room temperature and then 
washed in warm tap water with 1.5% lithium carbonate for 30 seconds. The 
sections were briefly rinsed again in tap water and then placed in 0.1% eosin 
(the counterstain) for five minutes at room temperature. The sections were then 
dehydrated in ascending graded ethanol solutions, cleared in xylene and then 
mounted in Pertex mountant (Vector Laboratories, U.K.). The slides were then 
ready for visualisation.  
2.1.7.2.1 Visualisation 
The slides were visualised under a light microscope (Leitz Laborlux S, Germany) 
using the X10 and X20 objectives. The sections were digitally captured and 
recorded using Spot 32 software (Diagnostic Instruments Inc., U.S.A.).  
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2.1.7.3 Nissl Staining 
The wax-embedded tissue was sectioned in 50m intervals to different 
thicknesses ranging from 5m to 40m.  For subsequent Nissl experiments, the 
cerebellar tissue was cut at a thickness of 5m. 0.1% cresyl violet solution 
(Fisher Scientific, U.K.) was warmed to 65oC.  The sections were immersed in 
this solution for ten minutes at room temperature, with gentle agitation. The 
slides were rinsed briefly in tap water and then placed in 95% ethyl alcohol for 
one hour at room temperature, with gentle agitation. The sections were then 
dehydrated in ascending graded ethanol solutions, cleared in xylene and then 
mounted in Pertex mountant (Vector Laboratories, U.K.). The slides were then 
ready for visualisation.  
2.1.7.3.1 Visualisation 
The slides for both brain tissues were visualised under light microscopy (Leitz 
Laborlux S, Germany) using the X10 and X20 objectives. The sections were 
digitally captured and recorded using Spot 32 software (Diagnostic Instruments 
Inc., U.S.A.). Using Image J software (N.I.H., U.S.A.), each captured image was 
examined in five random areas of each slide (fours slides per sample). In each 
of the five random areas, five sections of the cerebellar tissue were measured 
so that five widths were obtained for the EGL, ML and IGL and the mean for 
each layer was then calculated.  
2.1.7.3.2 Statistical Analysis 
All statistics were performed as two-tailed unpaired t-tests (GraphPad Prism 6, 
GraphPad Software Ltd., U.S.A.). This allowed us to investigate if there were 





2.1.7.4 Immunohistochemistry as a protein detection method 
2.1.7.4.1 Immunohistochemistry 
Immunohistochemistry is a technique that detects an antigen within a tissue 
section, by the use of a specific antibody (Ramos-Vara, 2005). There were 
many steps involved and begins with the deparaffinization and rehydration of 
the sections (see Rae et al., 2013). Antigen retrieval was then performed to 
release the cross linking that the fixative (neutral formalin buffer) has caused 
and allowed the epitope of the antigen to be exposed. Antigen retrieval was 
achieved using 0.1M citrate buffer (0.1M citric acid monohydrate, pH 6). The 
slides, submerged in citrate buffer, were placed in a microwave for five minutes 
on high setting (750W) with one minutes rest, and then a further five minutes on 
high setting, followed by twenty minutes rest. Each slide was then blocked in 3% 
hydrogen peroxide (Sigma Aldrich, U.K.) solution in distilled water (dH2O) for 
twenty minutes at room temperature. The purpose of the hydrogen peroxide 
step was to quench any endogenous peroxidise activity in the tissue (Ramos-
Vara, 2005). The slides were washed in distilled water followed by two 
washings in (Tris buffered saline) TBS for five minutes each. In a humidified 
chamber, the samples then underwent serum blocking using prediluted 2.5% 
horse serum (Vector Laboratories, U.K.) for thirty minutes at room temperature. 
This step is performed to reduce non-specific binding sites. Following the serum 
block, excess serum was blotted from each section, with care taken not to 
permit any drying of the tissue sections. 50l of the appropriate primary 
antibody was added to each section.  
Tables 2.13 and 2.14 refer to the antibodies and dilutions used in 
immunohistochemistry. Each primary antibody was diluted in commercially 
prediluted horse serum. The slides were then incubated overnight at 4oC in a 
humidified chamber. As with all primary antibodies, they need to react with the 
tissue species so in this case the antibodies used, detected antigen in or were 
predicted to react in ovine and/bovine tissue. Lamb adrenal gland tissue was 
used as a positive tissue control in order to validate the antibodies, as it is 
known to express high levels of the proteins of interest (Nussey and Whitehead, 
2001). IgG serum, specific to which species each antibody was raised in, was 
used instead of primary antibodies, as a negative control.  
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The primary antiserum incubation was followed by two washes of TBS and 0.1% 
Tween (TBS-T) at five minutes each, with gentle agitation.  
The sections were then incubated with biotinylated secondary antibody (1:200 
dilution, prediluted multi-species secondary antibody, Vector Laboratories, U.K.) 
for thirty minutes at room temperature in a humidified chamber. The slides were 
then washed in TBS-T, twice for five minutes. Avidin-biotin-HRP (horse radish 
peroxidise) complex (ABC complex, Vector Laboratories) was applied to each 
section and incubated at room temperature for thirty minutes in a humidified 
chamber. The ABC complex is a complex of avidin mixed with biotin linked with 
appropriate label (in this case, horseradish peroxidise). The avidin and labelled 
biotin react together, resulting in the formation of a large complex with 
numerous molecules of label (Polak and Van Noorden, 2003) . The slides were 
washed again in TBS-T, twice for five minutes, with gentle agitation.  
3,3‟-diaminobenzidine (DAB) substrate solution was made up, as per 
manufacturer‟s instructions (Vector Laboratories, U.K.) and then added to the 
slides. DAB reacts by staining cells which are positive for the specific antigen. 
DAB binds to the ABC complex and oxidizes the horseradish peroxidase, thus 
producing a brown precipitate (as per manufacturer‟s instructions, Vector 
Laboratories). The colour development of the DAB substrate was carefully 
monitored by microscopy and once the colour development was sufficient, the 
slides were rinsed in dH2O for five minutes. The counterstain used was 
haematoxylin (Harris modified, Vector Laboratories, U.K.) so that cells that do 
not express the particular protein of interest are stained blue. 
The slides were immersed in haematoxylin for 1 minute and then placed in 
running tap water. The sections were then dehydrated in ascending graded 
ethanol solutions, cleared in xylene and then mounted in Pertex mountant 
(Vector Laboratories, U.K.). The slides were then ready for visualisation. 
2.1.7.4.1.1 Visualisation for cerebellar tissue 
The slides were visualised using light microscopy (Leitz Laborlux S, Germany) 
using the X40 objective. The number of positive cells was counted for each 
slide using a grid eyepiece. The sections were digitally captured using CellSens 
1.9 software (Olympus, U.S.A). Each slide was examined in five random areas 
using the grid eyepiece. The sections counted were also randomly allocated. 
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The eye grid was measured in conjunction with a stage micrometer, so that the 
real size of the grid can be calculated (in this study this number was 0.28mm). 
This number was then divided by 1mm to obtain the number, which is needed to 
be multiplied with 0.28mm, in order to achieve a conversion of mm into positive 
cells per mm2. This did not have any bearing on whether or not there were any 
differences in cell number due to TP-treatment, as all data was subjected to the 
same calculation. The mean of the five grids was calculated and then multiplied 
by 3.57 to convert the mean into positive cells/mm2. The value of each grid of 
positive cells was 0.28mm and by multiplying each grid by 3.57 converts the 
mean into mm2. This analysis allowed us to determine if androgen exposure 
had altered the number of cells expressing the antigen per unit area of 




2.1.7.4.1.2 Primary antibody selection 
The antibodies used in our study are all polyclonal antibodies. Polyclonal 
antibodies are a heterogeneous mix of antibodies that recognise several 
epitopes. This is in contrast to monoclonal antibodies, which show specificity for 
a single epitope and are therefore considered more specific to the target 
antigen than polyclonal antibodies. Therefore there will be more background 
staining of polyclonal antibodies, which is reflected in our findings. A way to 
minimise non-specific background staining, is to use highly diluted antibodies 
and so we have chosen these for all immunohistochemical analysis. Table 2.13 
shows the antibodies and dilutions used for optimisation studies and the 
optimised dilution for cerebellar tissue.  























Abcam ab101896 1:250 
1:2000 
1:2000 
Calbindin Sigma Aldrich C9848 1:2000 
1:3000 
1:3000 


















2.1.7.4.1.3 Localisation studies 
We investigated the colocalisation of AR and calbindin in the developing male 
cerebellum and attempted to do this in male cortex tissue (Table 2.14). We 
chose these proteins as we have previously shown that AR is located in the 
nuclei of Purkinje cells and calbindin is a known Purkinje cell marker (Dougherty 
et al., 2013).  
Protein of 
interest 
Antibody Company Product code Dilution titer 
experiments 





Santa Cruz Sc-816 1:100 
1:1000 
T-box, brain, 1 





TBR-1  rabbit 
polyclonal 
Merck Millipore AB10554 1:50 
1:100 
1:400 












Table 2.14: A list of the antibodies used in localisation studies on cerebellar and cortex tissue 
2.1.7.4.1.4 Statistical Analysis 
All statistics were performed as two-tailed unpaired t-tests (GraphPad Prism 6, 
GraphPad Software Ltd., USA). This allowed the investigation of potential 
differences in protein expression and Purkinje cell morphology between the 




2.1.7.5 Simultaneous Immunofluorescence 
Antigen retrieval was achieved using 0.1M citrate buffer (0.1M citric acid 
monohydrate, made upto 800ml in distilled water, pH 6). The slides, submerged 
in citrate buffer, were placed in a microwave for five minutes on high setting 
(750W) with one minutes rest. This cycle was repeated a further two times and 
followed by twenty minutes rest. The slides were washed in (phosphate 
buffered saline) PBS (tablets, Sigma, U.K.) for five minutes. In a humidified 
chamber, the samples then underwent serum blocking using goat serum (20% 
NGS / 5% BSA in PBS) for thirty minutes. Following the serum block, excess 
serum was blotted from each section, with care taken not to permit any drying of 
the tissue sections. Avidin block was added to each section for 15 minutes and 
the slides were then briefly washed in PBS. Biotin block was then added to the 
sections for a further 15 minutes and briefly washed in PBS. 50l of the primary 
antibody dilution was added to each section. The two primary antibodies 
(calbindin, 1:1000 dilution and AR, 1:50 dilution) were diluted in goat serum (20% 
NGS / 5% BSA in PBS). The slides were then incubated overnight at 4oC in a 
humidified chamber. The negative controls used in this study were goat serum 
in place of a primary antibody for one section and goat serum in place of a 
secondary antibody for another section. 
The primary antiserum incubation was followed by two washes of PBS at five 
minutes each, with gentle agitation. The sections were then incubated with 
biotinylated secondary antibody (goat anti-rabbit antibody, Vector Laboratories, 
U.K.) at a 1:500 dilution in goat serum (20% NGS, 5% BSA, PBS) for 1 hour at 
room temperature in a humidified chamber. This was followed by two washes of 
PBS at five minutes each. The sections were further incubated with 
fluorescently-labelled StreptAvidin 594 (Vector Laboratories, U.K.) and 
Alexafluor goat anti-mouse 488 (Invitrogen, U.K.) which were both diluted to 
1:100 in goat serum (2.0% NGS, 0.5% BSA in PBS). This incubation was 
followed by two washes of PBS in a light tight box, at five minutes each. The 
slides were mounted in Vectashield (aqueous mounting medium containing 
DAPI, Vector Laboratories, U.K.), air-dried in the dark and stored at 4oC. The 
slides were then ready for visualisation. 
2.1.7.5.1 Visualisation 
Images were captured using confocal microscopy. 
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2.1.7.6 Sequential Immunohistochemistry 
Antigen retrieval was achieved using 0.1M citrate buffer (0.1M citric acid 
monohydrate, made upto 800ml in distilled water, pH 6). The slides, submerged 
in citrate buffer, were placed in a microwave for five minutes on high setting 
(750W) with one minutes rest, and then a further five minutes on high setting, 
followed by twenty minutes rest. Each slide was then blocked in 3% hydrogen 
peroxide (Sigma Aldrich, U.K.) solution in distilled water for twenty minutes. The 
slides were washed in dH2O followed by two washings in PBS for five minutes 
each. Avidin block was added to each section for 15 minutes and the slides 
were then briefly washed in PBS. Biotin block was then added to the sections 
for a further 15 minutes and briefly washed in PBS. 50l of the primary antibody 
dilution was added to each section. 50l of the primary antibody dilution was 
added to each section. The first primary antibody, AR, (1:50 dilution) was 
diluted in goat serum (20% NGS / 5% BSA in PBS). The slides were then 
incubated overnight at 4oC in a humidified chamber. The negative controls used 
in this study were goat serum in place of a primary antibody for one section and 
goat serum in place of a secondary antibody for another section. 
The first primary antiserum incubation was followed by two washes of TBS-T at 
five minutes each, with gentle agitation. The sections were then incubated with 
biotinylated secondary antibody 1:500 dilution in goat serum (20% NGS, 5% 
BSA, PBS) for thirty minutes at room temperature in a humidified chamber. The 
slides were then washed in TBS-T, twice for five minutes. Avidin-biotin-HRP 
(horseradish peroxidise) complex (ABC complex, Vector Laboratories, U.K.) 
was applied to each section and incubated at room temperature for thirty 
minutes in a humidified chamber. The slides were washed again in TBS-T, 
twice for five minutes, with gentle agitation. NovaRED substrate solution (Vector 
Laboratories, U.K.) added to the slides. The colour development of the 
substrate was carefully monitored by microscopy and once the colour 
development was sufficient (approximately 5 minutes), the slides were rinsed in 
dH2O for five minutes. The counterstain used was haematoxylin (Harris 
modified, Vector Laboratories, U.K.). The slides were immersed in haematoxylin 
for 1 minute and then placed in running tap water. 
These slides were then exposed to an Avidin block for 15 minutes and the 
slides were then briefly washed in PBS. Biotin block was then added to the 
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sections for a further 15 minutes and briefly washed in PBS. 50l of the primary 
antibody dilution was added to each section. 50l of the primary antibody 
dilution was added to each section. The second primary antibody, calbindin, 
(1:3000 dilution) was diluted in goat serum (20% NGS / 5% BSA in PBS). The 
slides were then incubated overnight at 4oC in a humidified chamber. The 
negative controls used in this study were goat serum in place of a primary 
antibody for one section and goat serum in place of a secondary antibody for 
another section. 
The second primary antiserum incubation was followed by two washes of TBS-
T at five minutes each, with gentle agitation. The sections were then incubated 
with biotinylated secondary antibody 1:500 dilution in goat serum (20% NGS, 5% 
BSA ,PBS) for thirty minutes at room temperature in a humidified chamber. The 
slides were then washed in TBS-T, twice for five minutes. Avidin-biotin-HRP 
(horseradish peroxidise) complex (ABC complex, Vector Laboratories, U.K.) 
was applied to each section and incubated at room temperature for thirty 
minutes in a humidified chamber. The slides were washed again in TBS-T, 
twice for five minutes, with gentle agitation. 3,3‟-diaminobenzidine (DAB) 
substrate solution was made up, as per manufacturer‟s instructions (Vector 
Laboratories, U.K.) and then added to the slides. The colour development of the 
DAB substrate was carefully monitored by microscopy and once the colour 
development was sufficient, the slides were rinsed in dH2O for five minutes. The 
counterstain used was haematoxylin (Harris modified, Vector Laboratories, 
U.K.). The slides were immersed in haematoxylin for 1 minute and then placed 
in running tap water. The sections were then dehydrated in ascending graded 
ethanol solutions, cleared in xylene and then mounted in Pertex mountant 
(Vector Laboratories, U.K.). The slides were then ready for visualisation. 
2.1.7.1.6.1 Visualisation 
The slides were visualised under light microscopy (Leitz Laborlux S, Germany) 
using the X10 and X20 objectives. The sections were digitally captured and 





2.1.8 Microarray experiments 
Microarray was performed by the Oxford Gene Technology company (U.K.). GD 
90 male cortex samples were used from four different treatment groups – 
control, TP, DES and DEX. Each treatment group comprised of six samples. 
The microarray was performed on an Agilent sheep transcriptome wide 
microarray (AGEOD-10778). In summary, TIFF image files were processed 
using Agilent's Feature Extraction software (v10.7.3.1) which carried out a 
number of normalization steps including; background correction, dye bias 
correction (via LOWESS normalization) and flagging outlier spots on each 
array. A pdf report was generated for each array to highlight whether any 
sample had failed a key QC metric. The 24 feature extracted files were then 
imported into GeneSpring GX v11.5 and log(2) ratios were calculated as 
Cy3(sample)/Cy5(reference) and sample annotation was added. Box plots were 
produced to examine the spread of data across all arrays. 
GeneSpring has a quality control module that was run on the samples. The data 
was examined using Principal Component Analysis (PCA) which shows how 
closely samples are related to each other based on the variance in the signal 
intensity data. Ideally, samples in the same replicate group will cluster closely 
together. To keep the data set as clean as possible, probes were filtered out if 
they were flagged as control probes, non-uniform, saturated or an obvious 
outlier 
Hierarchical clustering (HCL) was performed on the filtered data to see how well 
the samples cluster. Finally, boxplots of each group were produced to compare 
the signal distribution of the samples. Volcano analysis (which combines 
statistical T-Tests and fold change analysis) was used to compare the control 
and TP-treated. All groups were compared using ANOVA analysis with the 
Benjamini-Hochberg multiple testing correction applied. The significant result 
sets from the Volcano Analysis were analysed for over represented Gene 
Ontology terms (GO analysis). 
 



















3. Steroid synthesis and signalling in the developing ovine cerebellum 
3.1 Aims and Objectives 
3.1.1 Aim 1 and objectives 
To identify whether genes associated with steroid signalling and metabolism are 
expressed in GD 90 male sheep and whether mRNA expression levels are 
altered as a result of androgen over-exposure.  
Numerous genes, and the functional proteins they encode, are key to steroid 
synthesis and metabolism. These genes have been described in the cerebellum. 
However, the role of androgens in cerebellar development is unknown. The 
hypothesis for this study is that the full complement of steroid-associated genes 
are expressed in the cerebellum of male fetal sheep at GD 90. It is further 
hypothesised that prenatal excess androgen (2x20mg depot injections at GD 62 
and GD 82) alters cerebellar steroid-associated gene expression in GD 90 male 
sheep, as measured by qRT-PCR and Western blotting. RNA integrity, the 
optimisation of primer sets utilised in qRT-PCR and of components utilised in 
Western blotting were performed. 
3.1.2 Aim 2 and objectives 
To ascertain the cell types expressing steroid-associated proteins in the 
cerebellum of GD 90 male sheep and whether prenatal androgen over-
exposure affects the number of cells that produce these proteins. 
Optimisation studies included: -  
 The identification of the different cell types that the cerebellum is 
composed of and an investigation into cell migration through mid-late 
gestation utilised H&E staining. This aided in identifying the cerebellar 
layers of the cerebellum and the layers of the prefrontal cortex in control 
GD 90 male sheep (fetally injected) and GD 112 male sheep (maternally 
injected).  
 Determining the optimal section thickness using Nissl staining on GD 90 
male sheep. 
 AR localisation in fetal cerebellar and prefrontal cortex tissues was 
established using immunohistochemistry. The colocalisation of AR and 
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calbindin, a cerebellar neuronal marker, in control and TP-treated GD 90 
male sheep, simultaneous immunofluorescence and sequential 
immunohistochemistry were utilised.  
 Antibody titration studies allowed us to ascertain the optimal antibody 
dilution to use in immunohistochemistry for each protein of interest. This 
further enabled the determination of any differences in the number of 
Purkinje cells expressing StAR, 5-reductase 1, 5-reductase 2 and PR, 
between the control and TP-treated groups. Each slide was examined in 
five random areas using the grid eyepiece. The sections counted were 
also randomly allocated. The mean of the five grids was calculated and 
then multiplied by 3.57 to convert the mean into positive cells/mm2. The 
value of each grid of positive cells was 0.28mm2 and by multiplying each 






3.2.1 RNA integrity using denaturing paraformaldehyde gels 
All frozen brain samples were processed to extract total RNA for qRT-PCR 
analysis. Before any such analysis could take place, the integrity of the RNA 
was checked. Denaturing gel analysis demonstrated that each RNA sample had 
two distinct bands which implies that our RNA was of good quality. Intact RNA 
(run on a denaturing gel) should have sharp, clear 28S and 18S ribosomal RNA 
(rRNA) bands and the 28S rRNA band should be approximately twice as 
intense as the 18S rRNA band, (Figure 3.1, Fleige and Pfaffl, 2006),. Partially 
degraded RNA will have a smeared appearance, will lack the sharp rRNA 
bands, or will not exhibit the 2:1 ratio of high quality RNA. Completely degraded 
RNA will appear as a very low molecular weight smear (Fleige and Pfaffl, 2006).  
In all downstream analyses, inclusion of samples with known high quality gave 
confidence in the data obtained. Where this criterion was not met, the RNA 
sample was discarded and not included in any further analysis. This accounts 
for differences in initial numbers of samples and numbers of samples analysed 
– in each group there was one sample that after repeated attempts would not 
yield RNA of sufficient quality for further downstream analysis  
    
Figure 3.1: This gel is representative of a good quality total RNA sample. The upper band is 
28S RNA and the lower band is 18S RNA. Good integrity RNA has a 28S band of approximately 















3.2.2 qRT-PCR optimisation 
3.2.2.1 Determination of successful cloning of a PCR product for primer 
validation  
Colony PCR is a convenient high-throughput method for determining the 
presence or absence of insert DNA in plasmid constructs. In this study, the 
insert DNA was the PCR product for AR, where the primer set was custom 
designed within our lab. Figure 3.2 shows successful cloning of AR and the 
absence of this particular gene in negative controls.  
 
Figure 3.2: Colony PCR was performed to check AR PCR product had been successfully cloned 
into a vector. The bands shown are approximately 75bp which indicated that the AR PCR was 
successfully cloned. Lane 1 – ladder, Lane 2 – AR colony 1, Lane 3 – AR colony 2, Lane 4 – AR 
colony 3, Lane 5 – AR colony 4, Lane 6 – AR colony 5, Lane 7 – AR PCR product only, Lane 8 
– negative control.  
  









3.2.2.2 Standard curve of cloned AR PCR product to show validation of 
custom-made primers 
According to the Minimum Information for Publication of Quantitative Real-Time 
PCR Experiments (MIQE) guidelines (Bustin et al., 2009) all custom-made 
primers must be optimised and validated. One way to do this was to create a 
standard curve using DNA copy number (Wong and Medrano, 2005).  
Using a standard curve, the amplification efficiency of the AR primer sets was 
determined. Figure 3.3 illustrates the standard curve generated. A slope 
between –3.9 and –3.0 is acceptable for optimisation and our standard curve 
shows a slope of -3.152. R2 is the correlation coefficient. Our R2 value was 
0.985 and a value of >0.985 provides good confidence in correlating the two 
variables. The standard curve efficiency between 80-110% is generally 
satisfactory for optimisation and the results of our study show an efficiency of 
107.6%. Therefore we can conclude that the primers designed for AR were 
suitable for our experiments. In order to then determine if the AR primers 
designed were specific for the AR sequence, a cloned vector containing the AR 
insert was sequenced (by Eurofins MWG Operon, Germany) to ensure that the 
appropriate PCR product was indeed cloned. The results were put through 
BLAST (http://www.ncbi.nlm.nih.gov/BLAST) and confirmed that the DNA 
sequence was specific for AR.  
   









3.2.3 Gene expression analysis 
The level of gene expression for each gene of interest (GOI) was evaluated 
using qRT-PCR analysis via the CT method (Livak and Schmittgen, 2001).  
The fold difference relative to a single reference (control) sample was then 
calculated by 2(-CT). Relative gene expression from the male control group and 
the male TP-treated group were compared to determine differences in gene 
expression, if any, using a two tailed, unpaired t test (GraphPad Prism software, 
U.S.A.).  
The GOIs were chosen because they are involved in neurosteroidogenesis 
(Table 3.1), which involves local transformation of cholesterol or circulating 
steroid precursors into neurosteroids in the brain. Steroid hormones from 
endocrine organs will also reach the brain and therefore contribute to the effects 
of neurosteroids and/or serve as precursors for metabolism into steroid receptor 





Gene Name Classical Name Reason for being GOI Reference 
AR Androgen receptor To investigate T 
signalling 
Chang et al., (1995) 
CYP19 Aromatase Enzyme that converts T 
into E 
Naftolin (1994) 
ER Estrogen receptor  To investigate E 
signalling 
Belcher (1999) 
ER Estrogen receptor  To investigate E 
signalling 
Belcher (1999) 
CYP11A1 P450scc Converts cholesterol to 
pregnenolone 
Baulieu (1998) 
PR Progesterone receptor To investigate P 
signalling 
Sakamoto et al., (2003) 
SRD5a1 5 - reductase 1 Converts T and P into 
DHT and DHP 
Mensah-Nyagan et al., 
(1999) 
SRD5a2 5 - reductase 2 Converts T and P into 
DHT and DHP 
Mensah-Nyagan et al., 
(1999) 
StAR Steroidogenic acute 
regulatory protein 
Rate-limiting step in 
steroidogenesis 
Stocco and Clark (1996) 
HSD3 3 hydroxysteroid 
dehydrogenase 
Key enzyme in 
steroidogenesis 
Payne and Hales (2004) 
CYP17 17 hydroxylase Key enzyme in 
steroidogenesis 
Payne and Hales (2004) 
Table 3.1: A list of all the initial genes of interest that were tested. The primary focus of this 
study was to identify changes in the cerebellar expression of genetic markers of steroid 
metabolism and signalling that result from exposure to testosterone propionate (TP) during 
development in sheep. T = testosterone, E = estradiol, P = progesterone, DHT = 




All steroid-associated genes examined were found to be expressed in GD 90 
male cerebellum (Table 3.2).  










StAR Adult rat Furukawa et al., 
(1998) 
Yes 
SRD5a1 Adult human Thigpen et al., 
(1993) 
Yes 
SRD5a2 Fetal sheep Petratos et al., 
(2000) 
Yes 
CYP11A1 Fetal sheep Petratos et al., 
(2000) 
Yes 
CYP17 Adult rat Stromsedt and 
Waterman (1995) 
Yes 
CYP19 Neonatal rat Lavaque et al., 
(2005) 
Yes 
HSD3 Adult rat Guennon et al., 
(1995) 
Yes 
AR Adult rat Takeda et al., 
(1990) 
Yes 
PR Neonatal rat Sakomoto et al., 
(2001) 
Yes 
ER Neonatal rat Belcher (1999) Yes 




Table 3.2: This table depicts whether mRNA expression for each GOI has been identified in the 
literature. In the majority of literature, cerebellar gene expression studies have been carried out 




3.2.3.1 The effect of excess fetal androgen on the mRNA expression of 
genes associated with steroidogenesis in the male cerebellum 
The level of gene expression for each GOI was evaluated using qRT-PCR 
analysis via the CT method, where the fold differences were calculated by 2
(-
CT).  The results of the fold differences from the male control group and the 
male TP-treated group were compared first to determine differences in gene 




 P value (* <0.05) Fold difference 
 
StAR 0.0264* 5.88-fold reduction 
SRD5a1 0.0770 2.93-fold increase 
SRD5a2 0.0986 5.55-fold reduction 
CYP11A1 0.1194 2.17-fold reduction 
CYP17 0.1102 2.32-fold reduction 
CYP19 0.1172 2.63-fold reduction 
HSD3 0.5111 2.09-fold increase 
AR 0.2604 < 2 
PR 0.0341* 5.01-fold increase 
ER 0.0721 7.14-fold reduction 
ER 0.3435 < 2 
 
Table 3.3: qRT-PCR analysis demonstrated significant changes in mRNA expression for StAR 
and PR in the cerebellum of TP-treated group compared to control of GD90 male sheep, (n=4; p 
= 0.0264 and 0.0341, respecitvely). Relative expression is the change in gene expression in a 
given sample, relative to reference sample (in our study the reference sample was always 






Figure 3.4: A summary diagram of the observed changes (significant or near significant) in gene 
expression in GD 90 male sheep in the TP-treated group.  Red indicates a reduction at the 





3.2.3.1.1 Determination of whether the changes in gene expression 
observed are due to an androgenic or estrogenic effect 
This study also investigated whether the observed alterations in mRNA 
expression are due to an androgenic or estrogenic effect. There is potential for 
the placental aromatisation of testosterone into estrogenic metabolites. 
Therefore, to define the effects of both sex hormones, fetal male sheep were 
directly injected with either TP or the potent estradiol receptor agonist, 
diethylstilbestrol (DES). There were no significant changes between the control 
and DES-treated groups at the mRNA level for StAR, PR, SRD5a1 and 
SRD5a2 (Table 3.4). Furthermore, Table 3.4 shows a comparison of p values 
and fold differences for TP-treated and control cerebellar samples and DES-
treated and control cerebellar samples. 
 
GOI TP-treated vs 
control group 
















STAR 0.0264* 5.88-fold 
reduction 
0.726 < 2  Androgen 
SRD5a1 0.0770 2.93-fold 
increase 
0.323 < 2 Androgen 
SRD5a2 0.0986 5.55-fold 
reduction 
0.387 < 2 Androgen 
PR 0.0341* 5.01-fold 
increase 
0.372 < 2 Androgen 
 
Table 3.4: qRT-PCR analysis demonstrated no significant changes in mRNA expression for 
StAR, PR, SRD5a1 and SRD5a2 in the cerebellum of DES-treated group compared to control of 
GD90 male sheep, (n=4). Relative expression is the change in gene expression in a given 
sample, relative to reference sample (in our study the reference sample was always 204/1). This 
is calculated by determining a fold change (2
(-CT)). By determining the statistical significance of the 
TP-treated and control group fold changes and the DES-treated and control group fold changes, 
it can be deduced whether TP exposure is mediated by androgen or estrogen. A fold change of 
less than 2 implies no change. 
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3.2.3.2 Protein analysis 
Western blotting was performed in order to determine whether the statistically 
significant changes in mRNA expression observed for StAR and PR (a 
decrease and an increase, respectively) using qRT-PCR, were recapitulated at 
the protein level. We further observed a trend toward an increase in SRD5a1 
mRNA expression and a trend toward a decrease in SRD5a2 mRNA expression. 
Due to the reported developmental regulation of expression in the brain of these 
two isoforms (SRD5a2 expressed almost exclusively in fetal life; SRD5a1 is 
mostly expressed in adult life, Melcangi et al., 1998), an investigation of both 






3.2.3.2.1 Visualisation of protein bands  
Protein was extracted from samples that had been used for RNA isolation using 
the TRIsure method (Chapter 2). The first phenol/ethanol supernatants were 
dialysed approximately 3 months after RNA isolation. In Figure 3.5, the protein 
transferred to the immunoblot does not appear degraded for any of the different 
protein preparations, as it can be observed that each lane (with the exception of 
Lane 1, Ladder) shows clear bands with different molecular weights. Each lane 
had the same amount of protein loaded (50g) but each lane has a different 
protein solubilisation buffer, so that the optimal one can be chosen for each 




Figure 3.5: Protein bands stained with Memcode Reversible Stain (Thermo Scientific) to show the protein 
has transferred from gel to membrane. Lane 1 – Ladder, Lane 2 – Supernatant (Sn) unconcentrated, Lane 
3 – Globular mass unconcentrated , Lane 4 – Glob mass in 1% SDS, Lane 5 – Glob mass in 8M urea and 





3.2.3.2.2 Western blotting 
Western blotting was attempted in order to quantify StAR and 5-reductase 2 
protein expression in GD 90 male sheep cerebellum using 50g protein, in 
order to determine whether there were any changes as a result of prenatal 
excess androgen exposure. This study also attempted to measure protein levels 
for PR and 5-reductase 1.  
3.2.3.2.2.1 Anti-actin as a positive control 
-actin is abundant in the developing cerebellum (Micheva et al., 1998). When 
each blot, containing four different protein solubilisation preparations, was 
probed for -actin, there were strong signals for each of the Western blots 
(Figure 3.6), which indicates -actin protein expression at GD 90 in the male 
sheep cerebellum. This immunoblot also demontrated that the protein 
preparation (the protein was extracted from this sample three months after RNA 
isolation of the same sample) and Western blotting protocol were successful. 
 
 
Figure 3.6: Protein bands show actin Ab (1 in 2000). The size of actin is 42 kDa.  Lane 1 – 
Molecular weight ladder showing 55 kDa (Page Ruler, Pierce), Lane 2 - Globular mass, Lane 3 
– Glob mass in 1% SDS, Lane 4 – Glob mass in 8M urea and Tris , Lane 5 - Glob mass in 1% 






3.2.3.2.2.2 StAR protein expression in the developing cerebellum 
When the Western blotting membrane was probed for StAR, there was no 
signal in the globular mass sample but there was a weak signal in the protein 
sample that contained 8M urea and tris (a solubilisation buffer), and the protein 
sample that included 1% SDS, 8M urea and tris (a solubilisation buffer, Figure 
3.7 A, lanes 7 and 8). This therefore suggests that these are optimal protein 
fractions for StAR protein.  These solubilising solutions, and others (Chapter 2), 
were added to the protein as demonstrated by (Hummon et al., 2007). The 
molecular weight for StAR is 37 kDa and the faint bands seen were just under 
the 35 kDa marker, therefore it suggests that this is the mature form of StAR 
protein. There also appears to be non-specific binding occurring above the 
StAR signal which could be the precursor forms of StAR at 32 and 37 kDa. The 
blot was stripped and reprobed for  -actin (1:2500 dilution) and shows bands 
for the concentrated protein preparations (Figure 3.7 B). When the immunoblot 
was re-probed for -actin protein, the protein preparations that were most 
abundant were the same samples as for StAR - the globular mass solubilised in 
8M urea and Tris and the globular mass with 1% SDS, 8M urea and tris (Figure 
3.7 B, lanes 7 and 8).  
 
Figure 3.7: A) StAR (1:500) was probed on a nitrocellulose membrane (semi-wet transfer from 
10% SDS-PAGE gel) at 180 second ECl exposure. 50g of protein was loaded into each lane. 
B) The membrane was then stripped and reprobed for -actin (1:2500). Lane 1 – Molecular 
weight ladder showing 35 and 50 kDa (Colour Burst, Sigma), Lane 2 – Sn unconcentrated, Lane 
3 – Sn concentrated, Lane 4 – Glob mass unconcentrated, Lane 5 – Glob mass concentrated, 
Lane 6 – Glob mass in 1% SDS, Lane 7 – Glob mass in 8M urea and Tris. 
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3.2.3.2.2.3 5-reductase 2 protein expression in the developing cerebellum 
Western blots probed with the 5-reductase 2 antibody (1:500 dilution) had a 
signal for the unconcentrated globular mass sample and a weak signal for the 
concentrated globular mass in 1% SDS (Figure 3.8, lanes 4 and 5 respectively). 
After protein dialysis, half of the protein was concentrated using centrifugal filter 
concentrator tubes and the other half was not treated. Concentration of the 
proteins should allow an enhanced yield in concentration however, here the 
unconcentrated protein, which had the same amount of protein loaded into the 
well as the concentrated one, had a strong signal for 5-reductase 2 (Figure 3.8, 
lane 4). The molecular weight for this protein is 28 kDa and the band appeared 
to be slightly above the 25 kDa marker, thus suggests that this is the correct 
band. The other bands could be due to non-specific background being detected 




Figure 3.8: 5-reductase 2 (1:500) was probed on a nitrocellulose membrane (semi-wet transfer 
from 12% SDS-PAGE gel) at 300 second ECl exposure. 50g of protein was loaded into each 
lane.  Lane 1 – Molecular weight ladder (Page Ruler, Pierce), Lane 2 – Sn unconcentrated, 




3.2.3.2.2.4 Using lamb adrenal gland as a positive control tissue 
Initially, protein isolation and Western blotting optimisation were successful i.e. 
protein bands were visualised on stained gels and blots. Unfortunately, further 
into the study, Western blotting was no longer successful.  Due to the limited 
sample number, each sample was used for both protein extraction and RNA 
isolation, together with prolonged storage at -20oC for more than three months, 
may have degraded the protein within the sample. To confirm that there was no 
issue with the antibodies used, a positive control tissue was used. Figure 3.9 
shows that there were weak bands for anti-StAR and PR, a strong band for anti-
5-reductase 1 and no signal for anti-5-reductase 2 in the lamb adrenal gland. 
Figure 3.9: Western blots for the lamb adrenal gland. ECL exposure time was 30 seconds. A) 
PR, 1:250 dilution B) StAR, 1:500 dilution C) SRD5a1, 1:500 dilution D) SRD5a2, 1:500 dilution 
E) b-actin, 1:2500 dilution. Lane 1 – Ladder (Page Ruler, Pierce), Lane 2 – Ladder (Page Ruler, 
Pierce), Lane  – Globular mass unconcentrated, Lane 4 –  Ladder (Page Ruler, Pierce), Lane 5 
– Globular mass unconcentrated, Lane 6 – Ladder (Page Ruler, Pierce),  Lane 7 - Globular 
mass unconcentrated, Lane 8 – Ladder (Page Ruler, Pierce),  Lane 9– Globular mass 






Immunohistochemistry was utilised to investigate protein expression in the fetal 
cerebellum, by enabling the visualisation of cell types in the developing 
cerebellum that express the proteins of interest for this study. The number of 
protein positive cells/mm2 were counted to determine if there were any changes 
in the number of cells expressing a particular protein between the control and 
TP-treated groups. The same antibodies were utilised that were used for 
Western blotting and all were successful (i.e. positive staining).  
The number of positive cells (stained brown) were counted using a grid 
eyepiece at five random areas of each cerebellar section (GD90 male sheep). 
The mean was calculated and then converted into positive cells/mm2. 
Immunohistochemical analysis of StAR, PR, 5-reductase 1 and 5-reductase 
2 revealed a significant increase in the number of Purkinje cells that express 
each protein of interest (p = 0.0002, 0.0201, 0.0001 and 0.0001, Figures 3.16-




3.2.3.3.1 Investigation of cell migration in the developing cerebellum 
Two time points during ovine gestation were observed in order to look at the cell 
migration in the developing cerebellum of GD 90 (fetally injected) and GD 112 
(maternally injected) control male sheep. Figure 3.10 demonstrates how the 
cytoarchitecture has changed within this period of time. 
 
 
A) GD90                                                             B) GD112  
 
C) GD90                     D) GD112  
Figure 3.10: Haematoxylin and Eosin Staining of cerebellar tissue of control male sheep to 
distinguish the different layers. Two gestational periods were investigated to show how the 
cerebellum develops. All slices were 5m thick. A) GD90 and B) GD112, scale bar = 10m. C) 
GD90 and D) GD112, scale bar = 5m. EGL – external granule layer, ML – molecular layer, 




3.2.3.3.2 Exploring optimal tissue thicknesses for Nissl staining studies 
Previous Nissl stain studies have used methodology that cuts tissue sections at 
at a thickness of 50m using a vibratome (Pilati et al., 2008). We did not have 
access to a vibratome, so a microtome was utilised, which is more suited to 
cutting at a lesser thickness. Therefore we cut cerebellar tissue sections of 
varying thicknesses to determine the optimal thickness (Figure 3.11). Our 
conclusion was that 5m tissue sections were the most suitable, due to the fact 
we could see the cytoarchitecture of the developing cerebellum more clearly 
than the thicker sections. 
  
A) 5m cerebellar slice                                            B) 10m cerebellar slice 
 C) 15m cerebellar slice                                       D) 20m cerebellar slice 
Figure 3.11: Nissl Staining of cerebellar tissue of control male sheep at GD90, scale bar = 5m. 
Nissl staining is used to stain neurons and also to understand the cytoarchitecture of different 
brain areas. Traditionally, the tissue sections are cut thick (approximately 20-50m). However 
we are unable to distinguish the different layers and neurons with this thickness, therefore we 
optimised Nissl staining to identify a suitable different thickness. A) 5m slice. B) 10m slice. C) 
15m slice. D) 20m slice. 
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3.2.3.3.3 Primary antibody titration studies 
Titration studies were performed to determine the optimal antibody dilution for 
immunohistochemical analyses. As an example of the titration experiments, PR 
is illustrated in Figure 3.12. The more concentrated primary antibody dilution of 
1:100 showed the cells expressing PR being masked by non-specific 
background staining. This would make cell counting more difficult and more 
prone to errors. Therefore the PR antibody dilution of 1:1000 was more suitable 
for analysis of protein expression (Figure 3.12). 
 
Figure 3.12: An example of dilution titers for anti-PR in GD90 cerebellar ovine tissue, scale bar 






3.2.3.3.4 Localisation of AR in the developing cerebellum 
As we have treated our samples with an androgen (TP), we decided to examine 
the location of AR in the cerebellum of GD90 male sheep. We have illustrated, 
through immunohistochemistry, that AR are located within the nuclei of the 
Purkinje cells of the cerebellum in GD90 male sheep, as there is strong positive 
staining (brown) within the nuclei (Figure 3.13, positive cells were stained 
brown). 
 
Figure 3.13: Immunohistochemical studies show localisation of AR (dilution 1:500) in the nuclei 
of Purkinje cells in the cerebellum of GD90 male sheep. A)  X10 magnification. B) X20 




3.2.3.3.5 Colocalisation of AR and calbindin in the cerebellum 
We investigated the colocalisation of AR and calbindin in the developing male 
cerebellum. We chose these proteins as we have previously shown that AR is 
located in the nuclei of Purkinje cells and calbindin is a known Purkinje cell 
marker (Dougherty et al., 2013).  
3.2.3.3.5.1 Examining colocalisation by means of double 
immunofluorescence  
Calbindin is a good neuronal cell marker and Figure 3.14 confirms that the 
positive calbindin staining is exclusive in the Purkinje cells of the cerebellum. It 
is difficult to say whether there is any positive nuclear AR staining (in red) or if 
our results show only background staining. There does appear to be signs of 
more intense nuclear staining within the PCL which corresponds with the 
positive cytoplasmic calbindin staining. The top and bottom left panel shows the 
two images merged. 
 
Figure 3.14: Colocalisation of AR and Calbindin in Purkinje cells of the cerebellum in GD90 
male sheep, scale bar = 5m. A) a merged image of AR and calbindin  Immunofluorescence. 
The green fluorescence indicates positive calbindin staining (1:1000 dilution) in the cytoplasm. 
B) the two fluorescent colours separately. Here we see green positive staining for calbindin (top 
left panel) and AR positive/background staining in red (right panel). 
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3.2.3.3.5.2 Determining colocalisation of AR and calbindin by using 
sequential immunohistochemistry 
As simultaneous immunofluorescence studies proved to be ambiguous in the 
determination of colocalisation of AR and calbindin in Purkinje cells of the 
developing male cerebellum, we chose another method which proved to be 
more suitable for our study (Figure 3.15). 
 
Figure 3.15: Colocalisation studies to show the location of AR and Calbindin (a Purkinje cell 
marker) in GD90 male sheep. (A and B) Cerebellar tissue was treated with NovaRED (Vector 
Labs) substrate after the first primary antibody incubation and then DAB after the first primary 
antibody incubation. A) X20 magnification. B) X40 magnification. Positive staining for DAB is 
brown and positive staining for NovaRED is red. AR positive cells had nuclear staining whereas 





3.2.3.3.6 Protein expression studies 
3.2.3.3.6.1 StAR protein expression 
StAR protein is located in the mitochondrion of Purkinje cells in the cerebellum 
of adult rats (Furukawa et al., 1998). Figures 3.16 A and B illustrates that in the 
developing male cerebellum, StAR is located in the cytoplasm of Purkinje cells 
and some granule cells within the EGL and IGL, as there is positive staining 
within this regions (stained brown) and the nuclei are stained blue (the 
counterstain). Due to limitations of magnification, this study could not identify 
mitochondria specifically. This study has illustrated that there are more positive 
Purkinje cells in the developing cerebellum that express StAR protein, as a 
result of excess androgen exposure (p = 0.0002, Figure 3.16), compared to the 
control group. 
    
A) A typical representative of GD90 control               B) A typical representative of GD90 
cerebellar ovine tissue                                               TP-treated cerebellar ovine tissue  
 
Figure 3.16: An increase in positive Purkinje cells/mm
2
 (p = 0.0002) expressing StAR in the TP-
treated group (n=4). A) a typical image of a GD90 control male sample at X20 magnification. 
StAR positive cells are stained brown (cytoplasmic). Scale bar = 5m B) a typical image of a 
GD90 TP-treated male samples at X20 magnification. StAR positive cells are stained brown 
(cytoplasmic). Scale bar = 5m C) Graphical representation of data. 
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3.2.3.3.6.2 PR protein expression 
Sakamoto et al. (2001) demonstrated that the nuclei of Purkinje cells of 
neonatal rats express PR, using immunohistochemical analysis. The current 
study shows that PR is detected at the nuclei or perinuclear region of Purkinje 
cells and some granule cells within the IGL in GD 90 male ovine cerebellar 
tissue (stained brown, Figures 3.17 A and B). This study has determined that as 
a result of androgen exposure, there is an increase in the number of Purkinje 
cells that express PR protein (p = 0.0201, Figure 3.17), compared to the control 
group. 
 
 A) A typical representative of GD90 control               B) A typical representative of GD90        
cerebellar ovine tissue                                                TP-treated cerebellar ovine tissue  
 
Figure 3.17: Analysis of anti-PR suggests in the TP-treated group, there is an increase in 
positive Purkinje cells/mm
2
 that express PR (p = 0.0201, n=4). A) a representative image of a 
GD90 control male sample at X20 magnification. PR positive cells are stained brown 
(nuclear/perinuclear). Scale bar = 5m B) a representative image of a GD90 TP-treated male 
samples at X20 magnification. PR positive cells are stained brown (cytoplasmic). Scale bar = 
5m C) Graphical representation of data. 
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3.2.3.3.6.3 5-reductase 1 protein expression 
Agís-Balboa et al., (2006) showed that there was 5-reductase 1 protein 
expression within the somata (specifically, the microsomal membrane) of 
Purkinje cells of adult male mice. This current study has established that 5-
reductase 1 expression is located in the soma of Purkinje cells and some 
granule cells within the EGL in fetal male sheep as there is positive staining 
within this regions (stained brown) and the nuclei are stained blue (the 
counterstain, Figures 3.18 A and B). This investigation has established that 
there is an increase in positive Purkinje cells that express 5-reductase 1 
protein, in the developing cerebellum, as a result of androgen exposure (p = 
0.0001, Figure 3.18).  
 
A) A typical representative of GD90 control                        B) A typical representative of GD90  
    cerebellar ovine tissue                                                        TP-treated cerebellar ovine tissue  
 
Figure 3.18: This study determined that there was an increase of positive Purkinje cells/mm
2
 
that express 5-reductase 1 in the TP-treated group (p = 0.0001, n=4). A) a typical image of a 
GD90 control male sample at X20 magnification. 5-reductase 1 positive cells are stained 
brown (cytoplasmic). Scale bar = 5m B) GD90 TP-treated male samples at X20 magnification. 
5-reductase 1 positive cells are stained brown (cytoplasmic). Scale bar = 5m C) Graphical 
representation of data. 
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3.2.3.3.6.4 5-reductase 2 protein expression 
5-reductase 2 protein expression is found in the cytoplasm (specifically, the 
microsomal membrane) of Purkinje cell and some cells in the IGL of the 
cerebellum in fetal sheep (Petratos et al., 2000). Figures 3.19 A and B also 
demonstrates that 5-reductase 2 expression is detected in the cytoplasm of 
Purkinje cells and some granule cells within the IGL in developing male sheep 
as there was positive staining within these regions (stained brown) and the 
nuclei are stained blue (the counterstain). This study has ascertained that there 
is an increase in positive Purkinje cells that express 5-reductase 2 protein, in 
the developing cerebellum, as a result of excess androgen exposure (p = 
0.0001, Figure 3.19).  
 
A) A typical representative of GD90 control               B) A typical representative of GD90 
cerebellar ovine tissue                                               TP-treated cerebellar ovine tissue  
 
Figure 3.19: An investigation of anti- SRD5a2 revealed an increase in positive Purkinje 
cells/mm
2
 (p = 0.0001) in the TP-treated group (p = 0.0001, n=4). A) a representative image of a 
GD90 control male sample at X20 magnification. 5-reductase 2 positive cells are stained 
brown (cytoplasmic). Scale bar = 5m B) a representative image of a GD90 TP-treated male 
sample at X20 magnification. 5-reductase 2 positive cells are stained brown (cytoplasmic). 




3.3.1 Determining RNA integrity using A260/A280 ratio 
RNA concentration was determined by measuring the optical density (OD) of 
each sample. UV spectroscopy is a widely used method to quantify RNA. 
Contaminants such as residual proteins and phenol can interfere with 
absorbance readings, thus care was taken during the RNA isolation procedure 
to remove such things. This method does not discriminate between RNA and 
DNA; therefore all of our RNA samples were treated with RNase-free DNase to 
remove contaminating DNA prior to determining concentration. The absorbance 
of a diluted RNA sample was measured at 260 and 280 nm. The nucleic acid 
concentration was calculated using the Beer-Lambert law, which predicts a 
linear change in absorbance with concentration (Fuwa and Vallee, 1966). The 
A260/A280 ratio was also used to assess RNA purity, therefore in combination 
with RNA integrity analyses, ensured robust and valid data was generated by 
PCR methodology. 
There are other approaches to investigate RNA integrity. The 2100 Bioanalyzer 
instrument (Agilent, U.K.) uses a combination of capillary electrophoresis and 
fluorescent detection to evaluate both RNA concentration and integrity, the 
latter in an analogous way to that presented here via denaturing gel 
electrophoresis. The advantages of such an instrument, in addition to low 
sample input requirements, is that such instruments provide an analysis 
algorithm to assess the integrity of the RNA sample (the RNA Integrity Number, 
or RIN) with a maximum value of 10. Significant decreases in the RIN are 
indicative of degraded total RNA (Lightfoot, 2002). The RIN number was 
developed in order to standardise RNA integrity interpretation and therefore 
remove individual interpretation in RNA quality control (Mueller, et al., 2004). 
We did not have access to the 2100 Bioanalyser during this part of the study. 
Although the methods used in this study are more laborious and require larger 
input amounts of sample than, for example, the 2100 Bioanalyser mentioned 
above, they were critical in determining that the RNA isolated was of sufficient 
quality for downstream analysis, providing confidence in the fidelity of the PCR 




3.3.2 Fetal ovine cerebellar gene expression and alterations in response to 
excess androgen exposure in utero 
This study has shown that at GD 90, the male ovine cerebellum expresses 
genes involved in the steroid synthesis pathway and therefore illustrates that 
the fetal ovine cerebellum is capable of neurosteroidogenesis. Using assay to 
measure cholesterol and pregnenolone, two steroidal precursors involved in the 
rate limiting steps of steroidogenesis, would further establish this theory. All 
genes of interest have been shown to be expressed in the cerebella of other 
animal models (e.g. rodent) and so this current study not only confirms this 
cerebellar expression pattern but also provides novel information on the fetal 
ovine brain the time point at which these genes are expressed (Table 3.2). Only 
two of the genes of interest, SRD5a2 and CYP11A1, have been found to be 
expressed in the developing male sheep cerebellum in previous literature 
(Petratos, et al., 2000).  
The first aim of this study was to identify changes in the cerebellar expression of 
genetic markers of steroid metabolism that result from exposure to testosterone 
propionate (TP) during development in male sheep, by utilising qRT-PCR. 
Using statistical analysis, this study has revealed which genes are altered as a 
result of prenatal excess testosterone exposure. 
3.3.2.1 Steroidogenic transporter, enzymes and steroid hormone 
signalling 
The majority of the genes encoding steroidogenic enzymes and steroidal 
signalling investigated in this study have shown no significant alterations in 
mRNA expression after TP administration, however, there were clear alterations 





StAR is the transport molecule for cholesterol and therefore involved in the rate-
limiting step of steroidogenesis (Stocco and Clark, 1996). There is a significant 
decrease in STAR mRNA expression in the TP group (n=4, p= 0.0264, Figure 
3.4) compared to the control group. The decrease in STAR mRNA expression 
suggests that prenatal excess androgen exposure may reduce local steroid 
synthesis, as it is the rate-limiting transporter of this pathway, implying the 
existence of a negative feedback loop. Houk et al., (2004) examined the 
inhibition of StAR expression by androgens in cultured Leydig cells and 
suggested that this occurs at the transcriptional level. They proposed that an 
androgen-dependent feedback loop inhibits cAMP-stimulated StAR expression 
as this gene is regulated by cAMP-mediated signalling. In order to determine 
whether this is the mechanism that regulates StAR expression in our model, 
further experiments should be carried out. Utilising primary cell cultured 
cerebellar Purkinje cells from control and TP-treated samples would help 
establish whether levels of cAMP are altered (measured using a cAMP assay) 
at GD 90 and evaluating the effects of a direct adenylate cyclase inhibitor, 
would help assess if this is the mechanism involved in our results. Examining 
whether the inhibition of androgen receptor activity by flutamide, an AR 
antagonist, or whether DHT, a non-aromatizable androgen, affects STAR 
mRNA expression would allow us to determine whether it is indeed a direct 
effect of TP that has altered STAR mRNA expression in the current study. This 
could be achieved by treating cultured primary Purkinje cells with TP or DHT, in 
the presence and absence of flutamide and finally measuring StAR expression 
by means of qRT-PCR. 
Houk et al., (2004) demonstrated that testosterone directly inhibits STAR 
expression in Leydig cells, which suggests an autocrine mechanism through 
which steroid hormones can regulate their own production at the rate-limiting 
step of cholesterol transfer to the inner mitochondrial membrane. Investigating 
the interaction between the activation of the StAR promoter and its feedback 
inhibition of steroidogenesis would provide more insight into this in the current 
study‟s model. A way to be able to determine this would be to indirectly 
measure StAR gene transcription by determining gene promoter activity using 
reporter genes, where a reporter, such as luciferase of green fluorescent protein 
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(GFP), is placed next to and controlled by the promoter region of StAR. This 
could be achieved by treating cultured primary ovine Purkinje cells with TP and 
the addition of a reporter construct. The accumulation of the reporter gene 
mRNA is measured as an indicator of the promoter activity.  
Furthermore, Caron et al., (1997) concurred that cAMP induces StAR 
expression but that unlike many tissue specific and hormonally responsive 
genes, neither a canonical TATA box nor a consensus cAMP-responsive 
element (CRE) could be identified within StAR‟s promoter region. They further 
suggested that steroidogenic factor 1 (SF-1) was implicated in the regulation of 
StAR expression in fetal mice. Manna, et al. (2003) also reported that although 
SF-1 is necessary, it is not sufficient for complete cAMP responsiveness. Using 
reporter gene assays, they determined that a functional cooperation between 
CRE binding protein (CREB), CRE modulator (CREM) and SF-1 was observed 
in mediating mouse StAR gene expression. Therefore, the TP-mediated StAR 
downregulation observed in the present study may be due to alterations in the 
mechanism of StAR gene regulation. To examine whether SF-1, CREM and/or 
CREB are involved in the regulation of TP-mediated StAR regulation, primary 
cell cultured cerebellar Purkinje cells from control and TP-treated samples could 
be used for promoter studies involving SF-1, CREM and CREB and utilised for 
luciferase activity studies. This would have allow us to determine if either of 
these regions on StAR‟s promoter are also altered due to androgen over-
exposure. 
Pregnenolone is the main precursor of various steroid hormones metabolised 
from cholesterol by the action of P450scc (Lieberman et al., 1984). Cholesterol 
is transported into the inner mitochondria by StAR as this is the site of 
steroidogenesis. To test whether the formation of pregnenolone is altered as a 
consequence of StAR downregulation, cholesterol and pregnenolone levels 
should be measured in GD 90 male ovine cerebella by utilising 
radioimmunoassay and comparing the levels of the control and TP-treated 
groups. This could be achieved by using frozen or fresh tissue samples 





3.3.2.3 PR  
PR mRNA expression was increased in fetal sheep cerebellum from TP-treated 
fetuses as compared to controls (p = 0.0341, Figure 3.11). The link between an 
increase in PR expression and an increase in testosterone and estrogen, but 
not DHT levels has been reported by others (Godwin et al., 2000; Milgrom et al., 
1973). This suggests that testosterone‟s action is mediated by its aromatisation 
into estrogen and not into the reduction of the potent androgen, DHT. However 
it does appear that the level of PR mRNA expression and the 
activation/inactivation of this PR vary under different hormonal stimuli. For 
example, estradiol stimulates the synthesis of PR, and therefore increases its 
expression (Milgrom et al., 1973), whereas PR also shows sensitivity to 
progestins, and evidence has illustrated that progesterone decreases PR 
expression in most target tissues (Leavitt et al., 1977). Therefore, it could be 
that the high level of androgen administered to the samples is metabolised, via 
the aromatase pathway, into high levels of estradiol. This in turn may 
activate/increase PR mRNA expression. However, the current study has 
evaluated whether the increase observed for PR at the mRNA level was due to 
an androgenic and estrogenic effect. It was determined that testosterone is 
acting directly on PR expression, rather than indirectly through the actions of 
estrogen, as when compared to the control group, the TP-treated group results 
were significantly different whereas there was no change between the control 
and DES-treated groups results. On the other hand, the current study‟s results 
could imply that PR expression changes in the androgen over-exposed group 
may have been partially caused by a decrease in progesterone levels, which 
could have been initiated by a decrease in local steroidogenesis due to the 
downregulation of StAR. It would have been useful to measure the 
progesterone and DHP levels in the cerebellum, by utilising radioimmunoassay 
or luminescence immunoassay, to determine whether excess androgen 
exposure and the increase in PR gene expression is due to an alteration in PR 
ligand levels . Due to limited tissue availability, this was beyond the scope of our 
study. The current study has evaluated PR mRNA expression by using primers 
that were designed to specifically amplify an exon boundary that is located in 
both PR-A and PR-B gene products. Therefore it would be interesting to 
examine each isoform separately, by means of designing primer sets unique to 
each isoforms and utilising these sets in qRT-PCR, in order to determine 
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whether prenatal androgen over-exposure affects the transcriptional activation 
or  the inhibition of progesterone responsive genes (PR-B is involved in the 
activation; PR-A is in involved in the inhibition, (Tsutsui et al., 2000). It would be 
expected that the inhibition and therefore PR-A would be altered as this isoform 
has been established to repress PR-B-mediated transcriptional activity (Merlino 
et al., 2007). 
The increase in PR mRNA expression that we see as a result of androgen over-
exposure, may result in dysregulated cerebellar development. Progesterone, 
but not its metabolite allopregnenolone, is thought to act directly via PR on 
Purkinje cells through intranuclear receptor-mediated mechanisms to promote 
dendritic growth, spinogenesis and synaptogenesis in neonatal rats (Sakamoto 
et al., 2003). Therefore, the examination of fetal ovine Purkinje cell morphology 
was performed in order to observe whether any structural alteration to the 
cerebellum after prenatal androgen over-exposure was apparent.  
3.3.2.3.1 PR regulation by estrogen 
Estradiol activates the receptor ER, which drives the transcription of the PR 
gene directly by interaction with estrogen response elements (EREs) that exist 
within the promoter regions of the PR gene (Kraus et al., 1997) .  Previous 
studies have demonstrated that in several brain regions, within different species 
and age groups (medial preoptic nucleus and ventromedial nucleus in neonatal 
rats, Quadros and Wagner, 2008; periventricular preoptic area in male lizards, 
Godwin et al., 2000; cerebellum in adult male rats, Guerra-Araiza et al., 2002). 
show this regulation of PR gene expression Therefore, it could be assumed that 
this is the mechanism of PR regulation observed in GD 90 male ovine cerebella, 
which were over-exposed to androgens. However, the results suggest that this 
alteration is due to a direct androgen effect.  
It is interesting that the present study does not confirm previous literature 
findings in that PR expression is regulated by estrogen however, this cannot be 
ruled out. Evaluating the inhibition the ERE site by activated ER in the PR gene 
in primary cell cultured cerebellar Purkinje cells from control and TP-treated 
samples would establish whether the ERE site within the PR promoter region is 
altered in some way that would affect PR gene regulation. 
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Investigating the activation of a PR promoter, such as ERE, would provide more 
insight into the mechanisms of gene expression regulation. A way to be able to 
determine this would be to indirectly measure PR gene transcription by 
determining gene promoter activity using reporter genes, where a reporter, such 
as luciferase of green fluorescent protein (GFP), is placed next to, and 
controlled by, the promoter regions of StAR and PR and the accumulation of the 
reporter gene mRNA is measured as an indicator of the promoter activity.  
In the absence of hormone, steroid hormone receptors exist as inactive 
oligomeric complexes with a number of other proteins including chaperone 
proteins, namely the heat shock proteins Hsp90 and Hsp70, and cyclophilin-40 
and p23 (Smith and Toft, 1993). The role of Hsp90 and other chaperones may 
be to maintain the receptors folded in an appropriate conformation to respond 
rapidly to hormonal signals. Therefore, examining Hsp90, Hsp70, cyclophilin-40 
and p23 at the mRNA level, by utilising qRT-pCR, would allow us to determine 
whether these genes are altered due to excess prenatal androgen exposure. 
This would enable the identification of altered regulation of gene expression. 
3.3.2.4 Is the “TP effect” mediated by androgen or estrogen? 
There were no significant differences in gene expression, measured by qRT-
PCR, for the GOIs examined between the control and DES-treated group 
(Figure 3.13). These experiments aimed to determine whether the observed 
alterations in mRNA expression are due to an androgenic or estrogenic effect. 
This was achieved by utilising fetally injected DES-treated samples and 
comparing the mRNA levels to that of the control samples. The data indicates 
that the mRNA expression alterations seen for STAR, PR, SRD5a1 and 
SRD5a2 in the TP-treated group, are due to an androgen effect rather than an 
estrogen one (Table 3.4). One important point to consider is that RNA extraction 
DES-treated cerebellar samples were performed by a novice Honour‟s student. 
Therefore it may be due to inconsistencies during RNA isolation that have lead 




3.3.2.5 Trends in gene expression 
Trends towards alterations in SRD5a1, SRD5a2 and also ERmRNA 
expression were observed between the control and TP-treated groups. There 
was a trend towards an increase in SRD5a1 expression in the TP-treated group 
(p= 0.0770, Figure 3.5 A), when compared to the control group, whereas there 
appeared to be a decrease in SRD5a2 expression (p=0.0986, Figure 3.5 B). 
There was also a strong trend towards decreased ER mRNA expression in the 
developing male cerebellum in the TP-treatment group (p = 0.0721, Figure 3.12 
A). The trend observed in the current study may suggest that ER levels are 
downregulated due to an increase in ligand levels, namely 17-estradiol, which 
is synthesised by the aromatisation of testosterone. This could be evaluated by 
measuring 17-estradiol concentrations by means of radioimmunoassay, but 
was not performed in the current study due to time constraints. However, 
ERexpression is unaltered in DES-treated GD 90 male ovine cerebella (p = 
0.8307) which suggests that ligand levels are not the reason for the trend 
observed for ERmRNA expression in TP-treated cerebella. 
In general, it is acknowledged that sample numbers are low in the current study, 
which may lead to under powering of the analyses, but unfortunately such 
matters were out with the control of the researcher, since these were samples 
which were a by-product from a larger study carried out and funded by 
collaborators at The University of Edinburgh. 
3.3.2.6 No change in gene expression 
The other steroidogenic enzymes and hormone receptors examined in this 
study were unaltered in the TP-treated group, when compared to the control 
group. There was no significant difference in CYP11A1 gene expression 
between the control and TP-treated groups (p=0.1194, Figure 3.6). This 
suggests that during this specific stage of development, CYP11A1 mRNA 
expression is unaffected by excess testosterone levels. There were also no 
alterations at the mRNA level for the CYP17, CYP19 and HSD3 (p=0.1102, 
Figure 3.7, p= 0.1772, Figure 3.8 and p=0.5111, Figure 3.9, respectively), and 
AR and ER (p=0.2604, Figure 3.10 and p=0.3435, Figure 3.12 B, respectively). 
However, previous literature examining a different developmental time point, 
animal model, brain region or tissue has suggested that testosterone can alter 
gene expression for these GOIs. 
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3.3.2.6.1 Time point 
Ovine mid-gestation is a period of neuronal proliferation, migration, and axonal 
and dendritic growth and is therefore a vulnerable time for developmental 
damage. In particular, the cerebellum has a growth spurt at GD 90 (Rees, et al., 
1997), which is coincident with the current study. Indeed, McIntosh et al., (1979) 
suggested that the main growth period for the ovine brain is between GD 95 – 
130, which is just after sample collection for the current study (GD 90). The 
literature has illustrated that androgen can regulate certain genes (CYP11A1, 
AR, ER and ER) and at various time points from the early post natal period 
through to adulthood (Sanchez et al., 2006; Luo et al., 2004; Karolczak et al., 
1998; Burgess and Handa, 1993; Wu and Gore, 2010; Sharma and Thakur, 
2006). Therefore, animals studied in the previous literature are more developed 
than the time point chosen for the current study (GD 90 in sheep), which is just 
when a major cerebellar growth period occurs. Investigating these GOIs 
towards the end of the main growth period suggested by McIntosh et al., (1979, 
i.e. GD 130) in development may have allowed us to determine whether gene 
expression remains sensitive to prenatal excess androgen exposure later in 
gestation and allow the results to be comparable to those in the previous 
literature. Unfortunately, all samples that were collected at a later gestational 
period were maternally injected with vechicle or TP, as opposed to the fetally 




3.3.2.6.2 Determining animal model species or anatomical region 
differences  
The data from this study suggests that the developing cerebellum has a 
different steroidal regulatory system compared to the hypothalamus and 
pituitary gland. Previous literature has shown that testosterone treatment can 
affect mRNA levels of the genes investigated in this chapter, but in brain 
regions (and Leydig cells) which are known to play more pivotal roles in the 
regulation of peripheral steroid synthesis (Karolczak et al., 1998).  
(Sanchez et al., 2006; Luo et al., 2004; Karolczak et al., 1998; Burgess and 
Handa, 1993; Wu and Gore, 2010; Sharma and Thakur, 2006) performed their 
studies on rodents whereas the current study was examining sheep. Theses 
studies also examined different brain areas from the cerebellum, such as the 
hypothalamus, pituitary, cortex, medial preoptic nucleus and anteroventral 
periventricular nucleus.  
Examining mRNA levels of the hypothalamus and pituitary, which are more 
heavily involved in peripheral steroid hormone regulation of GD 90 male sheep 
would allow us to determine whether it is a species or anatomical variation. The 
data from the current study implies that the level of these steroidgenic enzymes 








3.3.3 Western blotting 
Western blotting of 50g total protein isolated from TRIsure fractions left over 
from total RNA extraction was utilised to attempt to measure the relative protein 
abundance for gene products of interest in each control and TP-treated sample. 
The method of protein extraction was necessary due to a small sample size. 
The positive control, -actin, which is highly abundant in the cerebellum, 
showed strong protein bands on each immunoblot. This study has 
demonstrated that StAR and 5-reductase 2 protein is expressed in the 
developing male ovine cerebellum. However, further into the study it transpired 
that poor protein quality in fetal cerebellar tissue and limited sample volume 
prevented reliable Western blotting detection of StAR, 5-reductase and PR. 
3.3.3.1 Troubleshooting Western blot difficulties 
Hummon et al., (2007) demonstrated that the phenol/ethanol supernatant from 
Trizol RNA isolation could be stored at -20oC for upto three years and 
successful protein dialysis, and subsequent Western blotting, could be achieved 
i.e. the protein would not be degraded. In this current study, the first 
phenol/ethanol supernatants were dialysed approximately three months after 
RNA isolation and storage of the supernatants. The protein did not appear 
degraded three months after RNA extraction. However after twelve months of 
storage at -20oC, the protein sample appeared to be smeared and  have very 
low molecular weights. This shows that the protocols in the Hummon, et al. 
(2007) study were incompatible with this study.  
Another confounding factor is that there is low expression of these target 
proteins in the developing cerebellum. We know that these genes are 
expressed in the fetal cerebellum at the mRNA level from qRT-PCR analysis 
(Table 3.2) and the immunohistochemistry data show that they are also 
expressed at the protein level (Figures 3.25-28), therefore we cannot suggest 
the proteins probed for in Western blotting are not expressed in the developing 
cerebellum. This was attempted to be rectified by taking half of the protein from 
each sample and concentrating the protein using centrifugal in concentrator 
tubes. However, this resulted in faint, ambiguous bands or none at all.  
A positive tissue control, the lamb adrenal gland with known high levels of 
steroid protein expression (Nussey and Whitehead, 2001), was used to attempt 
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to determine what factor had prevented the quantifying of the proteins of 
interest. Protein was extracted from the adrenal gland by using the method 
described in Chapter 2 and then Western blotting was performed. Futher 
investigation of the antibodies, by using lamb adrenal gland and utilising 
immunohistochemistry on cerebellar tissue demonstrated that these antibodies 
do work for ovine tissue and that the antibodies had not degraded over twelve 
months. In conclusion, the transfer of protein of SDS-PAGE gel to nitrocellulose 
membrane and the antibodies used were sucessful during this part of the study. 
Therefore it can be deduced that the problems with Western blotting described 
in this chapter, were due to low abundance in the fetal ovine cerebellum and 
protein degradation caused by the protein extraction method and/or the storage 




3.3.4 Immunohistochemistry  
3.3.4.1 Optimisation studies 
3.3.4.1.1 Investigation of cell migration in the developing cerebellum 
The haematoxylin and eosin (H&E) stain helps to determine various tissue 
types as it reveals a broad range of cytoplasmic, nuclear and extracellular 
matrix characteristics (Fischer et al., 2008). Haematoxylin has a deep blue-
purple color and stains nucleic acids whereas eosin is pink and stains proteins 
nonspecifically. In a typical tissue, such as the cerebellum, nuclei are stained 
blue, whereas the cytoplasm and extracellular matrix have varying degrees of 
pink staining. Nucleoli stain with eosin. If abundant polyribosomes are present, 
the cytoplasm will have a distinct blue cast. The Golgi zone can be tentatively 
identified by the absence of staining in a region next to the nucleus. Therefore 
this stain reveals abundant structural information (Fischer et al., 2008) and can 
help identify the different layers of the cerebellum. 
The main cell types, such as the Purkinje cells, of the cerebellum appear at 
different times during development and at different locations. Purkinje cells were 
identified through their large nuclei and cytoplasm in comparison with the other 
cells in the cerebellum (Salouci et al., 2012). Figures 3.19 A and C show H&E 
staining on GD 90 cerebellar tissue, at different magnifications (A, X10 
magnification and C, X20 magnification). It is observed that there are a number 
of granule cells (stained purple) in the molecular layer (ML). It is known that 
granules cells migrate from the external granule layer (EGL) to the internal 
granule layer (IGL) during development (Zhao et al., 2007). The pink cells 
stained in the Purkinje cell layer (PCL) appear to be Purkinje cells due to their 
large soma appearance. Using a Purkinje cell marker, such as calbindin, we 
can confirm that these are indeed Purkinje cells. It is likely that at this 
developmental time point, the PCL is in the initial stages of establishment. This 
is supported by the findings of Rees and Harding (1988), who demonstrated 
that immature Purkinje cells begin to appear in the PCL at approximately GD 80 
of fetal sheep. In contrast, Salouci et al., (2012) saw no sign of Purkinje cell 
development until GD 105 in fetal ovine cerebellar tissue where the cells were 
small, arranged in several rows and had an irregular shape. However these 
fetuses had been spontaneously aborted and although no malformations to the 
brains were found, the examination of the brains was not discussed extensively 
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nor compared to that of a typical brain. This suggests that the gross anatomy of 
the brain was unaffected by abortion. The fetal ovine samples in our study were 
all subjected to the same method of sacrifice (barbiturate injection), therefore a 
uniform manner of death for every sample in our study, and were tightly 
monitored up until then. The differences in the way in which the samples were 
obtained (spontaneous abortion in Salouci et al., (2012) and controlled sacrifice 
via barbiturate injection in our study),  is possibly why we are seeing differences 
in Purkinje cell migration and development. 
To consolidate the theory that the cerebellum is still developing at GD90, 
cerebellar tissue from GD 112 samples were stained. Figures 3.19 B and D 
show H&E staining on GD 112 ovine cerebellar tissue, at different 
magnifications (B, X10 magnification, D, X20 magnification). In these figures, 
there are fewer granule cells in the ML and the Purkinje cells are more apparent 
and in the PCL. This gestation timing does reflect the findings from Salouci, et 
al. (2012), who showed similar ovine Purkinje cell development at GD 112. 
Therefore our study confirms that the cerebellum does develop over a long time, 
which was also demonstrated by Petratos et al., (2000).    
There has not been extensive research on ovine cerebellar development. We 
do know that at GD 90, the fetal ovine cerebellum is immature, which is similar 
in other species in which neurogenesis and neuronal growth occurs later than in 
other brain regions (Jacobson, 1997). Neurogenesis in the external granular 
layer is yet to reach its peak, as judged by the thickness of the layer in sheep 
(Rees and Harding, 1988). However, a cerebellar growth spurt begins after GD 
90 where neuronal proliferation, migration and axonal and dendritic growth 
(Rees and Harding, 1988) all occur and therefore is a vulnerable period for 
developmental damage. This is relevant to our study we are investigating 
whether there are structural alterations in the cerebellum at this gestational 
period in fetal tissue that has been exposed to TP.  
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3.3.4.1.2 Exploring optimal tissue thicknesses for Nissl staining studies 
Nissl staining is used to investigate neurons and also to understand the 
cytoarchitecture of different brain areas. The Nissl-staining method is based on 
the interaction of a basic dye, such as cresyl violet, with the nucleic acid content 
of cells (Pilati et al., 2008). These dyes can bind to the DNA content of the cell 
nuclei, but also to the RNA that is highly concentrated in rough endoplasmic 
reticulum and ribosomes in the cytoplasm. Neurons are very active protein 
synthesizing cells and so the cytoplasm of these cells contains a high 
concentration of rough endoplasmic reticulum (Kosik and Krichevsky, 2002). 
Due to this special characteristic of neurons, the Nissl staining can specifically 
stain the cytoplasm of neurons. Nissl staining was subsequently used to 
measure and calculate EGL, ML and IGL widths and the results from the control 
and TP- treated group were compared, to determine if there is a difference in 
the migration of granule cells as a result of androgen exposure. 
Some papers suggest that the thickness of each section should be increased up 
to 50m for Nissl staining (Pilati et al., 2008). Therefore we investigated what 
thickness was best for this study. Figure 3.20 A shows ovine cerebellar tissue at 
GD 90 at a section thickness of 15m. At this thickness, it was difficult to see 
single cells and so it would be near impossible to determine cell number by 
counting. Figure 3.20 B shows ovine cerebellar tissue at GD 112 at a thickness 
of 5m, which is the thickness used for H&E staining and immunohistochemistry. 
Here we can observe clear cellular morphology, determine the different 
cerebellar cell types, and counting is more plausible. The difference in results 
between our study and that of Pilati et al., (2008) may be due to differences in 
methodology e.g. we used a microtome to prepare our sections, whereas Pilati 
et al., (2008) utilised a vibratome.  As a result of this, for subsequent 
experiments we used tissue sections of 5m for all histological stains. 
The current study has evaluated H&E and Nissl staining in fetal ovine cerebellar 
tissue. Although Nissl staining is a special stain specifically for identifying 
neurons, H&E allowed for a clearer histological method to distinguish all cells 




3.3.4.1.3 Colocalisation of AR and calbindin in the cerebellum 
3.3.4.1.3.1 Examining colocalisation by means of simultaneous 
immunofluorescence 
We examined the colocalisation of AR and calbindin in the developing male 
cerebellum. We chose these proteins as we have previously shown that AR is 
located in the nuclei of Purkinje cells and calbindin is a known Purkinje cell 
marker (Dougherty et al., 2013). By using sequential immunohistochemistry, we 
have shown that AR and calbindin colocalise in Purkinje cells of the developing 
cerebellum. The red nuclear staining show AR protein expression while the 
brown cytoplasmic staining demonstrates calbindin protein expression. 
Calbindin is a good neuronal cell marker and Figure 3.23 confirms that the 
positive calbindin staining is exclusive in the Purkinje cells of the cerebellum 
(green denotes positive staining). It is difficult to say whether there is any 
positive nuclear AR staining (Figure 3.23, in red) or if our results show only 
background (i.e. non-specific) staining. There does appear to be signs of more 
intense nuclear staining within the PCL which corresponds with the positive 
cytoplasmic calbindin staining. However, we cannot assume there is 
colocalisation of calbindin and AR from the simultaneous immunofluorescence 
method. 
This technique has been noted to be time-consuming and prone to background 
staining (Mason et al., 2000). Furthermore, simultaneous immunofluorescence 
can be unsuitable in detecting two antigens present at the same site, such as 
two markers at the cell surface, since one label tends to obscure the other 
(Valnes and Brandtzaeg, 1984). As a consequence of this, simutaneous 
immunofluorescence for the study of paraffin-embedded tissues has been 
largely restricted to the detection of pairs of antigens found either at different 
sites within a single cell (e.g. nucleus and cell surface) or in different cell 
populations (Mason et al., 2000). We chose this method to examine the 
colocalisation of calbindin and AR in the developing cerebellum due to the 
different compartments these protein are expressed in (calbindin is localised in 
the cytoplasm; AR is localised in the nuclei). The two antibodies we had access 
to were from different host species and therefore, in theory, this technique 
should have allowed us to visualise the colocalisation as the antibodies should 
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not cross react (calbindin was a monoclonal antibody; AR was a polyclonal 
antibody raised in rabbit). 
Reliable double immunofluorescence labeling for confocal microscopy requires 
that the fluorochromes used exhibit good spectral separation (Kumar et al., 
1999). In our study, we have used fluorescently-labelled StreptAvidin 594 
(Vector Laboratories, U.K.) and Alexafluor goat anti-mouse 488 (Invitrogen, 
U.K.) which excites the red and green wavelengths, respectively, and therefore 
we should not have any ambiguity in regards to what protein is fluorescing at a 
particular wavelength. Alexa 488 has been shown to be more photostable than 
fluorescein for conventional immunofluorescence (Kumar et al., 1999) and our 
results demonstrated that Alexa 488 is a suitable secondary antibody to use 
within our study. 
Steptavidin-based amplification is widely used in fluorescent imaging to improve 
detection sensitivity. Fluorescent conjugates of streptavidin are used to detect 
biotinylated biomolecules such as primary and secondary antibodies. 
Streptavidin exhibits low levels of nonspecific binding. Mammalian cells and 
tissues contain biotin-dependent carboxylases, which are required for a variety 
of metabolic functions (Holmberg et al., 2005). These enzymes often produce 
substantial background signals when biotin–streptavidin or biotin–avidin 
detection systems are used to identify cellular targets. Endogenous biotin is 
particularly prevalent in mitochondria and in brain tissues therefore we used a 
biotin block to quench all endogenous biotin within a tissue section. 
In our optimisation studies for simultaneous immunofluorescence, we observed 
that the antibody dilutions that were most suitable were of a higher 
concentration than what was required for standard immunohistochemistry, 
which implies that immunofluorescence is less sensitive. Therefore this may be 
why we are unable to definitively say whether we are seeing AR nuclear 




3.3.4.1.3.2 Determining colocalisation of AR and calbindin by using 
sequential immunohistochemistry 
The current study has observed that AR and calbindin colocalise in Purkinje 
cells of the developing cerebellum (Figure 3.24) by utilising sequential 
immunohistochemistry. The red nuclear staining show AR protein expression 
while the brown cytoplasmic staining demonstrates calbindin protein expression. 
(Van der Loos, 1999) suggested that this red-brown colour combination was 
only useful in demonstrating two different cell populations or constituents 
without any overlap and that colocalisation studies was not possible due to a 
lack of the visual colour distinctions. If the colours chosen for sequential 
immunohistochemistry, can be unambiguously differentiated, a technique 
known as spectral imaging can be applied (Van der Loos, 2008). Spectral 
imaging allows images of the single stains to be scanned and by using 
specialised software algorithms the colours are unmixed, displaying the 
distribution and abundance of the individual chromogens i.e. DAB‟s brown 
staining and NovaRED‟s red appearance. However we had no access to the 
software needed to do this.  
As per manufacturer‟s instructions (A Guide to Multiple Antigen Labelling 
Handbook, Vector Laboratories, 2005, page 7), the order of the labelling of the 
primary antibodies is crucial and may significantly affect the quality of labelling. 
They suggest that if NovaRED is applied to the first primary antibody and DAB 
applied to the second, then the distinct red and brown colours should be visible 
after the labelling reactions are completed, using an optimised multiple labeling 
protocol. We confirm that this method of labelling was successful on fetal ovine 
cerebellar tissue (Figure 3.24). During our optimisation studies, we examined 
the result of applying DAB substrate to the first primary antibody and NovaRED 
to the second, which should not show as distinct colour as the method 
discussed above. We can also confirm that we were unable to pinpoint the 
localisation of the brown and red labelling due to the quality and ultimately 






3.3.4.2 Cerebellar cells that express the proteins of interest 
The cerebellum has a clear developmental pathway and an established 
cytoarchitecture that has enabled the identification of the effects of TP treatment 
on the development of this area of the brain.  
Although this study has identified that the proteins of interests are located in 
Purkinje cells, it was difficult to determine the exact subcellular location of StAR 
and 5-reductase 1 and 2. Due to the limitations of low magnification, this study 
could not identify mitochondria (the location for StAR protein expression) or the 
microsomal membrane (the location for 5-reductase 1 and 2 protein 
expression) specifically. This could have been rectified by using a double 
staining technique, where a mitochondrion, cell or microsomal membrane 
marker was used as well as the antibody for the particular protein of interest. 
This would help determine if the protein of interest is indeed located within the 
mitochondria or microsomal membrane. Electron microscopy would also have 
given a higher resolution to the precise location of the protein of interest. This 
study could identify that the subcellular location for PR protein was in the nuclei 
or perinuclei of Purkinje cells.  
Purkinje cells of the cerebellum are the major site for local steroidogenesis and 
express StAR, 5-reductase 1, 5-reductase 2 and PR protein (Petratos et al., 
2000; Sakomoto et al., 2001). By means of immunohistochemical analysis, this 
study has determined that the number of Purkinje cells that express these 
proteins of interest has significantly increased as a result of prenatal excess 
androgen exposure in the developing male cerebellum.  
SRD5a1 and SRD5a2 mRNA levels were not significantly altered in the TP-
treated group but each gene showed a trend towards an increase, or a 
decrease (SRD5a1 and SRD5a2, respectively). However, there is an increase 
in the number of Purkinje cells that express these proteins. A possible 
explanation for this is that each Purkinje cell is expressing an altered amount of 
protein in the TP-treated samples, when compared to the control samples. 
Furthermore, qRT-PCR determined the mRNA levels of one hemisphere of the 
developing male cerebellum, and therefore all the cells that comprise this tissue, 
whereas the immunohistochemical analysis examined only the Purkinje cell 
count in part of the other hemisphere. Therefore, it is possible that mRNA levels 
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in the whole tissue decline where protein in one cell type increases and vice 
versa.  To determine whether this was case, single cell PCR could be 
performed. Cerebellar Purkinje cells, from the control and TP-treated groups, 
could be isolated using laser capture and then DNA extraction could be 
performed using cell lysis. The appropriate primers sets for each GOI could be 
designed and then used for qRT-PCR, to measure expression levels. 
This increase in the number of Purkinje cells expressing all the proteins of 
interest could be due to an increase in overall Purkinje cell number as a 
consequence of androgen exposure during the developmental phase. Therefore 
the effect of treatment may be directly on Purkinje cell number. Whether these 
cells are producing more or less of each protein remains unclear and further 
investigation, such as utilising laser capture microdissection to obtain Purkinje 
cells and then measuring gene expression levels using qRT-PCR, would have 
to take place for a conclusive answer. Due to time constraints, this could not be 
examined in this study. A more detailed examination of Purkinje cell number 
and size would assess if prenatal androgen over-exposure has altered the 





This study has demonstrated that the number of positive Purkinje cells 
expressing the proteins of interest had greatly increased as a result of androgen 
exposure. It has been observed that there is decreased mRNA expression of 
STAR (Figure 3.4, p = 0.0264) and increased mRNA expression of PR (Figure 
3.11, p = 0.0341) in the TP-treated group. Immunohistochemical analysis of 
StAR, PR, 5-reductase 1 and 5-reductase 2 revealed increases in the 
number of Purkinje cells that express these proteins (Figures 3.25-28, p = 
0.0002, 0.0201, 0.0001 and 0.0001, respectively) in the TP-treated group. 
Western blot analysis should have allowed for an examination of whether the 
amount of protein expression had been altered due to excess androgen 
exposure, and would have given a better understanding of the relationship 
between mRNA and protein expression from the same sample, and ultimately 
cerebellar hemisphere. It was determined that the problems that were 
encountered in the current study could be very much due to sub-optimal protein 
quality in the developing male cerebellum protein samples. Little is currently 
understood regarding the relationship between gene expression as determined 
by measuring mRNA levels and the corresponding abundance of the protein 
products. So in conclusion, this study has ascertained possible structural effects, 
by means of immunohistochemical analysis, as well as alterations in gene 
expression for StAR and PR, by means of qRT-PCR, of developmental 














Alterations in the developing ovine cerebellar cytoarchitecture 




4. Alterations in the developing ovine cerebellar cytoarchitecture after 
prenatal androgen exposure 
4.1 Aims and Objectives 
4.1.1 Aim 1 and objectives 
To identify whether a panel of genes associated with cell markers and neuronal 
activity are expressed in GD 90 male sheep cerebella and whether mRNA 
expression levels are altered due to androgen over-exposure. 
Numerous genes, and therefore the functional proteins they encode, are key to 
the development of the cerebellum but the role of androgen in cerebellar 
development are unknown. The hypothesis is that the cell marker and neuronal 
activity-associated genes, specifically chosen for this study, are expressed in 
the cerebellum of male fetal sheep at GD 90. It was further hypothesised that 
prenatal excess androgen ( 2x20mg depot injections at GD 62 and GD 82) 
alters cerebellar steroid-associated gene expression in GD 90 male sheep as 
measured by qRT-PCR.  
4.1.2 Aim 2 and objectives  
To detect any alterations in cerebellar granule cell migration, after prenatal 
androgen exposure in GD 90 male sheep. 
This study wanted to confirm if androgen exposure has any effect on granule 
cell migration in the cerebellum. Nissl staining was utilised to determine if there 
is a difference in the width of several cerebellar layers (EGL, ML, IGL) between 
the control and TP-treated groups. This would establish whether androgen 
exposure has any effect on granule cell migration in the cerebellum.  
4.1.3 Aim 3 and objectives 
To ascertain whether Purkinje cell morphology and distribution is altered in GD 
90 male sheep after TP-treatment. 
The observation made by immunohistochemical analysis in Chapter 3 was that 
the Purkinje cell layer appeared different in our TP-treated group samples 
compared to the control group. Therefore the investigation was expanded to 
examine specific cell markers and genes involved in neuronal differentiation, 
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using qRT-PCR and histology. This study further explored the developing male 
cerebellar cytoarchitecture by means of immunohistochemistry.  
4.1.3.1 Purkinje cell number 
In order to determine whether any observed changes in Purkinje cell number 
were due to an androgenic or estrogenic effect, DES-treated samples were 
used for immunohistochemical purposes and compared to the control treated 
samples, using calbindin. The examination of whether there was a difference in 
the number of Purkinje cells expressing calbindin (a Purkinje cell marker) 
between the control and TP-treated groups was evaluated using 
immunohistochemistry. 
4.1.3.2 Purkinje cell morphology 
The examination of whether there was a difference in the number, shape, 
formation and arrangement of Purkinje cells expressing calbindin (a Purkinje 
cell marker) between the control and TP-treated groups was also undertaken by 
utilising immunohistochemistry.  The Purkinje cell soma were measured to 
determine if there was a difference in size between the control and TP-treated 
groups. We also was investigated the PCL arrangement and compared 
between the control and TP-treated groups, to examine if there are any 
alterations in PCL width of the developing cerebellum. The hypothesis is that 
Purkinje cell development is altered after excess androgen exposure. 
4.1.3.3 Apoptosis and proliferation 
We examined whether there was any changes to apoptosis and proliferation 
between the control and TP-treated groups, using cleaved caspase 3 as an 
apoptosis marker and Ki-67 as a proliferation marker. The current study aims to 
provide insight into whether either of these two cell regulation mechanisms in 
the cerebellum is affected after prenatal androgen over-exposure. 
4.1.3.4 Procedure for measuring Purkinje cell morphology 
Each slide was examined under a light microscope (Leitz Laborlux S, Germany) 
using the X10, X20 and X40 objectives. The number of positive cells was 
counted for each slide using a grid eyepiece in five random fields per slide. The 
sections were digitally captured, using CellSens 1.9 software (Olympus, U.S.A). 
Using Image J software (N.I.H., U.S.A.), the images were then able to be 
measured and in each of the five random areas, five random sections were 
chosen and the unit width of the PCL was measured. The Purkinje cell 
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diameters were normalised to the corresponding unit width. The mean of the 
five measurements was calculated. Five Purkinje cell soma were also randomly 
chosen and measured in each field view.  
The mean of the five grids was calculated and then multiplied by 3.57 to convert 
the mean into positive cells/mm2. The value of each grid of positive cells was 
0.28mm2 and by multiplying each grid by 3.57 converts the mean into mm2. This 
analysis determined whether androgen exposure has altered the number of 






4.2.1 Gene analysis 
The level of gene expression for each GOI was evaluated using qRT-PCR 
analysis via the CT method.  The fold difference relative to a single reference 
(control) sample was then calculated by 2CT*(-1). Relative gene expression 
from the male control group and the male TP-treated group were compared to 
determine differences in gene expression, if any, using a two tailed, unpaired t 
test (GraphPad Prism software, U.S.A.).  
 
The GOIs were chosen because they have already been established as either 
neuronal activity or cell markers (Table 4.1).  
 
 
Table 4.1: A list of the genes of interest that were examined. The primary focus of this study 
was to identify changes in the cerebellar expression of neuronal activity and cell markers that 
result from exposure to testosterone propionate (TP) during development in sheep. 
 
  
Gene Name Classical Name Reason for being GOI Reference 
BDNF Brain-derived neurotrophic 
factor 
Modulated by steroids, 





Immediate early gene Marker for neuronal activity 
in neuroendocrine systems 
Hoffman et al., 
(1993) 
GABRA6 Gamma-aminobutyric acid A 
receptor, alpha 6 
Altered in autism, target for 
schizophrenia treatment and 
granule cell marker 
Dean et al., 
(2005); Fatemi 
et al., (2010)  
GAD1 Glutamate decarboxylase 1 Enzyme required for GABA 
synthesis. GABAergic 
Purkinje neuron marker. 
Westmoreland 
et al., (2001) 




All cell and neuronal activity genes examined were found to be expressed in GD 
90 male cerebellum (Table 4.2).  








BDNF Fetal sheep Duncan et al., 
(2004) 
Yes 
FOS Adult rat Chen et al., 
(2005) 
Yes 
GABRA6 Neonatal rat Bovolin et al., 
(1995) 
Yes 
GAD1 Neonatal rat Chan-Palay et al., 
(1981) 
Yes 




Table 4.2: This table depicts whether mRNA expression for each GOI has been identified in the 
literature. In the majority of literature, cerebellar gene expression studies have been carried out 
on neonatal or adult rats. Here, it was ascertained that all GOI are expressed in the male fetal 




4.2.1.1 The effect of excess fetal androgen on the mRNA expression of 
genes associated with cell and neuronal activity in the male cerebellum 
The data indicates that there was no change at the mRNA level for the genes of 
interest that are cell markers or involved in neuronal activity.  
BDNF is a critical neurotrophin that regulates cell differentiation, cell survival, 
neurotransmission, and synaptic plasticity in the CNS (Numakawa, 2010). The 
data from this present study indicates that there was no change in BDNF 
expression in the cerebellum of TP-treated samples when compared to the 
controls (p=0.3475, Figure 4.1 A).  
FOS is a marker of neuronal activation in the cerebellum (Chen et al., 2005). It 
was hypothesised that FOS mRNA expression in the TP-treated group would be 
altered. However, there was no change in expression between the control and 
TP-treated group (p=0.2603, Figure 4.1 B).  
Bovolin et al., (1992) demonstrated that GABRA6 was abundant in granule cells 
of neonatal rats. The current study determined that there was no significant 
change in GABRA6 expression between the two groups (p=0.8058, Figure 4.1 
C).  
GAD1 is expressed abundantly in Purkinje cells of the cerebellum (Chan-Palay 
et al., 1981). There was no change in GAD1 mRNA expression in this study, as 
a result of TP treatment (p=0.3315, Figure 4.1 D). 
GFAP is a known glial marker (Westmoreland et al., 2001). The results from this 
current study suggest a non-significant trend towards an increase of GFAP 
expression in the TP-treated males in the developing cerebellum (p=0.0641, 






Figure 4.1: qRT-PCR analysis has shown that there are no differences at the mRNA expression 
level of cell and neuronal activity marker in cerebellar tissue of GD90 male sheep, n=4. A) 
BDNF mRNA expression for control and TP-treated samples, p = 0.3475, a 2.66-fold reduction 
in the TP-treated group was calculated B) Fos mRNA expression for control and TP-treated 
samples, p = 0.2603, a 3.06-fold reduction in the TP-treated group was calculated C) GABRA6 
mRNA expression for control and TP-treated samples, p = 0.8058, a 3.96-fold reduction in the 
TP-treated group was calculated D) GAD1 mRNA expression for control and TP-treated 
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4.2.2 Examination of the developing cerebellar layer widths after androgen 
exposure 
The EGL, ML and IGL cerebellar layers were identified by comparing the slides 
from the current study with data from Kirsch et al. (2012), Pilati et al., (2008) 
and the Allen Brain Atlas. The widths of the cerebellar layers in GD90 male 
sheep that were either exposed or not to excess androgen (TP-treated and 
control group, respectively) were measured and compared to determine 
whether androgen exposure affected layer width. Figure 4.2 shows that there 
was no change in EGL, ML or IGL layer width between the control and TP-
treated groups (p= 0.4042, 0.9293 and 0.3727, respectively)  
 
 
Figure 4.2:  Using Nissl staining, the width of each cerebellar layer of GD90 male sheep were 
measured using Image J software. Using an unpaired t-test, these measurements were used to 
investigate if there were any differences in layer width between the control and TP-treated 
groups (n=4). A) mean width of EGL for the control and TP-treated groups,  p = 0.4042 B) mean 
width of ML for the control and TP-treated groups, p 0.9293 C) mean width of IGL for the control 
and TP-treated groups, p = 0.3727 D) a representative image of a Nissl stained section GD90 
control sample at X20 magnification E) a typical image of a GD90 TP-treated sample of a Nissl 
stained section. The arrows on panels D and E represent how each cerebellar layer was 
measured. 
E) Typical image of GD 90 male TP-
treated cerebellar tissue 
 
D) Typical image of GD 90 male 
control cerebellar tissue 
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4.2.3 Observation of Purkinje cells, using immunohistochemistry 
4.2.3.1 The number of Purkinje cells increases after androgen over-
exposure 
Immunohistochemistry was performed to investigate any Purkinje cell 
alterations that arose from androgen over-exposure, using calbindin as a 
Purkinje cell marker. The number of calbindin positive cells were counted using 
a grid eyepiece at five random areas of each cerebellar sections (GD90 male 
sheep). The mean was calculated and then converted into positive cells/mm2. 
Figures 4.3 A and B show typical images for the immunohistochemical analysis, 
using anti-calbindin, for the control and TP-treated groups. This Purkinje cell 
marker showed an increase in positive Purkinje cells/mm2 (p = 0.0008, Figure 
4.3) in the TP-treated group. 
 
       A) A typical representative of GD90 control               B) A typical representative of GD90 TP- 
           cerebellar ovine tissue                                                treated cerebellar ovine tissue  
 
Figure 4.3: Immunohistochemistry was performed to investigate any Purkinje cell alterations as 
a result of androgen over-exposure, using calbindin as a Purkinje cell marker. The data 
indicates an increase in positive Purkinje cells/mm
2
 (p = 0.0008, n=4) in the TP-treated group.  
A) GD90 control male sample at X20 magnification.  B) GD90 TP-treated male samples at X20 
magnification. C) Graphical representation of data. 
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4.2.3.2 Is the “TP effect” on Purkinje cell number mediated by androgen or 
estrogen? 
This study also investigated whether the observed alterations in Purkinje cell 
are due to an androgenic or estrogenic effect. There is potential for the 
placental aromatisation of testosterone into estrogenic metabolites. Therefore, 
to define the effects of both sex hormones, fetal male sheep were directly 
injected with either TP or the potent estradiol receptor agonist, diethylstilbestrol 
(DES). There was a no significant change between the control and DES-treated 
















Figure 4.4: Immunohistochemistry was performed to investigate any changes in Purkinje cell 
number as a result of androgen over-exposure, using calbindin as a Purkinje cell marker. The 
data indicates no change in positive Purkinje cells/mm
2
 (p = 0.3522, n=4) in the DES-treated 
group.  A) GD90 control male sample at X20 magnification.  B) GD90 TP-treated male samples 
at X20 magnification. C) Graphical representation of data. 
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4.2.3.3 Perturbed Purkinje cell development after prenatal excess 
androgen exposure 
Typically, the PCL is arranged into a monolayer, observed in the majority of the 
control samples. However, using calbindin as a Purkinje cell marker, we 
observed an increase in the number of Purkinje cells within the PCL in the TP-
treated samples, compared to the control samples (Figure 4.5 E, p = < 0.0001). 
The arrows indicate how this was measured i.e. Figures 4.5 A and C) 1 Purkinje 
cell and Figures 4.5 B and D) 4 Purkinje cells. The Purkinje soma were also 
reduced in size in the TP-treated samples (Figure 4.5 F, p = 0.0328). The PCL 
width was measured and had increased in the TP-treated samples (Figure 4.5 
G, p = 0.0002).  
 
        A) GD90 control cerebellar ovine                               B) GD90 TP-treated cerebellar 




        C) GD90 control cerebellar ovine                                D) GD90 TP-treated cerebellar 




Figure 4.5: In the TP-treated samples, there was an increase in the number of Purkinje cells 
within the PCL (E, p = < 0.0001, n=4). The Purkinje soma were also reduced in size in the TP-
treated samples (F, p = 0.0328, n=4). The PCL width was measured and had increased in the 
TP-treated samples (G, p = 0.0002, n=4). (A and C) GD90 male control samples. (B and D) 
GD90 male TP-treated samples. (A and B X20 magnification. (C and D) X40 magnification. 




This study has demonstrated that there are more, smaller Purkinje cells but with 
smaller soma diameter in the cerebellum of androgen exposed GD 90 male 
sheep. The PCL arrangement was also examined. The unit width of the PCL 
was measured and the Purkinje cell diameters were normalised to the 
corresponding unit width. This confirmed that there are more Purkinje cells per 
layer as a consequence of androgen administration (Figure 4.6 E, p = < 0.0001).  
Although an increase of Purkinje cell number and PCL width as a result of 
androgen exposure was observed, the total area that the Purkinje cells occupy 
was reduced in the PCL (Figure 4.6, p = 0.0078).  In the TP-treated samples, 
there were more gaps, which were also included in the total PCL width 
measurement, between the Purkinje cells, when compared to the controls. 
 
Figure 4.6: The percentage of Purkinje cells that cover the PCL was reduced as a response to 











4.2.3.4 Purkinje cell observations 
Using calbindin as a Purkinje cell marker, it was possible to observe a more 
highly developed dendritic network in the ML in the control group (Figures 4.7 A 
and C) whereas the TP-treated samples appear to have little, or no, dendritic 
network (Figures 4.7 B and D). Figure 4.7 A and C also illustrates how the 
Purkinje cells have taken on their typical unipolar shape whereas Figure 4.7 B 
and D shows that the Purkinje cells have not matured to that extent. 
 
           A) GD90 control cerebellar ovine                              B) GD90 TP-treated cerebellar 




           C) GD90 control cerebellar ovine                             D) GD90 TP-treated cerebellar 
                tissue at X40 magnification                                      ovine tissue at X40 magnification 
 
Figure 4.7: A and C) GD90 male control samples. B and D) GD90 male TP-treated samples. A 
and B) X20 magnification. C and D) X40 magnification. Panels A-D are representative images 
for the control and TP-treated groups. 
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In the control group, Purkinje cells display a typical large, triangular shape 
(Figure 4.8 A and C) whereas the TP-treated samples appear to exhibit smaller, 
round Purkinje cells (Figure 4.8 B and D). This may suggest that the Purkinje 
cells examined in the TP-treated group are immature and not at the same 
developmental point as that of the control group. 
 
            A) GD90 control cerebellar ovine                           B) GD90 TP-treated cerebellar 




            C) GD90 control cerebellar ovine                           D) GD90 TP-treated cerebellar 
            tissue at X40 magnification                                         ovine tissue at X40 magnification 
 
Figure 4.8: A and C) GD90 male control samples B and D) GD90 male TP-treated samples. A 
and B) X20 magnification. C and D) X40 magnification. Panels A-D are representative images 
for the control and TP-treated groups. 
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4.2.4 The apoptosis and proliferation cycle is modified in Purkinje cells 
due to excess androgen exposure 
4.2.4.1 Apoptosis 
Cleaved Caspase 3 was used as a marker for cell apoptosis in the PCL. Tissue 
from control and TP-treated (GD 90 male sheep, n=4) was sectioned, stained 
for cleaved caspase 3 and positive Purkinje cells (stained brown) were counted 
(4 sections per sample) and converted into a percentage. Figure 4.9 
demonstrates an increase in cleaved caspase 3 positive Purkinje cells with TP-
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Cleaved caspase 3 was used as an apoptosis marker. Positive cleaved 
caspase 3 staining revealed which cells were undergoing apoptosis. The data 
suggests that there is an increase of cleaved caspase 3-positive cells in the TP-
treated group (Figure 4.10, p = 0.0064).  
 
 
            A) GD90 control cerebellar ovine                             B) GD90 TP-treated cerebellar 
                tissue at X20 magnification                                       ovine tissue at X20 magnification 
 
 
           C) GD90 control cerebellar ovine                             D) GD90 TP-treated cerebellar 
                tissue at X40 magnification                                      ovine tissue at X40 magnification 
 
Figure 4.10: A and C) GD90 male control samples. B and D) GD90 male TP-treated samples. A 
and B) X20 magnification. (C and D) X40 magnification. Panels A-D are representative images 




Ki-67 was used as a marker of cell proliferation in the PCL. Tissue from control 
and TP-treated groups was sectioned, stained for Ki-67 and analysed in terms 
of positive staining in GD90 male sheep (n=4, 4 sections per sample) and 
converted into a perecentage. Figure 4.11 demonstrates an increase in Ki-67 









Figure 4.11: an increase in Ki-67 positive Purkinje cells with TP-treatment (p = 0.0406, n=4).   
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Ki-67 was used as a proliferation marker. The data suggests that there is an 
increase of Ki-67-positive cells the TP-treated group (p = 0.0064, Figure 4.12). 
 
          A) GD90 control cerebellar ovine                             B) GD90 TP-treated cerebellar 
               tissue at X20 magnification                                      ovine tissue at X20 magnification 
 
 
          C) GD90 control cerebellar ovine                             D) GD90 TP-treated cerebellar 
               tissue at X40 magnification                                      ovine tissue at X40 magnification 
 
Figure 4.12: A and C) GD90 male control samples. B and D) GD90 male TP-treated samples. A 
and B) X20 magnification. C and D) X40 magnification. Panels A-D are representative images 
for the control and TP-treated groups.  
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 4.3 Discussion 
4.3.1 Fetal ovine cerebellar expression is unaltered in cell and neuronal 
activity markers 
This study has shown that at GD 90, the male ovine cerebellum expresses the 
cell and neuronal activity markers that were examined in the present study 
(BDNF, FOS, GABRA6, GAD1 and GFAP). All genes of interest have been 
shown to be expressed in the cerebella of the rat model so this current study 
not only confirms this cerebellar expression pattern but also provides novel 
information on the fetal ovine brain (Table 4.2). Only two of the genes of interest, 
BDNF and GFAP, have been found to be expressed in the male ovine 
cerebellum in previous literature (Duncan et al., 2004; Mallard et al., 1998).  
 
The cell and neuronal activity markers examined in this study were unaltered in 
the TP-treated group, when compared to the control group. The data implies 
that there was no change in BDNF expression in the cerebellum of TP-treated 
samples when compared to the controls (p=0.3475, Figure 4.1 A). However, 
BDNF expression has been found to be up-regulated by increasing testosterone 
levels in the frontal cortex of pre-pubertal male mice (Hill et al., 2012) . There 
was no observed change in FOS mRNA expression as a result of prenatal 
excess androgen exposure (p=0.2603, Figure 4.1 B). Previous literature has 
demonstrated that FOS mRNA expression is regulated by testosterone, in the 
amygdala of male green anole lizards (Neal and Wade, 2007). The results imply 
that there is no change in cell differentiation, measured via BDNF expression, 
and in neuronal activation, measured via FOS expression in the cerebellum of 
GD 90 male sheep that were over-exposed to androgens and could be 
attributed to the immaturity of cerebellar neurons.  
  
The current study determined that there was no significant change in GABRA6 
mRNA expression between the two groups (p=0.8058, Figure 4.1 C). This 
suggests that granule cell number was not affected by testosterone 
administration, assuming steady levels of GABRA6 in the treated and untreated 
conditions. Using immunohistochemistry, we would expect to observe GABRA6 
positive granule cells within the IGL (Laurie et al., 1992), however using Nissl 
staining, we detected no difference within the granular layers.  There was also 
no change observed in GAD1 mRNA expression, as a result of TP treatment 
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(p=0.3315, Figure 4.1 D). GAD1 is a key enzyme in GABA synthesis that occurs 
within cerebellar and cortical interneurons (Benes and Berretta, 2001), therefore 
the data implies that at this stage of cerebellar development, GABAergic 
neurons, i.e. Purkinje cells, are not altered by prenatal androgen excess. 
However, the structural effects of excess androgens have been evaluated in the 
current study and have demonstrated that there are in fact some marked 
alterations in the Purkinje cell layer development (Figures 4.3-11). It could be 
that the more, smaller Purkinje cells have the same level of expression as fewer, 
larger cells. To be able to determine whether this was a possible cause for no 
significant change in GAD1 mRNA levels, immunohistchemistry would have 
allowed the visualisation of Purkinje cells expressing GAD1 protein and 
Western blotting would have enabled the quantification of GAD1 protein. Due to 
lack of suitable antibody that reacts in ovine tissue and an optimised protein 
extraction protocol, these investigations were unable to be performed. 
There was only one GOI, GFAP, where a non-significant trend towards an 
increase of expression in the TP-treated males in the developing cerebellum 
(p=0.0641, Figure 4.1 E). Testosterone has been previously shown to down-
regulate GFAP mRNA expression in facial nuclei of adult male hamsters (Jones, 
et al., 1997). Glial cells are crucial in the development of the nervous system 
and are involved processes such as synaptic plasticity and synaptogenesis 
(Ullian et al., 2004). Therefore the present study suggests that GFAP shows an 
upward trend as a result of prenatal excess androgen exposure. This would 
imply that the number of glia cells and the synaptic plasticity and/or 
synaptogenesis is altered in the TP-treated cerebella, which is indicative of 
immaturity of the glial cells and ultimately, delayed cerebellar development. Due 
to limitations in sample size, it was impossible to increase the sample numbers 
in order to determine if an alteration in GFAP mRNA expression would show 
any significance with a larger population of samples. It would be difficult to 
identify and determine, if any, differences in glial cell number and morphology 
by utilising GFAP protein, by means of immunohistochemistry due to the small 
size of glial cells (0.37m3 in soma volume and 7m in stalk length, Grosche et 




4.3.2 No change in developing cerebellar layer widths after androgen 
exposure 
Using Nissl staining, the mean widths of the EGL, ML and IGL were measured 
and calculated in the control and TP-treated male groups and then compared. 
The study determined that there were no significant differences in the EGL, ML 
or IGL (p = 0.4042, 0.9293 and 0.3727, respectively, Figure 4.2) between the 
two groups. This implies that granule cell migration was not affected by 
androgen exposure.  
The processes of granule cell differentiation and migration depend on many 
extracellular factors, such as BDNF, which is expressed in cerebellar granule 
cells in neonatal rats (Rocamora et al., 1993) . Rocamora et al., (1993) 
demonstrated that BDNF mRNA expression increases during development in 
rats. Furthermore, BDNF mRNA expression is up-regulated by increasing 
testosterone levels in the frontal cortex of pre-pubertal male mice (Hill et al., 
2012). Therefore, the current study had hypothesised that there would be some 
change in granule cell migration, as a result of androgen exposure. However, 
no alterations were observed for BDNF expression, as previously discussed (p 
= 0.3475, Figure 4.1 A), therefore the results indicate that cerebellar granule 
cells of the TP-treated samples, develop in a typical granule cell migration 
pathway (Borghesani, et al., 2002). Hill et al., (2012) examined pre-pubertal 
mice and the granule cell migratory pattern was not established. In conclusion, 
androgen exposure does not seem to affect the widths of each of the cerebellar 
layers, and ultimately granule cell migration, during ovine gestation. This, taken 
together with the altered Purkinje cell development observed in the TP-treated 





4.3.3 Purkinje cell morphology is altered due to androgen over-exposure 
Calbindin was used as a specific Purkinje cell marker (Dougherty et al., 2013) 
as it is abundantly expressed in these cells and is a Purkinje cell-specific protein 
in the cerebellum (Bastianelli, 2003). The present study has evaluated whether 
there is a difference in Purkinje cell numbers between the control and TP-
treated samples. The data also shows multiple differences in Purkinje cell 
development between the control and TP-treated groups. 
4.3.3.1 Is the “TP effect” on Purkinje cell number mediated by androgen or 
estrogen? 
The data indicates that the number of cerebellar Purkinje cells in GD 90 male 
sheep have increased as a result of prenatal androgen over-exposure (Figure 
4.3). The current study has established that the observed change is due to a 
direct androgen effect on these cells as there was no significant change in the 
number of Purkinje cells in the DES-treated group, when compared to the 
control group (Figure 4.4). There is very little literature that examines the effect 
of androgens on Purkinje cell development. Wright and Smolen (1983) have 
demonstrated that TP administration in neonatal male rats resulted in a 40% 
increase in the number of superior cervical ganglion neurons compared to the 
control group. 
On the other hand, estrogen, progesterone and their metabolites have been 
shown to promote the development and survival of Purkinje cells in non-
castrated rats (Sakamoto et al., 2003). A previous study has shown that indeed 
androgens do affect Purkinje cell number but rather in the opposite manner to 
the current study. Zhang et al., (2000) demonstrated testosterone administration 
decreased undifferentiated and differentiated cell number in cultured cerebellar 
neurons from GD 14 rats (The equivalent to GD 18-22 in sheep); whereas 
estrogen increased neuronal cell number. However the current study‟s results 
indicate that this is not the reason in our cohort of samples. This could be 
further investigated by evaluating the effects of DHT, a non-aromatizable 
androgen, has on the developing ovine cerebellar cytoarchitecture. If the results 
were similar as the ones observed for the present study then it could be 




4.3.3.2 Purkinje cell number alterations in neurodevelopmental disorders 
Bailey et al., (1998) observed that again adult male humans with autism had a 
lower number of Purkinje cells, however when a four year old male was 
examined, there was no change in Purkinje cell number. This may suggest that 
the loss of Purkinje cells occurs during adult life, a time point not examined in 
the current study. There was also no report of Purkinje cell abnormalities in 
sixteen year old autistic females (Guerin et al., 1996) which suggests that 
Purkinje cell dysfunction is more likely in autistic males and somehow females 
are “protected” from structural cerebellar abnormalities by high estrogen levels. 
Why this occurs remains unclear. Examining the cytoarchitecture of GD 90 
female ovine cerebellar samples that have been treated with TP, would allow us 
to determine whether females demonstrate the same abnormal development as 
males of the same gestational age. However due to time constraints, this was 
not investigated. 
4.3.3.3 Purkinje soma diameter 
The results from the current study indicate that there was a reduction in Purkinje 
cell soma diameter in the TP-treated group (Figure 4.5 F). Androgen regulation 
of cerebellar development has not been investigated in depth in previous 
literature but various different brain regions have. For example, Wright and 
Smolen (1983) demonstrated that TP administration in neonatal male rats does 
not affect Purkinje soma diameter. The current study and Wright and Smolen 
(1983) demonstrate that TP alters neuronal development; however as different 
brain regions have been investigated; they cannot be compared to one another. 
These findings, from both the present study and previous literature, give more 
insight into how androgen exposure can affect different regions in a variety of 
ways. 
4.3.3.4 PCL arrangement  
The PCL width had increased in the TP-treated samples (Figure 4.5 G, p = 
0.0002). Although an increase of Purkinje cell number and PCL width as a 
result of androgen exposure was observed, the total area that the Purkinje cells 
cover was reduced in the PCL (Figure 4.6, p = 0.0078).  In the TP-treated 
samples, there were more gaps, which were also included in the total PCL width 
measurement, between the Purkinje cells, when compared to the controls. 
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Rees and Harding (1988) observed that Purkinje cells were generally arranged 
in a monolayer, although multilayered regions were found in GD 90-92 sheep, 
which is what was observed in the current study‟s control samples. The current 
study also observed that in the TP-treated group, multilayered regions of 
Purkinje cells were predominant over the typical monolayer arrangement, which 
is usually observed at an earlier gestational time point (Rees and Harding, 
1988). This suggests that excess prenatal androgen exposure delays the 
progression of Purkinje cell development. In the rat, Purkinje cell clusters begin 
to disperse after birth (Chung et al., 2009), the equivalent of GD 25-35 in ovine 
gestation. Therefore, it is possible that the increase in Purkinje cell number and 
PCL width, demonstrated in the TP-treated group of the current study, may be 
due to delayed development. Cerebellar samples from a later gestational time 
point, the neonatal and pubertal periods and adulthood would help to determine 
whether this developmental delay ever catches up to typical development by 
comparing the morphology from control and TP-treated samples. However, this 
was beyond the scope of the current study. 
4.3.3.5 Observations 
When Purkinje cells were examined using immunohistochemistry in the current 
study, it became apparent that there were other anatomical features that may 
be altered by prenatal androgen over-exposure. However these variations were 
not statistically analysed but are important to point out. Rees et al., (1997) 
performed Golgi staining on GD 90-92 ovine cerebellar tissue. They observed 
large, triangular Purkinje soma with several processes radiating mainly from the 
apical dendrite during typical cerebellar development. However, dendritic 
arborisation was still immature at this developmental stage and so it was 
deemed not possible to carry out any morphometric analysis.  
The control cerebellar samples displayed typical large, triangular shaped 
Purkinje cell soma (Figures 4.8 A and C); whereas the TP-treated samples 
exhibited small and round soma (Figures 4.8 B and D). Salouci et al., (2012) 
demonstrated that Purkinje soma shape is modified during cerebellar 
development in fetal sheep. The data suggested that prior to the Purkinje cell 
displaying large and triangular soma, the soma were small and round; which is 
what was observed in the TP-treated samples. It was also observed that the 
TP-treated cerebellar samples displayed an underdeveloped dendritic network 
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compared to that of the control samples (Figures 4.7 B and D; Figures 4.7 A 
and C, respectively). This implies that the cerebella over-exposed to androgens, 
has not matured at same pace as the control tissue. Sotelo (1978) 
demonstrated that postnatal rats (the approximate equivelant to GD 90 in sheep) 
possessed extensive dendritic trees from which Purkinje cells extended upward 
in a single plane into the molecular layer, where they synapsed with parallel 
fibers of granule cells. Indeed, Purkinje cells of the control samples displayed 
signs of apical dendrites forming and therefore, an indication that these cells 
were assuming their typical unipolar organisation (Salouci et al., 2011). 
However the dendritic network and apical dendrite was not observed in TP-
treated group. This further suggests that what is observed in the current study is 
the delayed development of the cerebella over-exposed to androgens.  
In order to be able to investigate and statistically analyse any true soma shape 
and dendritic morphological differences that have occurred through prenatal 
androgen over-exposure, the Golgi staining technique could be utilised. This 
would allow the proper visualisation of the Purkinje cell dendritic network and 
enable the number of dendritic processes and/or the total length of processes 
per Purkinje cell to be measured and quantified, to give further insight into the 
development of the Purkinje cell and its dendritic network. Due to time 
constraints, this was beyond the scope of the current study. 
Sakomoto, et al., (2003) demonstrated that treatment of the neonatal male rat 
with exogenous estradiol and progesterone promoted the dendritic growth and 
spine formation of Purkinje cells. The increase in PR mRNA expression that is 
observed as a result of androgen over-exposure (Chapter 3) may result in the 
dysregulated cerebellar development observed in the current study. The 
observation of an underdeveloped dendritic network of Purkinje cells, among 
other Purkinje cell alterations, were detected as a result of androgen over-
exposure. Further investigation into measuring Purkinje cell dendritic and spine 
length, using Golgi staining would allow statistical analysis to be carried out.  If 
the results from this experiment were the same to ones discussed in this thesis 
i.e. increased PR gene expression, delayed Purkinje cell development then it 
could be implied that these alterations are mediated by PR. Furthermore, Zhang 
et al., (2000) demonstrated that testosterone inhibited neuronal differentiation in 
cultured cerebellar neurons from GD 14 rats. These findings taken together, 
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suggest that progesterone contribute to the development of Purkinje cells during 
neonatal life whereas androgens appear to operate in the opposite manner, 
which is what the current study has observed in the TP-treated cerebellar tissue 
samples, compared to the controls. 
4.3.3.6 Apoptosis and proliferation of altered Purkinje cells 
Within the ovine cerebellum, there was an increase in Purkinje cell apoptosis in 
the TP-treated samples compared to the control group (Figures 4.9 and 4.10). 
There is evidence to suggest that neurosteroids can influence the typical 
physiological rate of apoptosis and in the developing brain. For example, 
Ahlbom et al., (2001) demonstrated that testosterone administration rendered 
cultured cerebellar granule cells less susceptible to apoptosis that was induced 
by oxidative stress. Furthermore, Yawno et al. (2007) revealed that the 
suppression of allopregnanolone via finasteride, a 5-reductase 2 inhibitor, 
increased apoptosis in the granular and molecular cerebellar layers, in GD 125 
fetal sheep. This suggests that the reduction in 5-reductase 2 mRNA 
expression observed in the current study (Chapter 3, Figure 3.5 B), may play 
some part in the increased apoptosis in the TP-treated samples. In humans, 
apoptosis involves the normal loss of 50% or more of the neurons within a brain 
region (Stiles and Jernigan, 2010) therefore, it could be assumed that the level 
of apoptosis observed in the TP-treated cerebellar samples may have occurred 
earlier in gestation in the control samples, which is further evidence for the 
immature Purkinje cell development detected in the androgen exposed tissue. 
Zhang et al., (2000) determined that these changes did not occur through an 
alteration in proliferation, i.e. more/less neuronal cell growth, but rather through 
the regulation of apoptosis. This finding is in contrast to the current result as 
both apoptosis and proliferation have significantly increased in the TP-treated 
group, which again suggests this may be a symptom of immaturity of the TP-
treated cerebella. 
In the current study, there was also an increase in Purkinje cell proliferation as a 
result of prenatal androgen over-exposure (Figures 4.11 and 4.12). Zhang et al., 
(2000) examined whether testosterone or estrogen modulated cell proliferation 
in cultured cerebellar neurons. The results suggested that testosterone 
decreased neuronal cell numbers whereas estrogen increased neuronal cell 
numbers. (Thomaidou et al., 1997) suggested that apoptosis is important in the 
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proliferating neuroepithelium of the developing cerebellum in rats. Therefore, 
the increase in apoptosis may buoy the rate of proliferation in developing 
Purkinje cells that have been prenatally exposed to excess androgens. The high 
rate of apoptosis and proliferation are also indicative of immaturity of Purkinje 
cells (Stiles and Jernigan, 2010). As there was no change in Purkinje cell 
number between the control and DES-treated groups, apoptosis and 





The results of the investigation into gene expression changes in GOI that are 
cell and neuronal activity markers showed no significant changes between the 
control and TP-treated groups. GFAP was the only GOI which showed a trend 
towards increased mRNA expression in the TP-treated group (p=0.0641, Figure 
4.1 E). The results of the current study suggest that the time point used in the 
current study, GD 90 in ovine gestation may be too early to detect any changes 
in mRNA levels of these GOIs. Androgens have been shown to regulate these 
GOIs, by the action of testosterone, in pre-pubertal and adult animal models 
(Hill et al., 2012; Janmaat et al., 2011; Neal and Wade, 2007; Jones et al., 
1997). Therefore, the age of the animal models in previous literature are more 
developed whereas the specific time point chosen for the current study was GD 
90 in sheep, which is just when a major cerebellar growth period occurs. 
Examining male ovine cerebellar samples from a later point in gestation or even 
into adulthood would allow the results to be comparable to those in the previous 
literature. Another factor to take into consideration is that the expression of 
these genes does not reflect the conclusions of previous studies (Hill, et al., 
2012; Janmaat, et al., 2011; Neal and Wade, 2007) on other brain regions. One 
possible explanation for this is that we are investigating a brain area that has a 
different functional role (the cerebellum plays a role in motor function) than the 
other well-characterised areas of the brain (such as the hippocampus which is 
involved in memory and spatial capacity).  
The gestational age for the current study (GD 90) was chosen as it is within the 
period of neuronal proliferation, migration and axonal and dendritic growth 
(Rees and Harding, 1997) in the brain region of interest in the study (the 
cerebellum), and thus is likely to represent a vulnerable period for 
developmental damage. Therefore, cerebellar development is still occurring 
during the time point that was evaluated in the current study.  
The control cerebellar tissue samples demonstrated the typical Purkinje cell 
monolayer arrangement, with large, triangular soma and signs of a growing 
dendritic network and apical dendrites, which also demonstrates that these cells 
are showing signs of becoming unipolar. In contrast to this, we observed 
Purkinje cell clustering, small and round Purkinje soma, a larger number of 
Purkinje cells and a very underdeveloped dendritic in network TP-treated 
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cerebellar tissue. This cytoarchitecture is found in normal ovine cerebellar 
development at an earlier stage (GD 80, Rees and Harding, 1988). Therefore, 
the control cerebellar samples likely had this disorganised pattern earlier in 
gestation but since developed in a typical fashion. The current study illustrates 
how excess prenatal androgens dysregulate and delays cerebellar Purkinje cell 
development and begs the question “does delayed development reach the 
typical cerebellar cytoarchitecture at a later stage?” Examining ovine cerebellar 
samples from a later gestational period, postnatally and into adulthood would 
give us insight into this. If the delayed development never reaches a fully 
matured cerebellum then this may have detrimental consequences on cognitive 
and/or motor function as the cerebellum plays a vital role in these areas. This 
could be achieved by a battery of tests that examine executive and cognitive 
function, such as discrimination and reversal learning, attentional set shifting 
and intra- and extradimensional set shifting tasks. These tests have already 
been assessed in sheep and it was concluded that sheep can not only perform 
these tasks but also display executive and cognitive function (Morton and 
Avanzo, 2011). 
The ovine gestational period examined, GD 90, is a time of neuronal apoptosis 
and proliferation. Taken together, the increase in apoptosis and proliferation of 
Purkinje cells in the TP-treated group, may suggest during typical development, 
most of the immature Purkinje cells undergo apoptosis in order to allow some 
Purkinje cells to fully develop into maturity. This alteration in the 
apoptosis/proliferation cycle may be due to direct androgen over-exposure or 
perhaps is a knock-on effect from another cycle that androgen has disrupted. 
The fact that estrogen enhances cell survival while testosteone promotes cell 
death (Zhang et al., 2000) also begs the question of what is driving this 
dyregulated development in our model and why is there an increase in both 
apoptosis and proliferation in the androgen over-exposed group. Investigating 
cerebellar samples that have been over-exposed to estradiol or DHT would 
confirm which steroid hormone is the driving force behind this. As progesterone 
promotes dendritic growth (Sakomoto et al., 2003), examining the effects of 
excess progesterone on ovine cerebellar development would also allow more 
insight on Purkinje cell dendritic growth. 
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The staggerer mutation, a deletion of the RORA gene, causes severe ataxia 
which is associated with dysgenesis of the cerebellum. A typical feature of this 
is that Purkinje cells are small, ectopic and possess rudimentary dendritic 
arbors (Crepel and Mariani, 1975). Sarachana et al., (2011) proposed that 
RORA was a candidate gene for autism and that the gene is regulated by 
androgens. There is evidence that links testosterone as a contributing factor in 
the occurrence of autism (Manning et al., 2001). Baron-Cohen (2002) described 
the “extreme male brain” theory in which the behaviour seen in autism is an 
exaggeration of typical sex differences and that exposure to high levels of 
prenatal testosterone may be a risk factor. This, taken together with the present 
study‟s findings, suggests that this altered cerebellar cytoarchitecture which is 
seen in male ovine tissue that was treated with TP, an androgen, may in some 
part be involved in the aetiology of autism. 
Ju et al., (1998) reported that the growth arrest specific gene (GAS7) is 
expressed preferentially in the brain and particularly in the Purkinje neurons of 
the cerebellum. Treatment of primary cerebellar cell cultures with antisense 
oligonucleotides inhibited GAS7 expression and interfered with neurite 
formation in Purkinje cells. Conversely, overproduction of GAS7 in mouse 
neuroblastoma cells promoted neurite-like outgrowth. Together, these results 
suggest that GAS7 may have a role in promoting, and possibly maintaining, 
maturation and morphological differentiation of these cerebellar neurons. 
However, in contrast to the morphological consequences of inhibiting GAS7 
expression or overproducing the GAS7 gene product, at least some biochemical 
concomitants of neuronal differentiation do not appear to be affected by GAS7 
in Purkinje cells. Examining genes that have been reported to arrest Purkinje 
cell development, such as GAS7, by utilising qRT-PCR may provide more 
insight into the mechanism behind the delayed Purkinje cell development 





















5. Neurodevelopmental disorder candidate genes in the cerebellum 
5.1 Aims and objectives 
To determine whether any candidate genes associated with autism and 
schizophrenia are altered at the mRNA level in GD 90 male sheep, after TP-
treatment. 
The current study has shown that there are Purkinje cell abnormalities as a 
result of prenatal androgen exposure – an increase in cell number, smaller and 
rounder cells, an underdeveloped dendritic network and clustering of Purkinje 
cells (i.e. larger PCL width, Chapter 4). Previous literature has suggested a 
reduction in eventual Purkinje cell number and size in neurodevelopmental 
disorders. It remains to be seen whether this dysregulated structural 
developmental pattern of the cerebellum observed in the TP-treated sheep is a 
relevant model for neurodevelopmental disorders. 
There is mounting evidence that gender is a risk factor and may contribute to 
neurodevelopmental disorders such as autism and schizophrenia (Baron-Cohen, 
2002; Rees and Harding, 2004). A link between fetal testosterone levels, 
structural abnormalities and neurodevelopmental disorders has already been 
investigated in the literature. The RELN and RORA genes are candidate genes 
for autism (Bonora et al., 2003; Nguyen et al., 2010) and DISC1 and NPAS3 are 
associated with schizophrenia (Nguyen et al., 2010; Thomson, et al., 2005). 
Alterations in some candidate genes (RELN and RORA) for 
neurodevelopmental disorders have been described in the cerebellum, however 
we do not know the effects that prenatal androgen exposure would have on the 
gene expression of these candidate genes in the cerebellum. Within the current 
study, four candidate genes were examined, to determine whether prenatal 
androgen exposure alters the mRNA levels of these genes. The hypothesis is 
that the full complement of candidate genes (DISC1, NPAS3, RELN and RORA) 
examined are expressed in the cerebellum of male fetal sheep at GD 90. It is 
further hypothesised that prenatal excess androgen (2x20mg depot injections at 
GD 62 and GD 82) alters cerebellar candidate gene expression in GD 90 male 
sheep as measured by qRT-PCR, and ultimately suggest that androgen over-




5.2.1 Gene expression analysis 
The level of gene expression for each GOI was evaluated using qRT-PCR 
analysis via the CT method.  The fold difference relative to a single reference 
(control) sample was then calculated by 2CT*(-1). Relative gene expression 
from the male control group and the male TP-treated group were compared to 
determine differences in gene expression, if any, using a two tailed, unpaired t 
test (GraphPad Prism software, U.S.A.).  
The genes of interest (GOIs) were chosen because they are suggested to be 
candidate genes for autism or schizoprenia (Table 5.1).  
 
 
Table 5.1: A list of the genes of interest that were examined. The primary focus of this study 
was to identify changes in the cerebellar expression of candidate genes for neurodevelopmental 




Gene Name Classical Name Reason for being GOI Reference 
DISC1 Disrupted in schizophrenia 1 Altered in schizophrenia Millar et al., 
(2000) 
NPAS3 Neuronal PAS domain 
protein 3 
Altered in schizophrenia and 
regulates glucose 
metabolism 
Pickard et al., 
(2005) 
RELN Reelin Autism marker Serajee et al., 
(2006) 
RORA Retinoid-related orphan 
receptor alpha 






All candidate genes examined were found to be expressed in GD 90 male 
cerebellum (Table 2). With the exception of RELN, this is the first time that the 
other GOIs have been found to be expressed in the fetal male sheep 
cerebellum. 
  







DISC1 Fetal and adult 
mice 
Schurov et al., 
(2004) 
Yes 
NPAS3 Fetal mice Brunskill  et al., 
(2005) 
Yes 
RELN Neonatal lambs Suarez-Vega et 
al., (2013) 
Yes 




Table 5.2: This table depicts whether mRNA expression for each GOI has been identified in the 
literature. In the majority of literature, cerebellar gene expression studies have been carried out 
on neonatal or adult rats.  
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5.2.2 Neurodevelopmental disorder candidate genes mRNA expression 
data 
DISC1 has been identified as a susceptibility gene for schizophrenia due to the 
link between psychiatric disease and a large Scottish family (Millar et al., 2000). 
This current study wanted to examine whether androgen over-exposure altered 
mRNA levels of DISC1 however, there was no change in DISC1 expression in 
the TP-treated group, when compared to the control group (p=0.2289, Figure 
5.1 A).  
Pickard et al., (2005) demonstrated that NPAS3 expression is altered in 
schizophrenia. No significant changes in NPAS3 mRNA expression in the 
developing male ovine cerebellum were observed between the control and TP-
treated groups in this current study (p=0.2755, Figure 5.1 B).  
Low reelin expression in the cerebellum of adult humans has been found to be 
associated with autism (Fatemi et al., 2005). This study has demonstrated that 
no significant changes were observed in RELN mRNA expression between the 
two groups (p=0.5673, Figure 5.1 C) at the GD90 stage of cerebellar ovine 
development.  
RORA has been proposed as a novel candidate gene in autism (Sarachana et 
al., 2011). No significant changes in cerebellar RORA mRNA expression were 







Figure 5.1: qRT-PCR analysis has shown that there are no differences at the mRNA expression 
level of neurodevelopmental disorder candidate gene marker in cerebellar tissue of GD90 male 
sheep, n=4. A) DISC1 mRNA expression for control and TP-treated samples, p = 0.2289 B) 
NPAS3 mRNA expression for control and TP-treated samples, p = 0.2755 C) RELN mRNA 
expression for control and TP-treated samples, p = 0.5673 D) ROR mRNA expression for 
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5.3.1 Fetal ovine cerebellar expression of neurodevelopmental disorder 
candidate genes 
This study has shown that at GD 90, the male ovine cerebellum expresses 
candidate genes of autism and schizophrenia (DISC1, NPAS3, RELN and 
RORA) and therefore illustrates that the fetal ovine cerebellum is capable of 
being vulnerable, to contributing to the aetiology of neurodevelopmental 
disorders. All genes of interest have been shown to be expressed in the 
cerebella of other animal models and so this current study not only confirms this 
cerebellar expression pattern but also provides novel information on the fetal 
ovine brain (Table 5.2). Only one of the genes of interest, RELN, has been 
found to be expressed in the male ovine cerebellum from the neonatal period 
and into adulthood, in previous literature (Suarez-Vega et al., 2013) and is 
therefore after the gestational period examined in the current study (GD 90).  
5.3.2 No change in gene expression of candidate genes as a response to 
prenatal androgen over-exposure 
5.3.2.1 Schizophrenia 
There is no literature that documents whether DISC1 and NPAS3 cerebellar 
mRNA expression is regulated by androgens or whether over-exposure to 
androgens during gestation alters their gene expression. Therefore, this current 
study can provide insight in that these genes are not regulated or influenced by 
androgens in the developing ovine cerebellum. Further experiments on GD 90 
male cortex tissue would determine whether these genes are altered as a result 
of over-exposure to androgen in utero. 
The prefrontal cortex region is strongly implicated in schizophrenia and it has 
been previously reported that the density of DISC1 positive neurons was 
significantly reduced in certain layers of the cortex of schizophrenics (Millar et 
al., 2000).  Schurov et al., (2004) demonstrated that DISC1 expression is 
developmentally regulated with two major peaks at embryonic day (ED) 13 and 
post-natal day (PND) 35 in the cortex and hypothalamus of mice whereas the 
current study is examining the cerebellum. This is the equivalent of GD 20 and 
approximately 1 postnatal month, respectively, in the sheep. These time periods 
are critically important in the development of rodents and correspond to the 
period of neurogenesis in the developing rodent brain (Nadri et al., 2003) but 
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not in the ovine cerebellum. Therefore this current study avoids disturbing the 
critical period of as the ovine fetuses were injected at GD 62 and 82, assuming 
the same DISC1 expression pattern occurs in the cerebellum. Pieper et al., 
(2005), reported reduced neurogenesis in the hippocampus of NPAS3 knockout 
mice and suggested the possibility that impaired hippocampal neurogenesis 
may be relevant to some aspects of hippocampal pathology, that are associated 
with schizophrenia. Schizophrenia candidate genes have been extensively 
examined in the prefrontal cortex and hypothalamus and shown to have altered 
expression patterns in people with this neurodevelopmental disorder (Millar et 
al., 2000; Schurov et al., 2004; Pieper et al., 2005).  
5.3.2.2 Autism 
One theory concerning the aetiology of autism is the “extreme male brain theory”  
which suggests that behaviours seen in autism are an exaggeration of typical 
sex differences and that exposure to high levels of prenatal testosterone might 
be a risk factor (Baron-Cohen, 2002). The RELN gene encodes for Reelin 
protein and has a major role in neuronal migration and in prenatal development 
of neuronal connections (D'Arcangelo et al., 1995). Low reelin expression in the 
cerebellum of neonatal mice has been found to be associated with autism 
(Fatemi et al., 2005). There is evidence that testosterone may regulate RELN 
mRNA expression in the hypothalamus and cerebellum of rats aged PND 10 
and 2.5 months (Lakatosova et al., 2010). However this current study does not 
reproduce this finding which could be due to the earlier time point used in our 
animal modal (GD 90). RORAactivates genes in the cerebellum that stimulate 
proliferation of granule cell precursors in the external granule layer while also 
regulating a set of genes in Purkinje cells involved in processing 
neurotransmitter signalling (Gold et al, 2003). Sarachana et al., (2011) 
demonstrated that estradiol treatment significantly enhanced RORA expression 
in the human neuroblastoma cell line, SH-SY5Y, whereas dihydrotestosterone 
(DHT) had the opposite effect and led to reduced RORA expression. These 
findings imply that RORA expression is regulated by steroids however the 
current study did not reflect this. This could be due to the time point chosen for 
examination in this study (GD 90) whereas the literature has previously focused 
on postnatal and adulthood gene expression in autism. Re-visiting RELN and 
RORA gene expression at a later time point, such as adulthood, by means of 
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The results of the investigation into gene expression changes of GOIs involved 
in neurodevelopmental disorders showed no significant changes or trends 
between the control and TP-treated groups. This suggests that prenatal 
androgen over-exposure does not alter the expression of these candidate 
genes at GD 90 stage of development of the ovine cerebellum. Androgen 
exposure has been shown in other areas of the brain to be influential in 
affecting gene expression of these genes (Millar et al., 2001; Fatemi et al., 2005; 
Sarachana et al, 2011; Baron-Cohen, 2002). It is feasible that the period of 
cerebellar development and therefore the age of the animals in the current 
study may be too early to detect any changes in these genes as the literature 
above evaluates adult tissue of other models. Therefore, evaluating the 
expression of candidate genes in male ovine cerebellar samples from a later 
point in gestation, or even into adulthood which is similar to the previous studies 
mentioned, would allow the results to be comparable to those in the previous 
literature. 
 
Previous literature has demonstrated that in neurodevelopmental disorders 
such as autism and schizophrenia, there is abnormal cytoarchitectural 
development in the cerebellum (Bauman and Kemper, 1985; Bailey et al., 1998; 
Reyes and Gordon, 1981; Tran et al., 1998). Chapter 4 demonstrated marked 
Purkinje cell layer dysregulation as a result of prenatal androgen over-exposure, 
and this abnormal cytoarchitecture, i.e. reduced Purkinje cell size, is seen in 
post mortem adult tissue from people afflicted with autism and schizophrenia. 
However, the candidate gene expression data implies that excess androgen 
administration does not alter their expression pattern in the fetal cerebellum of 
sheep at this stage of development. It is also important to point out that DISC1, 
NPAS3, RELN and RORA also play major roles in neurogenesis, neuronal 
migration, proliferation of granule cells and act as regulators of neurotransmitter 
signalling in the brain (Pieper et al., 2005; D'Arcangelo et al., 1995; Gold et al., 
2003) and so the changes seen in the cerebellar cytoarchitecture must be due 
to alterations on development via other pathways. 
There has been extensive research on structural abnormalities of the frontal 
and temporal cortex in schizophrenia.  So perhaps investigating the prefrontal 
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cortex and/or the hippocampus would allow us to illustrate how androgen over-
exposure may alter the genetic and structural development of the area of the 
brain heavily involved in cognitive and social functions. Due to time constraints, 
the examination the prefrontal cortex cytoarchitecture was beyond the scope of 
the current study. However, microarray analysis was performed on GD 90 ovine 
prefrontal cortex tissue to evaluate any change in gene expression in this brain 



















6. Microarray analysis of gene expression in the cortex 
6.1 Aims and objectives 
6.1.1 Aim 1 and objectives 
Examining the cortical cytoarchitecture of GD 90 male sheep and identifying 
whether pyramidal cell number and distribution are affected by TP-treatment. 
This study explored the developing male cortex cytoarchitecture by means of 
Nissl staining and immunohistochemistry, with the intention of evaluating 
whether there was a difference in pyramidal cell number, shape, formation and 
arrangement of pyramidal cells expressing T-box brain 1 (tbr1, a pyramidal cell 
marker, Bulfone et al., 1995) between the control and TP-treated GD 90 ovine 
samples (2x20mg depot injections at GD 62 and GD 82). The hypothesis is that 
pyramidal cell development is altered as a consequence of prenatal androgen 
over-exposure.  
6.1.2 Aim 2 and objectives 
To evaluate and compare gene expression levels between the control and TP-
treated GD 90 male sheep cortices. 
A link between fetal testosterone levels, structural abnormalities and 
neurodevelopmental disorders has already been investigated in the literature. 
The DISC1 and NPAS3 are associated with schizophrenia (Nguyen, et al., 2010; 
Thomson, et al., 2005). The role of androgens and their effect on gene 
expression during the development of the cortex is unknown. In order to 
evaluate and compare the gene expression between the control and TP-treated 
cortex samples, microarray analysis was performed. This allowed the 
measurement of 15 000 genes and their expression levels, in order to gain a 
broader insight into how prenatal androgen over-exposure can alter various 
genes in GD 90 ovine male cortex. 
6.1.3 Aim 3 and objectives 
To validate the microarray data. 
A selection of significantly altered genes, as determined by microarray analysis, 
was then validated by utilising qRT-PCR. This was performed in order to verify 




6.2.1 Identifying pyramidal cells by Nissl staining 
The current study set out to determine whether there was a change in the 
number of pyramidal cells in GD90 male sheep, as a result of prenatal excess 
androgen exposure. This was investigated by the use of Nissl staining, whereby 
distinct pyramidal cells are usually seen (Santana et al., 2004). However the 
current study could not differentiate between cell type although the different 
layers of the cortex were determined using Nissl staining (Figure 6.1).  
 
Figure 6.1: Representative images of a Nissl stained section GD90 control cortex tissue sample. 
A) X10 magnification. B) X20 magnification. The pyramidal cells were undistinguishable to 
granule cells at this developmental period. Layers I-VI are annotated on A) and B). 
192 
 
6.2.2 Examining the cortex using neuronal markers 
As Nissl staining was unsuccessful in illustrating pyramidal cells of the 
developing cortex, neuronal markers were utilised as an alternative method. T-
box, brain, 1 (Tbr1) was used as a pyramidal cell marker for the present study, 
as it is expressed in migratory and postmigratory neurons (Bulfone et al., 1995) . 
However there was no success in observing any positive Tbr1 cells at different 
dilutions (Figures 6.2 A and B). Calbindin is a Purkinje cell marker (Dougherty, 
et al., 2013) as it is abundantly expressed in these cells in the cerebellum 
(Bastianelli, 2003). Due to its specificity to neurons, we elected to try this as a 
pyramidal cell marker, but once again, there does not appear to be any positive 
staining (Figure 6.2 C). Both neuronal markers did work in the developing 
cerebellum (Figures 6.2 D and E). 
 
Figure 6.2 A) GD90 cortex tissue. Anti-TBR-1 at 1:50 dilution B) GD90 cortex tissue. Anti-TBR-1 
at 1:100 dilution C) GD90 cortex tissue. Calbindin at 1:1000 dilution 
 
Figure 6.2 D) GD90 cerebellar tissue. Anti-TBR-1 at 1:50 dilution E) GD90 cerebellar tissue. 
Anti-TBR-1 at 1:400 dilution 
Figure 6.2:  Anti-TBR1 was used for the detection of Pyramidal cells in the cortex in GD90 male 
sheep. A) 1:50 dilution. Pyramidal cells were undistinguishable. B) 1:100 dilution. No positive 
staining for Pyramidal cells were seen and this low dilution. C) Due to its remarkable staining of 
the Purkinje cells of the cerebellum, calbindin (1:1000 dilution) was used as another neuronal 
marker. D) To determine whether there was a problem with the anti-TBR1, GD90 male ovine 
tissue was used as a tissue control. TBR1 (1:50 dilution) shows positive staining for cerebellar 
Purkinje cells and so does the recommended 1:400 dilution (E). Therefore it was determined 
that the antibody used was suitable for ovine tissue. 
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6.2.3 Localisation of AR in the developing cortex 
AR localisation has been demonstrated in the nuclei of pyramidal cells of the 
cortex in neonatal rats (Nunez et al., 2003). However, there was no positive 
staining for AR in GD90 male sheep (Figure 6.3). 
 
Figure 6.3: Immunohistochemical studies shows no localisation of AR (dilution 1:500) in the 
nuclei of Pyramidal cells in the cortex of GD90 male sheep. A)  X10 magnification. B) X20 




6.2.4 Cortex Gene Expression using Microarray Analysis 
6.2.4.1 Differences in gene expression in the cortex, as a result of prenatal 
androgen over-exposure 
Microarray analysis evaluated 15 000 genes, in order to determine whether 
prenatal androgen over-exposure alters gene expression in the developing 
cortex. Using volcano analysis, the genes identified as being significantly 
altered in their expression in the cortex of GD 90 male sheep, are listed in order 




Gene Name Accession 
number 






Signals through the Robo 
receptor as a repellent 




Thyroid hormone receptor 







Neuropeptide Y receptor 
type AKA Chemokine (C-
X-C motif) receptor 4 0.019454515 
2.13-fold 
reduction 










glycosylation 10, alpha 







F-box & WD repeat 







Arginine glutamic acid 
dipeptide (RE) repeats 0.02133858 2.11-fold increase 




Collagen type IV alpha 2 










activated receptor delta, 
transcript variant 1 0.027523464 2.08-fold increase 





transhydrogenase 0.033152565 2.05-fold increase 
POMC NM001009266 Proopiomelanocortin 0.037072923 2.0-fold increase 





protein band 4.1-like 2, 




Amyloid beta (A4) 
precursor protein, 






methyltransferase 1 0.047516413 2.13-fold increase 
Table 6.1: The genes which are affected in GD 90 male ovine cortex as a consequence to 




6.2.4.2 Determining whether gene expression changes are due to an 
androgenic or estrogenic effect 
Microarray analysis evaluated 15 000 genes, and compared expression levels 
between the TP- and DES- treated GD 90 male ovine cortical tissue. If there is 
a change in gene expression between the TP- and DES-treated samples, then 
the expression would have changed in one treatment and not the other. If the 
same altered gene is reported in the comparison of control and TP-treated 
samples, then it is the TP administration that has changed the expression of the 
gene and is therefore deemed to be due to an androgenic effect.  The gene 
expression levels for DES-treated sample wouldn‟t be altered in this scenario 
thus, it is similar to comparing the control and TP-treated samples. Using 
volcano analysis, the genes identified as being significantly altered in their 
expression in the cortex of GD 90 male sheep of TP- and DES-treated samples, 






Gene Name Accession 
number 














activated receptor delta, 













Arginine glutamic acid 









Neuropeptide Y receptor 
type AKA Chemokine (C-
X-C motif) receptor 4 0.018649546 2.05-fold increase 
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Table 6.2: The genes which have altered expression in GD 90 TP-treated male ovine cortex, 





6.2.5 qRT-PCR validation of the microarray data 
qRT-PCR analysis was used to validate some of the significant findings of  
microarray analysis. The genes that were selected for validation were altered in 
the TP-treated group, and were chosen due to their roles in either cerebellar 
development, cellular/neuronal migration, steroidogenesis, endocrine disruption 
and neurodegenerational disease. However, the validation illustrated no 
significant differences at the mRNA level for five of the six genes of interest: 
SLIT2, POMC, ERBA 1 and NPY3R and APP (Figures 6.4 A-E). There was an 
increase in COL4A2 mRNA expression in the TP-treated cortex tissue with a 
8.95-fold increase in expression, which correlates with the result from 





Figure 6.4: qRT-PCR analysis has shown that there were no differences at the mRNA 
expression level of these gene of interests in cortex tissue of GD90 male sheep (n=6). A) Slit2 
mRNA expression for control and TP-treated samples, p = 0.4138 B) POMC mRNA expression 
for control and TP-treated samples, p = 0.516, a 2.05-fold increase in the TP-treated group was 
calculted C) ERBA 1 mRNA expression for control and TP-treated samples, p = 0.7907 D) 
NPY3R mRNA expression for control and TP-treated samples, p = 0.1796, a 3.97-fold increase 
in the TP-treated group was calculated E) APP mRNA expression for control and TP-treated 
samples, p = 0.4538. There was an increase in COL4A2 mRNA expression in the TP-treated 




The SLIT/ROBO pathway was also investigated due to SLIT2 being the most 
altered gene in the TP-treated cortex tissue in the microarray analysis. This 
pathway has already been investigated in the context of fetal programming 
(Hogg et al., 2011). SLIT2 is mediated by members of the ROBO receptor 
family (Andrews et al., 2007); therefore, due to the availability of primer sets, 
certain ROBO receptors were examined to deterimine whether androgen over-
exposure alters their gene expression. There was a significant increase in 
mRNA expression of ROBO1 (Figure 6.5 A). This suggests that after TP 
administration, there was a 3.54-fold increase in ROBO1 mRNA expression in 
the developing male cortex. However there was no change in the expression of 
ROBO2 and ROBO4 in GD90 male sheep, which were exposed to androgens 
(Figures 6.5 B and C).  
 
Figure 6.5: qRT-PCR analysis was used to further examine the SLIT/ROBO pathway, at the 
mRNA expression level in cortex tissue of GD90 male sheep (n=6). There was a significant 
increase in mRNA expression of ROBO1 in the TP-treated group, when compared to the control 
group (A, p = 0.0422) and no change in the expression of ROBO2 and ROBO4 in GD90 male 
sheep, that were exposed to androgens (B and C, p = 0.1406 and 0.1584 respectively). A 4.21-
fold increase in ROBO2 and a 2.47-fold increase in ROBO4 mRNA expression in the TP-treated 
group were calculated. 
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6.2.6 Comparison of microarray and validation results 
A comparison of a panel of significant microarray results taken (TP-treated 
versus control-treated group) and their validation by qRT-PCR on GD90 male 
sheep was performed (Table 6.3). Although the validation showed a trend 
towards upregulation of the GOIs, only one showed a significant increase in 
mRNA as a result of androgen exposure (COL4A2, p = 0.0352). Interestingly, 
NPY3R was downregulated in the microarray analysis but in the validation 
method of qRT-PCR, the mRNA expression showed a trend towards 
upregulation but this was not significant (p = 0.1796). 
 
Gene Name Fold Change Compacted P 
value (sig < 0.05) 










































0.044590697  < 2  0.4538 
ROBO1 N/A N/A 3.54-fold 
increase  
0.0422 
ROBO2 N/A N/A 4.21-fold 
increase  
0.1406 
ROBO4 N/A N/A 2.47-fold 
increase 
0.1584 
Table 6.3: A table to summarise the panel of significant microarray results and their validation 








6.3.1 No identification of pyramidal cells of the developing cortex  
We have observed that androgen over-exposure in utero dysregulates Purkinje 
cell development in the cerebellum. Therefore, we wanted to determine whether 
similar changes occur in pyramidal cells of the cortex in GD90 male sheep, as a 
result of androgen exposure. Basic features of the dendritic arbors of pyramidal 
neurons emerge during gestational weeks 17–25 in humans (Mrzljak et al., 
1988), approximately GD 50-80 in sheep. From weeks 26 to 34 (approximately 
GD 85-120 in sheep), migration should be completed and layer III and V 
dendrites continue to mature, as spines develop, basal dendritic length 
increases, and interneurons differentiate in layer IV (Mrzljak et al., 1992). 
Therefore, the literature suggests that pyramidal cells can be detected in GD 90 
ovine cortex tissue. Initially, the use of Nissl staining was utilised, whereby 
distinct pyramidal cells are usually observed (Ongur, et al., 2003). However, we 
could not differentiate between cell type using this method but the developing 
different layers of the cortex could be observed, using Nissl staining (Figure 
6.1). 
Neuronal markers were used as an alternative method in identifying pyramidal 
cells. There were no positive Tbr1 cells within the ovine cortex observed when 
evaluating the optimal primary antibody dilution (Figures 6.2 A and B). Bulfone 
et al., (1995) examined the protein expression of Tbr1 in the developing cortex 
and showed that Tbr1 is expressed in migratory and post-migratory pyramidal 
cells of fetal mice, and is an important factor in early brain development; which 
was why Tbr1 was chosen as a pyramidal cell marker for the current study. 
Calbindin is a Purkinje cell marker (Dougherty et al., 2013) as it is abundantly 
expressed in these cells in the cerebellum (Bastianelli, 2003). Due to its 
specificity to neurons, we elected to try this as a pyramidal cell marker but there 
does not appear to be any specific, positive staining; but there was some 
staining of artefacts (Figure 6.2 C). Both neuronal markers did work in the 
developing cerebellum and therefore it can be concluded that the antibodies 
reacted with the ovine species (Figures 6.2 D and E). One explanation for no 
positive staining of pyramidal cells could be that these neurons are too 
immature i.e. undifferentiated at the gestational time point we are examining 
(GD90), which conflicts previous findings (Mrzljak et al., 1988). Another option 
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is that perhaps the use of another pyramidal cell marker may be more suitable. 
Muller et al., (2006) used calcium/calmodulin-dependent protein kinase II 
(CaMK) as a pyramidal neuron marker in rats whereas Chan et al., (2001) used 
EMX1, a homeobox-containing gene, as the preferred pyramidal cell marker for 
neonatal and adult rats. Due to time constraints, we were unable to investigate 
whether these markers would be successful in fetal ovine tissue. Therefore the 
investigation into whether prenatal androgen exposure altered the 
cytoarchitecture of the developing ovine cortex was abandoned. Pyramidal 
neurons compose approximately 80% of the neurons of the cortex, and release 
glutamate as their neurotransmitter, making them the major excitatory 
component of the cortex (Santana et al., 2004). Santana et al., (2004) used 
adult male human tissue to show pyramidal cells of the cortex whereas the 
current study examined the developing cortex of fetal sheep, therefore this 
suggests that the time point, GD 90 in sheep, was too early to detect cell 
differentiation. To determine whether androgen over-exposure affects cell 
migration in the developing ovine cortex, the layer widths could be measured 
and compared between the control and TP-treated groups. 
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6.3.1.1 No protein expression of AR in the developing cortex 
In the current study, AR protein expression was not observed in the developing 
cortex of sheep (Figure 6.3). By the end of the first postnatal week of the rat, 
neuronal migration into the cortex is complete (Bayer et al., 1991). Pyramidal 
cells need to arrive at the appropriate layer of cortex prior to expression of the 
androgen receptor and therefore pyramidal cells do not express androgen 
receptors until they are differentiating (Bayer et al., 1991). This may be the 
reason that in the present study AR expression was not observed in GD 90 
sheep, due to immature pyramidal cells. This theory is supported by the fidning 
that neuronal nuclei (NeuN), a marker for mature neurons, is detected in AR 
positive cells in the rat neonatal cortex (Nunez et al., 2003). Thus, the increase 
in the density of AR immunoreactive cells may reflect an increase in neuronal 
complexity and synaptic connectivity.  
Androgen receptors have been documented in the developing rat cerebral 
cortex, with the density of AR positive cell nuclei varying as a function of age 
and cortical layer (Nunez et al., 2003). Specifically, Nunez et al., (2003) 
demonstrated that AR positive staining in pyramidal cells of the cortex was less 
intense than in the pyramidal cell layer of the hippocampus. At PND 0 (the 
equivalent to GD 36-42 in ovine gestation), AR positive neurons were only 
observed in layer V and VI of the developing cortex of male rats. At PND 4 (the 
equivalent to GD 50-55 in ovine gestation), Nunez et al., (2003) demonstrated 
that AR immunoreactivity was observed in layers II–VI. On PND 10 (the 
equivalent to GD 70-75 in ovine gestation), there were robust increases in the 
density of AR positive cells in layers II–IV and small increases in layers V and 
VI. This suggests that AR expression increases as the cortex develops. The 
current study has illustrated that this particular AR antibody was successful in 
locating AR positive nuclei in the developing male cerebellum (also GD 90) 
therefore it can be assumed that there was no issue with AR species reactivity. 
One explanation of why AR protein was not detected in GD 90 ovine cortex 
tissue include the gestational time point that has been examined in the current 
study is before neuronal differentiation in sheep and may be why AR positive 
pyramidal cells were not observed in the present study. Another may simply be 
that there is low AR protein expression in GD 90 ovine cortex tissue and 
therefore is below the threshold of detection, using immunohistochemistry.  
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6.3.1.2 Testosterone may be indirectly mediated by the estrogen receptor 
Shughrue et al., (1990) showed that cortical cells migrate while expressing the 
estrogen receptor (ER), so it could be suggested that testosterone acts 
indirectly by the aromatisation into estrogen and ultimately mediated through 
ER. (Nunez et al., 2003) illustrated that at PND 0, ER expression was restricted 
to pyramidal cells in layers V and VI of the cortex. At later stages of cortical 
development, ER expression occurred in the more superficial layers and not in 
the deep layers. Cortical cell migration into layers V and VI of the cortex is 
completed by PND 0, which is also when Nunez et al., (2003) detected AR 
expression in pyramidal cells. These findings suggest that during early stages of 
cortex development, testosterone effects maybe indirectly be mediated through 
ER, which could be why no AR expression was observed in the current study‟s 
cytoarchitectural investigations. However, qRT-PCR analysis demonstrated that, 
AR, ERand ERmRNA expression was detected in the cortex, but at low 
levels (CT values for each GOI was approximately 30). This suggests that the 
reason AR expression could not be detected using immunohistochemistry, is 
due to the level of expression being below the threshold detection limit for this 
technique. 
6.3.1.3 Summary 
Although Nissl staining revealed the different layers that comprise the cortex 
and neurons in the developing cortex, we could not identify pyramidal cells. This 
is because pyramidal cells were indistinguishable from granule cells. As a 
consequence, the investigation of whether the cytoarchitecture of the 
developing cortex, and in particular the pyramidal cells, was altered as a result 
of androgen exposure was abandoned. The current study has also 
demonstrated that there is no detectable AR protein expression at this particular 
time point in the gestational period of sheep. Although the cortex cannot be 
examined at the cellular level, an investigation into whether there are alterations 




6.3.2 Microarray analysis of GD 90 male ovine  cortex tissue 
6.3.2.1 Microarray validation using qRT-PCR 
Microarray analysis revealed nineteen genes had altered expression in TP-
treated GD 90 cortex tissue, when compared to the control. Fourteen of these 
genes were confirmed to be due to an androgenic effect, as they were altered 
when analyses were performed to compare TP- and DES-treated samples.  The 
remaining five genes were only altered when comparing expression levels of 
TP-treated samples with the control samples, thus, implying the genes are also 
due to an androgen-driven mechanism.  
To confirm the differential expression of genes identified by microarray analysis, 
a panel of six upregulated (five genes) and downregulated (one gene) genes 
was evaluated using qRT-PCR, as a means of microarray validation. The data 
from the microarray validation (using qRT-PCR) indicates that only one of these 
genes, COL4A2 (Figure 6.4 F), was significantly altered (upregulated) at the 
mRNA level, with a further four genes, SLIT2, POMC, ERBA-BETA1 and APP 
(Figure 6.4 A, B, C and E), revealing trends towards increases in the TP-treated 
cortex samples but no significant differences between the control and TP-
treated cortex groups. Interestingly, COL4A2 has the largest fold change for 
both microarray and qRT-PCR analysis, compared to the other GOIs. The qRT-
PCR data positively corresponds to the microarray data i.e. both techniques 
imply that these five genes are increased, significantly or not, as a response to 
prenatal androgen over-exposure. However, one gene, NPY3R (Figure 6.6 D), 
indicated a trends towards an increase in mRNA expression in the TP-treated 
samples using qRT-PCR, which is contradicting. 
6.3.2.1.2 Differences between microarray and qRT-PCR approaches 
Although both techniques measure mRNA levels of a particular sample, it is 
important to point out some of the differences between microarray and qRT-
PCR. Total RNA used in microarray experiments is subjected to an additional 
linear amplification step. This is used to amplify nanogram quantities of total 
RNA, where only small amounts of sample are available for microarray analysis 
(Jenson et al., 2003) whereas micrograms of total RNA is typically used in qRT-
pCR experiments. In addition, data normalisation fundamentally differs between 
microarray analysis and qRT-PCR, as microarray requires global normalisation, 
while qRT-PCR generally utilises the expression of one or more reference 
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genes against which all other genes are standardised to (Morey et al., 2006). 
Therefore, selection and appropriate application of normalisation criteria may 
play a major role in the differences found between these two methods. It is also 
likely that the probe and primer sequences chosen for microarray and qRT-PCR 
analysis, respectively, are not identical and therefore why we observe 
inconsistencies in the data from microarray and its validation using qRT-PCR. 
One approach to eliminate this factor would be to design primer and probe 
sequences that can be utilised in both microarray and qRT-PCR experiments. 
This would give confidence that both techniques are detecting the same fraction 
of the particular gene of interest. Investigating and quantifying protein levels 
would allow the evaluation of any alterations in protein expression of the 
aforementioned genes would also be beneficial to evaluate the functional 
consequence prenatal androgen exposure has on the translation of these genes. 
Another point to mention is that the two methods may have amplified different 
splice variants of each gene of interest. Previous literature suggests that all the 
genes of interest, SLIT2, POMC, ERBA BETA1, NPY3R, APP and COL4A2, 
have splice variants (Gupta and Pillarisetti, 1999; Karolak et al., 2011; Leder 
and Silverstein, 2006; Levy et al., 2006; Little et al., 2002; Strait et al., 1991). 
Therefore, the qRT-PCR data may not reflect the microarray analysis as the 




6.3.2.2 Microarray analysis - changes in gene expression  
The microarray data indicates that SLIT2, POMC, ERBA-BETA1, APP and 
COL4A2 genes are upregulated as a response of prenatal androgen 
overexposure (Table 6.1) whereas NPY3R was downregulated (Table 6.1). 
Here, each gene and function is briefly described (SLIT2 is discussed in greater 
detail below). 
6.3.2.2.1 ERBA BETA1 
Thyroid hormones are known to be important for optimal development of the 
human central nervous system. The thyroid hormone receptor beta1 (ERBA 
BETA1) has the ability to bind triiodothyronine (T3) with high affinity and 
specificity and has been shown to be expressed in the human developing cortex 
(Chan et al., 2002). Thyroid hormone deficiency during development results in 
multiple morphological alterations in the rat brain. These alterations include a 
decrease in dendritic spine number and reduced number and altered 
distribution of pyramidal cells of the cortex (Ruiz-Marcos et al., 1983; Schwartz, 
1983). These may be possible consequences of the up-regulation of ERBA 
BETA1 observed in the microarray data and could be established by examining 
pyramidal cell morphology by utilising histology, at a later time point, such a 
adulthood, in male ovine cortex tissue. 
6.3.2.2.2 NPY3R 
The neuropeptide Y receptor (NPY) is a 36-amino acid peptide that is widely 
distributed in the CNS. NPY stimulates food intake in sheep (Adam et al., 1997), 
modulates cognition in humans (Flood et al., 1987) and inhibits neuronal 
excitability (Colmers and Bleakman, 1994). In addition, NPY is thought to play a 
role in the pathophysiology of certain mood disorders and also in the 
mechanism of action of antidepressant drugs (Heilig et al., 1988; Wang et al., 
2013). There are 6 receptor found subtypes (NPY1R-NPY6R) and in the current 
study, NPY3R is downregulated in the TP-treated cortex samples. It has been 
proposed that NPY3R possesses a high affinity for NPY in the rat brain 
(Grundemar et al., 1991) and bovine adrenal glands (Wahlestedt et al., 1992). 
However, evidence for the existence of this subtype is circumstantial as the 
clone initially reported as the Y3 receptor (Rimland et al., 1991) does not 
actually bind NPY (Herzog et al., 1993). In fact, this clone was later found to 
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belong to the cytokine receptor family (Feng et al., 1996), and so the gene is 
also known as CXCR4. 
6.3.2.2.3 COL4A2 
Collagen type IV alpha 2 chain (COL4A2) is ubiquitously expressed in 
basement membranes during early developmental stages. (Favor et al., 2007) 
observed defects in mutant heterozygotes mice that reflect disturbances in the 
migration of neurons. They established that in the areas of defective migration, 
pseudocysts arise in the cortical plate and the neurons that normally would 
populate this area either migrate abnormally around this area, with pathological 
attachments to the arachnoid or remain trapped basal to the cyst. We have 
orbserved an upregulation of COL4A2 expression, both in microarray and qRT-
PCR, in GD 90 male ovine cortex that that been over-exposed to androgens. 
Therefore, this suggests that pyramidal cell migration is altered in these 
samples. Examining a later timepoint, such as the neonatal period, and 
investigating COL4A2 mRNA expression using qRT-PCR and pyramidal cell 
number, location and morphology using histology would aid in establishing 
dyresgulation of neuronal migration. 
6.3.2.2.4 POMC 
Proopiomelanocortin (POMC) encodes a polypeptide hormone precursor that 
undergoes extensive, tissue-specific, post-translational processing via cleavage 
by prohormone convertases (PC1 and PC2). The encoded protein is 
predominantly synthesised in corticotroph cells of the anterior pituitary and 
expressed in various brain regions. Adrenocorticotrophin (ACTH) is the only 
POMC-derived peptide with a clear action on adrenocortical function 
(Peytremann et al., 1973). Binding of ACTH induces cAMP production and 
steroidogenesis which results in the secretion of glucocorticoids, androgenic 
steroids and mineralocorticoids. The acute effect of ACTH is to increase 
conversion of cholesterol into pregnenolone, the initial step in cortisol 
biosynthesis and ultimately steroidgenesis. It has been suggested by two 
groups that PC1 deficits leads to an increase in POMC plasma levels is 
generated by highly stimulated corticotroph cells responding to the negative 
feedback loop between cortisol and ACTH the absence of PC1 disturbs POMC 
processing, which leads to striking accumulations of unprocessed POMC, and a 
significant upregulation of POMC mRNA in PC1 knockout mice (Jackson et al., 
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1997).  We have observed a similar relationship between PC1 and POMC – 
POMC gene expression is up-regulated in the TP-treated group, when 
compared to the control group whereas its precursor, PC1, gene expression is 
down-regulated in the DES-treated group, when compared to the TP-treated 
group. In other tissues, including the hypothalamus, placenta, and epithelium, 
POMC is also cleaved, giving rise to peptides with roles in melanocyte 
stimulation, and immune modulation (Cowley et al., 2001; Heijnen et al., 1987) 
Mutations in this gene have been associated with early onset obesity, adrenal 
insufficiency and red hair pigmentation (Krude et al., 1998).  
6.3.2.2.5 APP 
Amyloid beta (A4) precursor protein, transcript variant 8 (APP) encodes a cell 
surface receptor and transmembrane precursor protein that is cleaved by 
secretases to form a number of peptides. Multiple transcript variants encoding 
several different isoforms have been found for this gene. APP variants are 
highly expressed in neurons and have been localised to somata, dendrites and 
axons. APP undergoes fast axonal transport and recently all three APP variants 
have been identified as constituents of the pre-synaptic active zone of CNS 
neurons (Marcinkiewicz and Seidah, 2000). APP generates -amyloid which is 
central to the pathogenesis of Alzheimer‟s disease. Therefore, the up-regulation 
of APP gene expression, observed in the TP-treated group, implies that -
amyloid production is increased and this could be a predisposing factor of 
Alzheimer‟s disease. Alzheimer's disease, the most common type of 
progressive dementia in the elderly, is characterized by neurofibrillary tangles 
and parenchymal deposits of -amyloid (Terry and Katzman, 1983). In the 
United States of America, approximately two thirds of people with Alzheimer‟s 
disease are women (Alzheimer‟s Association, 2014). Furthermore, it has been 
suggested that APP is an androgen-induced gene that promotes proliferation 




6.3.2.3 An evaluation of the SLIT/ROBO pathway 
The most significant change in gene expression, in terms of the highest p value, 
from the microarray data was SLIT2, where we observe an increase in gene 
expression in the TP-group, when compared to the control group (Table 6.1). 
This gene‟s signalling mechanism was further investigated by examining the 
receptors which mediate SLIT2s effects - ROBO1, ROBO2 and ROBO4. qRT-
PCR was performed and the data indicated that only ROBO1 was altered at the 
mRNA level, as a response to prenatal androgen over-exposure (Figure 6.5 A).  
The SLIT/ROBO system represents an evolutionarily conserved 
chemorepulsive ligand-receptor system which is involved in axon guidance, 
axonal branching (Ozdinler and Erzurumlu, 2002; Sang et al., 2002; Wang et al., 
1999) and regulation of neural cell migration (Hu, 1999; Yuan et al., 1999). In 
vertebrates, three Slit homologs are known (SLIT1, SLIT2, SLIT3), The Robo 
family of transmembrane receptors encompasses four members in vertebrates - 
ROBO1, ROBO2, ROBO3 and ROBO4 (Mertsch et al., 2008). SLIT2 is thought 
to act as molecular guidance cue in cellular migration and its function appears 
to be mediated by interaction with roundabout homolog receptors (Ghose and 
Van Vactor, 2002). During neural development, SLIT2 is involved in axonal 
navigation at the ventral midline of the neural tube and projection of axons to 
different regions and further plays a role in the branching and arborization of 
CNS sensory axons (Dickson and Gilestro, 2006).  
Previous literature emphasises that a lack of expression of these two genes 
influences neurogenesis; but there appears to be no evidence for how an 
upregulation of SLIT2 and/or ROBO1 may shape cortical development. For 
example, the absence of ROBO1 leads to premature migration of interneurons 
to the cortex in ROBO1 knockout mice (Andrews et al., 2008) and evidence has 
further suggested that ROBO1 and SLIT2 signalling plays a role in the 
morphological differentiation of neurons of the forebrain (Andrews et al., 2008). 
In a similar study to that of the current one, Hogg et al., (2011) demonstrated no 
difference in SLIT2 mRNA expression between GD 70 ovine control and TP-
treated ovary samples, which were over-exposed to TP in utero, which implies 
that SLIT2 is not regulated by androgens in the ovary. This finding contradicts 
with our results, however this could be due to the earlier gestational period (GD 
70 as opposed to GD 90 in the present study) or simply that the ovine central 
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nervous system differs in the mechanism for the regulation of SLIT2, compared 





The developing ovine cortex is an androgen target tissue, which, if exposed to 
excess androgens, shows dysregulated gene expression of genes involved in 
diverse developmental functions such as cellular/neuronal migration, 
steroidogenesis, endocrine disruption and neurodegenerational disease, The 
altered genes of the ovine cortex, which were established by microarray 
analysis, need to be examined at the protein level, by means of protein 
quantification, in order to determine whether the changes observed at the 
mRNA level, are reflected at a functional level. SLIT2, ERBA-BETA1 and 
COL4A2 are genes that encode for proteins that are implicated in neuronal 
migration, synaptogenesis and differentiation. The genes, NPY3R, POMC and 
APP are associated with a variety of functions in the developing brain including 
appetite, steroidogenesis and neurodegenerative disorders. The altered mRNA 
levels observed for these genes would imply that these aformentioned 
processes are affected by androgens. The relationship between the 
upregulation of SLIT2 and ROBO1, needs to be established, in terms of any 
structural effects on the developing ovine male cortex. Another ROBO receptor 
that mediates SLIT2 signalling is ROBO3, whose interactions are also 
associated with neuronal migration (Barber et al., 2009). It would be interesting 
to examine ROBO3 in order to determine whether this ROBO isoform is altered 
at the mRNA level as a result of prenatal androgen overexposure as this was 
not investigated in the current study due to primer set availability.   
The validation of microarray needs to be reassessed by the production of primer 
sequences that are identical to the probe sequences used, in order to determine 
whether the significant changes in gene expression found through microarray 
analysis are truly altered at the mRNA level. Furthermore, an investigation 
should be carried to evaluate whether there are any alterations in the 
cytoarchitecture of the cortex. This could be achieved by utilising Golgi staining, 
optimising the immunohistochemistry protocols already identified in this chapter 
and the visualisation of such work by using an electron microscope. It would 
also be interesting to examine ovine cortex tissue at a later gestational time 
point through to adulthood, to determine whether the changes observed at the 
mRNA level at GD 90 remains throughout life. Due to time constraints, these 
options were not fully explored. It would have been interesting to be able to 
quantify and compare protein expression between the control and TP-treated 
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sample, in order to determine if the same result i.e. upregulation of these genes, 
is reflected at the functional protein level. 
The prefrontal cortex is known to play a pivotal role in cognitive function, 
personality expression, decision making, moderating social behavior and 
executive function (Fuster, 1997). Therefore examining the cognitive function of 
sheep from lambs into adulthood would give new insight in to whether prenatal 
androgen over-exposure has an impact on this cognitive ability. This could be 
achieved by a battery of tests that examine executive and cognitive function, 
such as discrimination and reversal learning, attentional set shifting and intra- 
and extradimensional set shifting tasks. These tests have already been 
assessed in sheep and it was concluded that sheep can not only perform these 


















7. General Discussion 
7.1 Summary  
Steroids exert effects on the nervous system and play a major role in the 
development of the CNS, e.g. in the hypothalamus and pituitary gland. These 
brain areas are involved in sexual behaviour and have been the focus of most 
neuroendocrine studies to date. However it is known that other areas of the 
brain, e.g. the cerebellum and cortex, express those proteins necessary for 
local steroidogenesis and steroid signalling (Baulieu, 1998) however the impact 
of steroids on cerebellar and cortex development has yet to be investigated.  
7.1.1 Methods 
We utilised a fetal programming model whereby ovine fetuses were subjected to 
an ultrasound-guided intraperitoneal 20mg injection of TP or sham (vegetable 
oil vehicle) at GD 62 and repeated at GD 82.  The fetuses were sacrificed at GD 
90 and their brain tissue was dissected. The brain was bisected along the 
midline and one hemisphere and half of the cerebellum stored in neutral 
buffered formalin. The other hemisphere cerebellum, hippocampus and 
prefrontal cortex was frozen on dry ice before being stored at -80oC. 
7.1.2 The cerebellum 
Total RNA and cDNA was isolated from the frozen fetal ovine cerebellar tissue. 
The expression of a panel of genes of interest, including genes that are 
responsible for steroidogenesis and steroid signalling, was measured using 
quantitative polymerase chain reaction (qRT-PCR). Using the CT method, a 
decreased mRNA expression of Steroidogenic acute regulatory (StAR, p value 
= 0.0264) and an increased mRNA expression of progesterone receptor (PR, p 
= 0.0341) was observed in the TP-treated group. There were also trends 
towards alterations in mRNA expression for several other genes; SRD5a1, 
SRD5a2, ER and GFAP observed between the control and TP-treated groups 
(an increase in SRD5a1 mRNA expression p= 0.0770; a decrease in SRD5a2 
expression p=0.0986; decreased ER mRNA expression, p = 0.0721 and 
increased GFAP expression, p = 0.0641).   
The cerebella that were stored in neutral formalin buffer were used for 
immunohistochemical analyses, in order to determine whether the number of 
Purkinje cells that express particular steroid proteins are altered due to prenatal 
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androgen exposure. Using light microscopy, Purkinje cells were counted 
(positive cells/mm2), data from treated and control groups were compared using 
statistical analysis. This revealed an increase in the number of cells which 
express of StAR, PR, SRD5a1 and SRD5a2 (p = 0.0002, 0.0201, 0.0001 and 
0.0001, respectively) in the TP-treated group. Using calbindin, a Purkinje cell 
marker, an increase in positive Purkinje cells/mm2 (p = 0.0008), a reduction in 
Purkinje soma size (p = 0.0328), increased Purkinje cell layer width (p = 0.0002) 
and that the Purkinje cells were arranged in clusters, as opposed to the typical 
monolayer usually observed (p = < 0.0001) were also observed.  
7.1.3 The cortex 
Total RNA and was isolated from the frozen fetal ovine cortex tissue from both 
the control and TP-treated groups (n=6). The concentration of each RNA 
sample was measured using a spectrophotometer. These samples were sent to 
Oxford Gene Technology (Oxford, U.K.) where microarray analysis was 
performed in order to detect differences in gene expression between the control 
and TP-treated groups. From the 15 000 genes that were analysed on the 
Agilent sheep transcriptome wide microarray (AGEOD-10778), 19 genes had 
altered gene expression in the TP-treated cortex samples. To confirm the 
differential expression of genes identified by microarray analysis, a panel of six 
genes (five upregulated and one downregulated) was evaluated using qRT-
PCR, as a means of microarray validation. The data from the microarray 
validation (using qRT-PCR) indicates that only one of these genes, COL4A2, 
was significantly altered (upregulated) at the mRNA level, with a further four 
genes, SLIT2, POMC, ERBA-BETA1 and APP, revealing trends towards 
increases in the TP-treated cortex samples but no significant differences 
between the control and TP-treated cortex groups. The qRT-PCR data 
positively corresponds to the microarray data i.e. both techniques imply that 
these five genes are increased, significantly or not, as a response to prenatal 
androgen over-exposure. However, for one gene, NPY3R, we identified a trend 
towards an increase in mRNA expression in the TP-treated samples using qRT-
PCR, whereas the microarray analysis indicated a significant downregulation of 
this gene and therefore, both data obtained contradict one another. 
Nissl staining revealed neurons in the developing cortex, however, pyramidal 
cells were not identified. The cortex tissue that was stored in neutral formalin 
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buffer were used for histological analyses, in order to determine whether the 
number, size and location of Pyramidal cells are altered due to prenatal 
androgen exposure. The different layers that comprise the cortex were 
ascertained, however, the migration of the layers seem immature. This finding 
suggested that the development of the cortex of GD 90 sheep was still at a very 
early stage. This may be why pyramidal cells were indistinguishable from 
granule cells. As a consequence, the investigation of whether the 
cytoarchitecture of the developing cortex was altered as a result of androgen 
exposure was abandoned. The current study has also demonstrated that there 
is no detectable AR protein expression at this particular time point (GD 90) in 
the gestational period of sheep.  
7.1.4 Summary of results 
The results observed throughout this thesis provide strong evidence that 
prenatal androgen over-exposure leads to delayed development of the ovine 
cerebellum and cortex. Specifically, we have demonstrated dyresregulated 
cerebellar Purkinje cell development in terms of number and morphology which 
suggests immaturity of the cerebellum. Altered cortical gene expression for 
genes associated in neuronal migration, synaptogenesis and differentiation was 
observed, thus indicating that the cortical development is also effected by TP 
administration. Further investigation into gene expression of these genes in the 
cerebellum using qRT-PCR; and immunohistochemical analysis in cortical 
tissue in order to determine pyramidal cell number and morphology would 
provide additional insight into the delayed brain development and immaturity of 
neurons already observed. 
Furthermore, genes which are associated with steroidogenesis have altered 
expression levels in the ovine cerebellum. In the cortex, changes in the level 
gene expression of a variety of functions including appetite, steroidogenesis 
and neurodegenerative disorders were also observed. The altered mRNA levels 
detected for these genes would imply that these aformentioned processes are 




7.2 Limitations in methodology 
7.2.1 Sample availability 
In general, it is acknowledged that sample numbers (n=4) were low in the 
current study, which may lead to under powering of the analyses. This was due 
to limited sample availability. It would have been ideal if more samples were 
obtained, in order to observe whether the alterations in gene expression reflect 
the bigger population. More samples would have also allowed for steroid assays, 
such as pregnenolone and progesterone, to be performed so that levels of 
these steroids could be determined. This would have provided more insight into 
the mechanisms of the regulation of StAR and PR genes. 
7.2.2 Protein expression 
It is of importance to evaluate whether the changes observed at the mRNA level 
are also reflected in the functional product i.e. protein level. Western blotting 
would enable the protein product to be quantified and the results from control 
and TP-treated sample could be compared. Due to limited sample size, protein 
extraction was attempted on the by-product of RNA isolation from the samples. 
This method of protein extraction, although published by Hummon et al., (2007), 
was deemed unsuitable as it resulted in poor quality protein thus, several 
proteins of interest could not be measured using Western blotting.  
The quantification of protein would have helped to identify whether changes at 
mRNA level are reflected in the functional product. Therefore at present, little is 
known about the functional consequences of the alterations observed at the 
mRNA level as a result of prenatal androgen over-exposure. Future studies 
should try and resolve the fundamental question of whether excess androgens 





7.3 Androgenic or estrogenic effect?  
Testosterone can be metabolised into estradiol (by the action of aromatase) and 
into DHT (by the action of 5-reductase), a non-aromatisable androgen with a 
high affinity to AR. Therefore, it should be determined whether the changes 
observed in the developing male ovine cerebellum and cortex are due to a 
direct androgen effect or an indirect estrogen effect.  
There is potential for the placental aromatisation of testosterone into estrogenic 
metabolites. Therefore, to define the effects of both sex hormones, fetal male 
sheep were directly injected with either TP or the potent estradiol receptor 
agonist, diethylstilbestrol (DES). We did investigate whether the observed 
alterations in cerebellar mRNA expression were due to an androgenic or 
estrogenic effect. The present study has examined DES-treated GD 90 male 
ovine cerebellar samples and compared gene expression levels for StAR, PR, 
SRD5a1 and SRD5a2 to the control samples. The results confirmed that the 
mRNA expression alterations seen for STAR, PR, SRD5a1 and SRD5a2 in the 
cerebellar TP-treated group are due to an androgen effect rather than an 
estrogen one. Therefore, an androgen-dependent mechanism is driving the 
changes observed at the mRNA level. The DES-treated samples should be 
further explored at the gene and protein level by utilising qRT-PCR and Western 
blotting in order to determine whether any of the observed changes are driven 
by an estrogenic effect. 
The current study has also established that the observed change in Purkinje cell 
number is due to a direct androgen effect on these cells as there was no 
significant change in the number of Purkinje cells in the DES-treated group, 
when compared to the control group. One observation from examining the DES-
treated GD 90 male ovine cerebellar tissue was that some of the random field 
views appeared to have the typical Purkinje cell monolayer, a sign of maturation 
whereas as others had several rows of Purkinje cells, which indicates 
immaturity. This implies that the Purkinje cell development seems to fall 
between the typical development observed in the control group, and the 
dysregulated development detected in the TP-treated group. Another 
observation is that the Purkinje cell typical shape, large and triangular soma, is 
prominently displayed in the DES-treated samples and these cells appear even 
more mature than the control samples. Estrogen has been shown to promote 
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the development and survival of Purkinje cells in rats (Sakamoto, et al., 2003), 
therefore the observed alterations may be due to estrogen over-exposure. The 
analysis of Purkinje and Pyramidal cell length from both cerebellar and cortical 
tissue from control and DES-treated samples would give insight into the 
observed morphological changes in cytoarchitecture.  
There appears to be hypervariance at both the mRNA level and Purkinje cell 
numbers amongst the DES-treated cerebellar samples. As discussed previously, 
the RNA isolation was performed by a student and therefore, the high variance 
was deemed to be due to inexperience and inconsistency. However, 
immunohistochemical analyses was performed by the experienced author and 
therefore, would suggest that manual error may not be the cause of 
hypervarience but down to natural causes. 
7.3.1 Examining androgen receptor activity to confirm whether TP effect is 
indeed mediated by androgen 
Examining fetal male sheep that were directly exposed to dihydrotestosterone 
(DHT) would also help identify whether the changes observed in the TP-treated 
samples were indeed an androgenic effect. If the DHT-treated samples showed 
similar significant changes, when compared to the control group, as the TP-
treated group did, then it could be conluded that androgen is directly generating 
alterations at the gene and protein level.  
Investigating whether the inhibition of androgen receptor activity by flutamide, 
an AR antagonist, or whether DHT affects StAR or PR mRNA expression would 
allow us to confirm whether it is indeed a direct effect of TP that has altered 
STAR and PR mRNA expression in the current study. This could be achieved 
by treating cultured primary Purkinje cells with TP or DHT in the presence and 
absence of flutamide and measuring downstream StAR and PR mRNA 
expression by means of qRT-PCR. If the TP and DHT treated cells both had 
significant differences in gene expression, compared to the control, then this 
would confirm that it is indeed an androgen effect. Alternatively, if cells treated 
with DHT showed no alterations at the mRNA level and the one treated with TP 
did, then the observed changes are most likely due to the mediating of 
testosterone into estrogen, thus an indirect effect of androgens. However, there 
was an issue with the DHT-treated cohort of animals which prevented the use of 
them and therefore these samples were not investigated. In short, our 
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collaborators at The University of Edinburgh were unable to verify any DHT 
treatment in positive control experiments. 
7.3.2 Lack of androgen receptors in the cortex 
The present study revealed that AR protein expression was not found in GD 90 
male ovine cortex tissue using immunohistochemistry. However, we have 
observed changes in gene expression due to androgen over-exposure. These 
changes therefore may have been mediated by the aromatisation of androgen 
into estrogen which then acted on estrogen receptors. By utilising qRT-PCR 
analysis, AR, ERand ER mRNA expression was detected in the cortex, but 
at low levels (CT values for each GOI was approximately 30). Conversely, the 
mRNA expression of these genes in the cerebellum appears to be higher with 
CT values ranging from 27-28 (AR), 19-24 (ER) and 25-27 (ER).  This 
suggests that the reason AR expression could not be detected using 
immunohistochemistry, is due to the level of expression being below the 
threshold detection limit for this technique. Therefore, we cannot rule out that 
the gene expression alterations observed in GD 90 male ovine cortical tissue, 
by utilising microarray analysis, are driven by an androgen-dependent 
mechanism. 
Future experiments should include exploring estrogen receptor localisation in 
the cortex by utilising immunohistochemistry to determine whether it is possible 
for androgens to be mediated by this mechanism. Another possible explanation 
is that immunohistochemistry analysis was unable to detect any AR protein as 
the level of expression was below the threshold of detection, as mRNA levels 




7.4 The consequences of prenatal androgen over-exposure 
7.4.1 The cerebellum  
Cerebellar Purkinje cells are a major site of neurosteroid formation  (Tsutsui et 
al., 2003), implying that these cells may be affected by developmental androgen 
exposure. The cerebellum has a clear developmental pathway and an 
established cytoarchitecture that has enabled us to more easily identify effects 
of TP treatment on the development of the brain. How cerebellar gene 
expression is affected by androgen exposure during development - and how 
this subsequently changes the brain‟s cytoarchitecture and function was 
investigated. 
7.4.1.1 Structural cerebellar alterations 
The current study has illustrated how excess prenatal androgen dysregulates 
cerebellar Purkinje cell development. How this occurs still remains unclear. As a 
result of prenatal androgen over-exposure, we have observed that Purkinje cells 
are smaller, rounder, more numerous, clustered together and appear to display 
an underdeveloped dendritic network. It appears that these findings may imply 
delayed Purkinje cell development, as Rees and Harding (1997) demonstrated 
similar findings in sheep (untreated, control group) of an earlier gestational 
period that the one used in the current study. The way in which androgen 
dyresgulates development should be examined, by evaluating signalling 
pathways and Purkinje cell arrester genes, such as GAS7 (Ju et al., 1998). 
COL4A2 gene expression was up-regulated in GD 90 male ovine cortical tissue 
that was exposed to excess androgens. This gene encodes for a protein that is 
implicated in neuronal migration (Favor et al., 2007) and should be investigated 
in the developing cerebellum to determine whether this gene is altered, by 
utilising qRT-PCR analysis, in the same manner as it is in the cortex. This may 
aid in establishing a mechanism by which Purkinje cell development is 
dysregulated due to androgen over-exposure. The migration of Purkinje cells is 
also regulated by factors secreted from the EGL, such as Reelin (Jensen et al., 
2002). The current study has examined RELN mRNA levels, using qRT-PCR, 
and saw no changes in expression between the control and TP-treated groups. 
This suggests that the Purkinje cell dysregulation that is observed as a result on 
androgen over-exposure does not involve RELN.  
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There is little literature on the effects of androgens on Purkinje cell development. 
Zhang et al., (2000) revealed that testosterone administration decreased 
differentiated cell number in cultured cerebellar neurons from GD 14 rats. The 
current study confirms this. Previous studies have shown that estrogen and 
progesterone are implicated in facilitating cerebellar Purkinje cell dendritic 
growth in neonatal rats, however soma diameter is not influenced by these 
steroids (Sakomoto et al., 2003; 2001). This suggests that in our study, dendritic 
growth has been dampened by a reduction of estrogen and/or progesterone. 
We have observed that PR gene expression is upregulated in the TP-treated 
samples which could be the result of low progesterone levels and therefore 
would support this theory. The measurement of progesterone levels and the 
dendritic networks and spines in the control and TP-treated groups and 
comparing them would establish whether there is a significant difference in the 




7.4.2 The cortex 
Grobin et al., (2003) demonstrated that developing rat forebrain neurons are 
sensitive to perturbation by neuroactive steroids. Pyramidal cells are the output 
neurons of the cerebrum (Elston, 2003), and so transmit signals to other parts 
of the CNS. There is substantial literature that illustrates that stress hormones, 
such as glucocorticoids, are associated with increased risk in illness and 
changes in cognition. Furthermore, anomalies in the cortex, genetic or 
structurally, have been implicated in several mental health disorders such as 
schizophrenia. For instance, stressful life events appear to increase the 
probability of a psychotic episode in schizophrenics (Ventura et al., 1989). 
Therefore, we wanted to examine whether androgen, a male sex hormone, 
would alter gene expression or cause structural affects in GD 90 male ovine 
cortex tissue. This was investigated by means of microarray analysis and 
histology. 
7.4.2.1 Microarray validation 
qRT-PCR was utilised as the preferred microarray validation method in the 
present study. However, only one gene of interest, COL4A2, was validated 
using this method. This gene had the largest fold change in both the microarray 
and qRT-PCR analysis and so it is possible that the issue with microarray 
validation is due to sensitivity and that qRT-PCR as a technique, was only 
sensitive enough to confirm alterations in gene expression for COL4A2. 
Therefore, as extensively discussed in Chapter 6, further work should be 
performed in order to re-attempt to validate the microarray results, such as the 
re-designing of primers. Nineteen genes were revealed to be altered as a result 
of prenatal androgen excess and from this, a panel of six genes were utilised for 
the validation. The other thirteen altered genes should also be examined by 
qRT-PCR in order to validate the microarray data. 
7.4.2.2 Gene expression alterations 
For the cerebellar samples, genes of interest were specifically chosen and 
investigated using qRT-PCR, as these genes had either been affected in other 
tissues after androgen exposure or the genes were vital in androgen 
metabolism and ultimately the steroid signalling pathway. In contrast, 
microarray analysis was performed on the cortex samples which allowed 15 000 
genes to be evaluated. Although both techniques measure mRNA levels of a 
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particular sample, it is important to point out some of the differences between 
microarray and qRT-PCR. It is interesting to note that the observed gene 
alterations in the cerebellar samples by qRT-PCR were not detected in the 
cortex tissue samples by microarray analysis. This demonstrates that 
androgens affect brain development in a region-specific manner. There were 
also differences in methodology when evaluating the two regions, therefore, 
selection and appropriate application of normalisation criteria may also play a 
major role in the differences found between these two methods.  
7.4.2.3 Establishing whether cytoarchitectural alterations are observed in 
the cortex 
The present study was unable to determine whether prenatal androgen 
exposure affects the cytoarchitecture of GD 90 male ovine cortex. This was 
mainly because pyramidal cells were indistinguishable from granule cells and 
the six layers that comprise of the cortex could not be differentiated enough to 
confidently measure each layer and then compare the results from the control 
and TP-treated groups. The pyramidal cells were being examined in further 
detail because these neurons are the primary output of the cortex and therefore 
have similar function to cerebellar Purkinje cells, which were altered in a variety 
of ways in the TP-treated group. Therefore, it was hypothesised that prenatal 
androgen exposure would alter pyramidal cell development. 
Immunohistochemistry and Nissl staining were utilised in the present study but 
with hindsight, perhaps Golgi staining would have been beneficial in helping 






7.5 Plasticity during development 
Developmental plasticity involves alterations to the projected development of a 
fetus as an adaptive response from insults to which they are exposed. Such 
adaptation during development may potentially modify the adult phenotype and 
predispose to diseases such as cardiovascular, metabolic, and neuroendocrine 
anomalies. The reproductive system is also acutely sensitive to the nutritional 
and hormonal milieus, which have been shown to induce phenotypic and 
functional changes. Connelly et al., (2013) demonstrated that androgen over-
exposure via fetal injection at GD 62 and 82 (the same conditions as the current 
study) resulted in altered cellular distribution in the testis. Furthermore, sons 
born to mothers with PCOS were found to have an increase in anti-Müllerian 
hormone (AMH) levels during infancy and childhood, which may indicate an 
increase Sertoli cell number or function. This suggests that exposure to 
androgens during fetal life can induce a permanent, functional effect on 
testicular physiology and it appears from these studies that such effects are 
likely to be dependent upon the timing of initial exposure to excess testosterone.  
In the brain, plasticity changes are not all permanent and can change 
dramatically over time. When rats are placed in complex environments, there is 
a transient increase in dendritic length in the prefrontal cortex that can be seen 
after four days of complex housing, but this change disappears after 14 days. In 
contrast, there are no obvious changes in the sensory cortex after four days but 
clear, and seemingly permanent, changes after 14 days (Comeau et al., 2010). 
The possibility that there are different chronic and transient experience-
dependent changes in cerebral neurons is consistent with genetic studies 
showing that there are different genes expressed acutely and chronically in 
response to complex environments (Rampon et al., 2000). The difference in 
how transient and persistent changes in neuronal networks relate to behavior is 
unknown. The observed changes in the current study show dysregulated 
cerebellar development in fetal male ovine, as a result of androgen exposure. 





7.6 Delayed cerebellar development in other models 
Some chemical pollutants have the ability to act as hormone mimics. Because 
of a structural similarity with endogenous hormones, an ability to interact with 
hormone transport proteins, or an ability to disrupt hormone metabolism, these 
chemicals have the potential to imitate or block the effects of the endogenous 
hormone (Kimura-Kuroda et al., 2007). These chemicals serve to disrupt the 
normal actions of endogenous hormones and thus have become known as 
“endocrine disruptors.” Because hormonally mediated events play a central role 
in CNS development and function, there is speculation that some of the 
cognitive deficits that arise from developmental exposure to environmental 
chemicals, and ultimately disrupted development, may be the result of 
endocrine disruption (Nishihara, et al., 2003).  Here, several different disruptors 
to Purkinje cells development are discussed. 
 
7.6.1 Thyroid homone 
Thyroid hormones (TH) promote the differentiation and growth of the Purkinje 
cell dendritic tree through the activation of the nuclear thyroid hormone 
receptors, TRα1 and TR1, and synapse formation (Boukhtouche et al., 2010). 
A deficiency of thyroid hormones during development in humans causes 
cretinism which, among other abnormalities, is characterised by severe mental 
retardation. Rabie et al., (1986) demonstrated that hypothyroidism during 
development can compromise the development of neurons. In cerebellar 
Purkinje cells of neonatal hypothyroid rats, there was a substantial delay and a 
permanent reduction of the size and branching of the Purkinje cell dendritic tree 
(Vincent et al., 1982) going together with a reduction in the number of synapses 
in the molecular layer (Lauder, 1978; Nicholson and Altman, 1972). In the 
current study, we have identified through microarray analysis that ERBA BETA1, 
the gene that encodes for TR1, is upregulated in GD 90 male ovine cortical 
tissue as a result of androgen over-exposure. It would be interesting to measure 
ERBA BETA1 gene expression levels by qRT-PCR in the developing 
cerebellum in order to determine whether any changes in expression may 





7.6.2 Biphenyls  
Biphenyls are organic compounds that are mainly utilised in the chemical 
industry, in the manufacture of textiles and dyes and of other chemicals. The 
are also used as a heat transfer agents to produce polychlorinated biphenyls 
(PCBs). However, these compounds are also toxic environmental pollutants 
which tend to accumulate in animal tissues and go on to cause detrimental 
effects for the animal (Ness et al., 1993). Kimura-Kuroda et al., (2002) 
demonstrated that endocrine disruptors, PCBs and hydroxy-PCB (OH-PCB) 
metabolites suppress the thyroid hormone (TH)-dependent dendritic 
development of Purkinje cells in mouse cell cultures. T4+ and the addition of 
endocrine disrupters inhibited dendritic development in mouse cerebellar cell 
cultures. The Purkinje cells displayed developed abnormally shaped dendrites. 
Dendrites developed in  the absence of T4 (T4-) but treated with a particular 
PCB metabolite, were immature forms similar to those in vivo, i.e. lack a primary 
thick shaft and have only thin branches directly coming from the soma.  
Bisphenol A (BPA) significantly inhibited the dendritic development of Purkinje 
cells in T4+. Therefore, this insult may disrupt normal brain development by 
both growth inhibitory and promoting effects. The literature discussed in this 
section points to the findings that thyroid hormone signalling is important to 
normal cerebellar development. Therefore, future experiments should involve 
examining thyroid hormone levels using radioimmunoassay and thyroid receptor 
gene expression levels and protein expression using qRT-PCR and 
immunohistochemistry, respectively, in GD 90 male ovine cerebellar tissue. It 
could be that our findings pose a similar mechanism to the findings of Kimura-
Kuroda et al., (2002) and that any type of insult, e.g. PCB exposure, steroid 
over-exposure or hypoxia, can have detrimental consequences to cerebellar 
development and ultimately motor and cognitive function. 
7.6.3 SRC-1 
SRC-1 is a nuclear receptor coactivator that plays a key role in tranactivation of 
steroid hormone receptors (Sheppard et al., 2001). Disruption of the SRC-1 
gene in mice delays the generation of Purkinje cell precursors at an early 
embryonic stage and further delays the maturation of Purkinje cells after birth. 
Nishihara et al., (2003) compared the brain function of SRC-1-/- mice with age-
matched WT mice using a battery of well established behaviour tests. The 
results suggested that SRC-1-/- mice may have a dysfunction of motor strength, 
230 
 
motor learning and the motor performance are partially impaired, Motor learning 
tasks are mediated by Purkinje cells in the cerebellum and are frequently 
implicated in altered function of Purkinje cells (Linden, 1994; Raymond and 
Lisberger, 1996). The morphology of SRC-1-/- Purkinje cells developed to the 
same extent as WT Purkinje cells by PND 10, adult SRC-1-/- mice exhibited 
moderate motor dysfunction, suggesting that the abnormal development of 
Purkinje cells at early stage may have a negative impact on the cerebellar 
function in adulthood. SRC-1 should be examined at the mRNA level using 
qRT-PCR in order to determine any changes between the control and TP-
treated groups and therefore establish whether this gene is involved in the 
dysregulated Purkinje cell development, observed in the TP-treated samples. 
7.6.4 Vulnerability during cerebellar development  
The literature as well as the results from the present study, indicate that 
cerebellar development is a critically vulnerable period and an array of insults 
can affect the morphology of the cerebellum that can have consequences for 
later life. What needs to be established is whether the insult inflicted on the 
fetally-injected ovine model used in the present study (TP administration) 
mirrors the cognitive deficits observed for other endocrine disruptors. To assess 
the role of androgen over-exposure in cerebellar function, a battery of 
behavioural tests should be performed to compare specific neural functions 
between the control and TP-treated groups. Motor coordination, strength, and 
balance could be assessed. Tests that examine executive and cognitive 
function, such as discrimination and reversal learning, attentional set shifting 
and intra- and extradimensional set shifting tasks could also be performed. 
These tests have already been assessed in sheep and it was concluded that 
sheep can not only perform these tasks but also display executive and cognitive 
function (Mortan and Avanzo, 2011). Futher histological examination at later 
timepoints i.e. neonatal, pre and post-pubertal would also ascertain whether the 
delayed cerebellar development observed reaches the typical cytoarchitecture 




7.7 Are the observed changes carried on in later life – the effect of 
disruption during cerebellar development 
The observed findings of altered cerebellar cytoarchitecture due to androgen 
over-exposure have brought further questions that need to be answered. One in 
particular is whether delayed development reaches the typical cerebellar 
cytoarchitecture at a later stage. Examining ovine cerebellar samples from a 
later gestational period, postnatally and into adulthood would give insight into 
this. The literature indeeds supports this conclusion as this delayed 
development is observed in autism (Bauman and Kemper 1985 and 1993; Ritvo 
et al., 1986; Fehlow et al., 1993), schizophrenia (Reyes and Gordon, 1981; 
Ritvo et al., 1998) and thyroid deficiency (Vincent et al., 1983; Kimura-Kuroda et 
al., 2002). 
From alterations at the mRNA level for genes involved in steroid signalling to 
changes to the cerebellar cytoarchitecture, the current study has demonstrated 
the vast effects that prenatal androgen over-exposure has on male ovine 
cerebellar development. What these changes during ovine mid-gestation mean 
for future life, in terms of development and cognitive function, still remain 
unclear, however this study has gained further insight and focus for further 
investigation.  
What needs to be established are the functional consequences of the changes 
observed in the current study and whether they are detrimental to the typical 
role of the cerebellum in later life. These findings indicate the delayed 
development and migratory pattern of Purkinje cells as a consequence of 
androgen exposure. Therefore, we have established the structural effects of 
developmental hormone treatment on the cerebellum. Whether this has an 
impact on motor and/or cognitive function in later life remains unclear. If 
cerebellar development never catches up then this may pose detrimental 
consequences on cognitive and/or motor function as the cerebellum plays a 
vital role in these areas. Behavioural studies would establish whether higher 
function is affected as a result from androgen over-exposure. 
Gene and protein expression, the cytoarchitecture and motor/cognitive function 
(by utilising behavioural studies aforementioned previously) should be 
examined in samples from late gestation, the neonatal, pre and post pubertal 
periods and adulthood. This would help identify whether the early insult of 
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excess androgen exposure in utero completely reconfigures the developed 
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